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The Road goes ever on and on 
Down from the door where it began. 
Now far ahead the Road has gone, 
And I must follow, if I can. 
- J.R.R. Tolkien, The Fellowship of the Ring 
  
iv 
 
 
 
 
 
 
 
 
 
v 
ABSTRACT 
Periprosthetic joint infection (PJI) is a disastrous complication of joint replacement 
surgery, and approximately 1–2% of replaced joints become infected over the years. 
PJIs are associated with increased morbidity and mortality and treatment is costly. 
Because of this, PJIs are part of most surgical site infection surveillance programs 
and considerable efforts are made to prevent them. Nevertheless, there is still no 
uniform definition for PJI and existing definitions are based on a varied level of 
evidence. In addition, the usefulness of some of the methods used to prevent PJIs, 
such as screening for preoperative bacteriuria, has been questioned. On the other 
hand, there is a continuing search to identify new methods to prevent PJIs. 
PJIs can be classified based on their timing with respect to previous surgery into 
early, delayed and late infections. Most of the late infections are hematogenous in 
origin, even though hematogenous PJIs can occur any time after surgery. Previous 
studies have shown that approximately one third of patients with Staphylococcus aureus 
bacteremia and a joint replacement develop a PJI, but little is known about the risk 
for other pathogens. Furthermore, the risk factors for developing a PJI during 
bacteremia are not known. 
The present study examines two different diagnostic criteria sets used to identify 
PJIs and potential risk factors and ways of preventing PJIs, with an added emphasis 
on hematogenous PJIs. Data sources to identify PJIs were microbiological results, 
hospital discharge records and revision surgeries done because of an infection and 
the hospital’s own infection records, in addition to prospectively collected infection 
surveillance data. Multiple data sources were used to identify PJIs as extensively as 
possible, especially late PJIs that are not identified by routine infection surveillance. 
In a one-year follow-up after primary hip or knee replacement surgery, the 
incidence of PJI was 0.68% (158/23 171). The incidence was lower for hip 
replacements than for knee replacements: 0.57% vs. 0.77%. In the longer follow-up 
period (up to 12 years) the incidence of PJI after primary joint replacement surgery 
was 1.50% and the incidence rate was 3.3 per 1000 person-years. 
Of the identified 405 PJI cases that met either one or both of the diagnostic 
criteria sets for PJI, 73 (18%) of the patients fulfilled only the older criteria, whereas 
only one (0.2%) fulfilled only the new criteria. Both sets of criteria were met by 331 
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(82%) of the patients. The diagnosis of PJI was based only on the clinician’s opinion 
in 39 (53%) of the cases not meeting the new criteria set. 
Of the previously reported risk factors for PJI, male gender (OR 2.21, 95% CI 
1.56–3.11), knee replacement (OR 1.43, 95% CI 1.01–2.04) and older age (OR 1.03, 
95% CI 1.01–1.05) were associated with an increased risk for PJI in a multivariable 
analysis, and the effect of diabetes was also almost statistically significant (OR 1.64, 
95% CI 0.99–2.73).  
On the other hand, preoperative bacteriuria was not associated with an increased 
risk for PJI in the univariate (OR 0.72, 95% CI 0.34–1.54) or multivariable analysis 
(OR 0.82, 95% CI 0.38–1.77). Furthermore, there was no correlation between the 
pathogens identified in the preoperative urine culture and those causing the PJIs, 
and treating the bacteriuria with effective antibiotics did not decrease the risk for 
developing a PJI (OR 0.62, 95% CI 0.07–5.14). Instead, the overall use of oral 
antibiotics preoperatively was associated with a decreased risk for developing a PJI 
(OR 0.40, 95% CI 0.22–0.73). In addition, the use of preoperative oral antibiotics 
was common, with 4106 (18%) joint replacement operations preceded by one or 
more courses of antibiotics. 
During the follow-up of up to 12 years, 542 patients with a joint replacement (out 
of 14 378, 3.8%) developed at least one episode of bacteremia and 85 patients had 
multiple bacteremias. In total, there were 643 episodes of bacteremia. The most 
common pathogen causing the bacteremias was Escherichia coli (241/643, 37%). A 
PJI as a consequence of bacteremia developed in 7.2% of the bacteremias (46/643). 
This was most common for beta-hemolytic streptococci (21%, 12/58), S.aureus 
(20%, 21/105) and viridans group streptococci (16%, 4/25), but rare for gram-
negative bacteria (1.3%, 4/314). There were no PJIs related to bacteremias caused 
by coagulase-negative staphylococci. Multiple bacteremias increased the risk for 
developing a PJI during bacteremia (OR 2.29, 95% CI 1.17–4.50) and the highest 
risk was for bacteremias occurring within one year from previous surgery. On the 
other hand, chronic diseases or other patient related factors did not influence the 
risk of developing a PJI as a consequence of bacteremia. 
In conclusion, the different diagnostic criteria used to identify PJIs, especially in 
surgical site infection surveillance and research work, are not concordant with each 
other. The new, more objective, criteria produce notably lower number of PJIs that 
are identified. On the other hand, a large proportion of cases defined as infected by 
the treating clinician, did not meet the new criteria. There is still a lack of a gold 
standard to identify PJIs, especially in research and surveillance. 
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Based on the results of the study, preoperative urinary screening of asymptomatic 
patients before elective joint replacement surgery is not necessary to prevent PJIs, 
nor is treatment of asymptomatic preoperative bacteriuria. The lower risk of 
developing a PJI associated with preoperative oral antibiotic use is a novel finding 
and warrants further research before any definitive conclusions can be made on its 
significance. In addition, no modifiable patient-related risk factors could be 
identified to prevent the occurrence of a PJI as a consequence of bacteremia.  
However, the pathogen causing the bacteremia, previous history of infections and 
the timing of the bacteremia with respect to previous surgery should be taken into 
account when considering the risk for developing a PJI during bacteremia. 
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TIIVISTELMÄ 
Tekonivelinfektio on tekonivelleikkauksen pelätyimpiä komplikaatioita, sillä niihin 
liittyy merkittävää sairastavuutta ja kuolleisuutta. Hoito on lisäksi kallista. Noin 1–
2% tekonivelistä infektoituu. Näiden syiden vuoksi tekonivelinfektioita seurataan 
useimmissa hoitoon liittyvien infektioiden seurantaohjelmissa ja niiden ehkäisyyn 
käytetään merkittävästi resursseja. Tästä huolimatta tekonivelinfektiolle ei ole 
olemassa yhtenäistä määritelmää ja olemassa olevat määritelmät pohjautuvat 
vaihtelevaan näyttöön. Lisäksi joidenkin tekonivelinfektoiden ehkäisyssä käytettyjen 
menetelmien, kuten leikkausta edeltävän virtsanäytteen seulonnan, merkitys on 
kyseenalaistettu. Toisaalta uusia keinoja ehkäistä tekonivelinfektioita etsitään 
jatkuvasti. 
Tekonivelinfektiot voidaan jakaa esiintymisajankohdan mukaan varhaisiin, 
viivästyneisiin ja myöhäisiin infektioihin. Suurin osa myöhäisistä infektioista on 
hematogeenisia, eli veriteitse levinneitä, mutta hematogeeninen tekonivelinfektio voi 
kehittyä missä vaiheessa vain leikkauksen jälkeen. Aiemmat tutkimukset ovat 
osoittaneet, että noin kolmasosa Staphylococcus aureus-bakteremioista johtaa 
tekonivelinfektioon potilailla, joilla on tekonivel, mutta muiden patogeenien osalta 
asiaa ei ole juuri tutkittu. Lisäksi riskitekijöitä tekonivelinfektion kehittymiselle 
bakteremian seurauksena ei tunneta. 
Tässä tutkimuksessa verrataan kahta eri tekonivelinfektion määritelmää 
tekonivelinfektion diagnosoinnissa ja lisäksi tekonivelinfektion riskitekijöitä ja 
ehkäisykeinoja. Lisähuomiota kiinnitettiin bakteremian seurauksena kehittyneisiin 
tekonivelinfektioihin. Prospektiivisen infektioseurannan kautta tunnistettujen 
tekonivelinfektiotapausten lisäksi tekonivelinfektioiden tunnistamiseen käytettiin 
mikrobiologisia tuloksia, sairaalan hoitoilmoitusrekisteriä ja infektion vuoksi tehtyjä 
revisioleikkauksia. Tämä tehtiin, jotta tekonivelinfektiot saataisiin tunnistettua 
mahdollisimman kattavasti, erityisesti myöhäisten tekonivelinfektioiden osalta, koska 
näitä ei löydetä tavanomaisessa infektioseurannassa. 
Tekonivelinfektion ilmaantuvuus oli 0,68% (158/23171) vuoden seurannassa 
ensitekonivelleikkauksen jälkeen. Lonkissa ilmaantuvuus oli hieman matalampi kuin 
polvissa: 0,57% vs. 0,77%. Pidemmässä seurannassa (12 vuoteen saakka) 
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tekonivelinfektion ilmaantuvuus oli 1,50% ja ilmaantumistiheys 3,3 tuhatta 
henkilövuotta kohti. 
Niistä 405:stä tekonivelinfektiotapauksesta, jotka täyttivät joko toiset tai 
molemmat tekonivelinfektion määritelmät, 73 (18%) täyttivät ainoastaan vanhemmat 
kriteerit, kun taas pelkästään uudet kriteerit täyttäviä oli ainoastaan yksi (0,2%). 
Tekonivelinfektion diagnoosi perustui kliinikon mielipiteeseen 39:ssä (53%) niistä 
tapauksista, jotka eivät täyttäneet uutta tekonivelinfektion määritelmää. 
Aiemmin raportoiduista tekonivelinfektion riskitekijöistä miessukupuoli (OR 
2,21, 95% luottamusväli (LV) 1,56–3,11), polven tekonivel (OR 1,43, 95% LV 1,01–
2,04) ja ikä (OR 1,03, 95% LV 1,01–1,05) lisäsivät tekonivelinfektion riskiä 
monimuuttujamallissa vuoden seurannassa. Diabeteksen vaikutus 
tekonivelinfektioriskiin oli lähes tilastollisesti merkittävä (OR 1,64, 95% LV 0,99–
2,73). 
Leikkausta edeltävä bakteriuria ei toisaalta lisännyt tekonivelinfektion riskiä yhden 
muuttujan (OR 0,72, 95% LV 0,34–1,54) tai monimuuttujamallissa (OR 0,82, 95% 
LV 0,38–1,77) vuoden seurannassa. Leikkausta edeltävässä virtsanäytteessä 
kasvaneiden taudinaiheuttajien ja tekonivelinfektion aiheuttajien välillä ei myöskään 
todettu yhteyttä, eikä bakteriurian hoitaminen tehokkailla antibiooteilla vähentänyt 
tekonivelinfektion riskiä (OR 0,62, 95% LV 0,07–5,14). Leikkausta edeltävä 
oraalisten antibioottien käyttö kuitenkin liittyi vähentyneeseen tekonivelinfektion 
riskiin (OR 0,40, 95% LV 0,22–0,73) ja antibioottien käyttö ylipäänsä ennen 
tekonivelleikkausta oli yleistä: 4106:tta (18%) tekonivelleikkausta edelsi yksi tai 
useampia antibioottikuureja. 
Pidemmässä seurannassa (12 vuoteen saakka) 3,8% (542/14378) potilaista, joilla 
oli tekonivel, sairasti veriviljelypositiivisen infektion. Useampia bakteremioita oli 
85:lla potilaalla, ja kaiken kaikkiaan bakteremiaepisodeja oli 643. Yleisin 
veriviljelypositiivisen infektion aiheuttaja oli Escherichia coli (241/643, 37%). 
Tekonivelinfektio bakteremian seurauksena kehittyi seitsemässä prosentissa 
(46/643) veriviljelypositiivisista infektioista. Riski oli suurin beetahemolyyttisille 
streptokokeille (21%, 12/58), Staphylococcus aureukselle (20%, 21/105) ja viridans-
ryhmän streptokokeille (16%, 4/25) ja pienin gramnegatiivisille bakteereille (1,3%, 
4/314). Koagulaasinegatiivisten stafylokokkien aiheuttamiin bakteremioihin ei 
myöskään liittynyt yhtään tekonivelinfektiota. Bakteremian seurauksena kehittyneen 
tekonivelinfektion riskiä lisäsivät toistuvat bakteremiat (OR 2,29, 95% LV 1,17–4,50) 
ja riski oli suurin vuoden sisään edeltävästä leikkauksesta ilmaantuneille 
bakteremioille. Pitkäaikaissairaudet tai muut potilaisiin liittyvät tekijät eivät 
kuitenkaan lisänneet tekonivelinfektioriskiä bakteremian aikana. 
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Yhteenvetona voidaan todeta, että eri tekonivelinfektion määritelmät eivät ole 
yhtenäisiä keskenään ja tämä tulisi huomioida tutkimustyössä ja seurannassa. Uusien, 
objektiivisempien kriteerien myötä tunnistettujen tekonivelinfektioiden määrä on 
pienempi. Toisaalta kliinikkojen tunnistamista tekonivelinfektioista suuri osa ei 
täyttänyt uusia tekonivelinfektion diagnostisia kriteerejä. Tekonivelinfektion 
määrittämiseen ei edelleenkään ole olemassa kultaista standardia, jota voitaisiin 
käyttää tutkimustyössä tai seurannassa. 
Tutkimuksen tulosten perusteella leikkausta edeltävän virtsanäytteen tutkiminen 
oireettomilta potilailta ei ole hyödyllistä tekonivelinfektion ehkäisyssä, ei myöskään 
oireettoman bakteriurian hoitaminen antibiootein. Leikkausta edeltävän 
antibioottien käytön ja vähentyneen tekonivelinfektioriskin yhteyttä ei ole 
aikaisemmin tutkittu tai raportoitu, joten tämän löydöksen merkitys täytyy arvioida 
myöhemmissä tutkimuksissa. Bakteremian aiheuttamaan tekonivelinfektioriskiin 
vaikuttavia muokattavissa olevia potilaskohtaisia tekijöitä ei pystytty osoittamaan, 
mutta tekonivelinfektioriskin arvioinnissa veriviljelypositiivisen infektion yhteydessä 
täytyy ottaa huomioon taudinaiheuttaja, potilaan infektiohistoria ja infektion 
ajankohta edeltävään leikkaukseen nähden. 
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1 INTRODUCTION 
Joint replacement surgery is one of the most common and successful forms of 
orthopedic surgery performed, with over one million hip and knee replacements 
performed globally each year. Most of the joint replacements are placed in hip or 
knee joints. Over 90% of primary total joint replacement surgeries are performed 
due to primary osteoarthritis, other reasons include inflammatory arthritis, especially 
rheumatoid arthritis, and previous trauma. The number of joint replacement 
surgeries is continually increasing, as the population is ageing and osteoarthritis 
becomes more prevalent. (Ferguson et al., 2018; Price et al., 2018.) However, the 
number of joint replacements performed due to rheumatoid arthritis has decreased 
(Jämsen et al., 2013). 
Periprosthetic joint infection (PJI) is a catastrophic, but rare, complication of joint 
replacement surgery, with significant morbidity and costs to the healthcare system as 
well as increased mortality (Gundtoft et al., 2017b). The occurrence of a PJI increases 
the costs related to joint replacement surgery and the length of stay in a hospital two- 
to four-fold when compared to noninfected joint replacements (Kapadia et al., 2014; 
Kapadia et al., 2016b; Klouche et al., 2010; Kurtz et al., 2008). The annual cost of 
treating PJIs in the United States has been projected to exceed 1.6 billion USD in 
2020 (Kurtz et al., 2012). Besides the financial costs, a PJI also affects patients’ quality 
of life negatively, especially physical functioning (Rietbergen et al., 2016), and the 
mortality risk more than doubles when compared with patients with joint 
replacements, but no need for revision surgery (Gundtoft et al., 2017b). 
PJIs pose several difficulties to the healthcare system: they can be difficult to 
diagnose and they can occur at any time after joint replacement surgery. In addition, 
treatment of PJIs is complex and expensive, and it usually requires revision surgery. 
In fact, about one fourth of revision surgeries are performed because of an infection 
(Bohm et al., 2012; Bozic et al., 2010). 
Treatment of PJIs is often time consuming. Treatment options depend on the 
timing of the onset of symptoms relative to the primary operation and the causative 
pathogen. In general, early and acute PJIs can be treated surgically with debridement 
and implant retention, whereas delayed and chronic infections require one- or two-
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stage revision surgery. Rarely, arthrodesis or amputation is needed in difficult-to-
treat cases. (Kapadia et al., 2016a; Osmon et al., 2013.) In addition to surgery, 
antibiotic treatment is needed. The overall duration of antibiotic treatment lasts from 
weeks to months, and occasionally lifelong suppressive antibiotic therapy is required 
(Osmon et al., 2013). 
Due to the increased burden on the healthcare system and patients’ lives caused 
by PJIs, it is extremely important to prevent them. Therefore, attempts have been 
made to identify risk factors for PJI and preventive measures are implemented at 
different stages of joint replacement surgery. The level of evidence for each measure 
is varied, however, and practices differ considerably on a national and international 
level. In order to form uniform policies regarding the diagnosis, prevention and 
treatment of PJIs, two international consensus meetings have been held in 2013 and 
2018. Importantly, more objective diagnostic criteria for PJI were introduced in the 
meeting in 2013. (Proceedings of the international consensus meeting on periprosthetic joint 
infection. 2013; Parvizi et al., 2019). Important research questions identified in the first 
consensus meeting also include, among others, the role of urinary tract screening 
before elective joint replacement and the association between preoperative 
bacteriuria and subsequent PJI, preoperative skin decolonization and the role of 
prophylactic antibiotics. 
The purpose of this study was to evaluate topics related to the diagnosis, risk 
factors and prevention of PJIs following primary hip or knee replacement. These 
include the concordance between the old and new diagnostic criteria for PJI, the 
effect of preoperative bacteriuria and preoperative oral antibiotic use on the risk for 
developing a subsequent PJI and finally, the risk for developing a PJI as a 
consequence of bacteremia. In addition, pathogens causing different types of PJIs 
were examined. 
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2 REVIEW OF THE LITERATURE 
2.1 Healthcare-associated infections 
In general, the term healthcare-associated infection (HAI) is used to separate 
infections related to procedures or to the use of invasive devices employed in the 
treatment of patients or acquired in a healthcare setting, from community-acquired 
infections. The CDC (Centers for Disease Control and Prevention) defines HAI as 
“a localized or systemic condition resulting from an adverse reaction to the presence 
of an infectious agent(s) or its toxin(s). There must be no evidence that the infection 
was present or incubating at the time of admission to the acute care setting”. (Horan 
et al., 2008.) Furthermore, an infection is considered to be healthcare-associated only 
if it occurs on or after the 3rd calendar day after admission to an inpatient location 
(day of admission is calendar day 1) (Centers for Disease Control 2019). 
HAIs can be caused by endogenous or exogenous infectious agents. Endogenous 
pathogens include microbes from the patient’s own microbiome from body sites, 
such as the skin, upper respiratory tract, gastrointestinal tract or vagina. Exogenous 
sources are external to the patient, and include patient care personnel, visitors, 
patient care equipment, medical devices or the health care environment. (Horan et 
al., 2008.) 
There are several infection prevention activities implemented against HAIs, as 
the burden they impose on the healthcare system is significant with increased 
morbidity and mortality, increased costs, and prolonged hospital stays. In a large 
survey from the United States, 4% of inpatients in acute care hospitals had at least 
one HAI (Magill et al., 2014). 
2.1.1 Surgical-site infections and periprosthetic joint infections 
Surgical-site infections (SSIs) are the most common form of HAIs along with 
pneumonia. Approximately one fifth of all HAIs are SSIs. (Magill et al., 2014.) 
According to the CDC definition, to be classified as having an SSI, the patient has 
to have undergone an operation where the surgeon has made at least one incision 
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through the skin or mucous membrane and closed the incision primarily before the 
patient has left the operating room (Horan et al., 1992).  
SSIs have been divided according to the depth of infection into superficial and 
deep incisional SSIs and organ/space SSIs. A superficial infection involves only the 
skin or subcutaneous tissue of the incision, whereas a deep incisional infection 
involves deep soft tissues (i.e. fascial and muscle layers). An organ/space infection 
extends deeper and involves any part of the anatomy, excluding the incision, opened 
or manipulated during the operation. (Horan et al., 1992.) Organ/space SSIs can be 
further divided according to specific infection sites with specific criteria for each site. 
PJIs are always organ/space infections. Other examples include endocarditis, 
intracranial infection and urinary system infection. (Centers for Disease Control 
2019.) 
The differentiation between deep incisional SSI and PJI can be difficult due to 
anatomic reasons, especially in the case of knee replacements. In a validation study 
of the Finnish Hospital Infection Program (SIRO), Huotari et al. found that only 
half of the infections identified as PJIs by the validation team were classified as such 
by routine surveillance. Almost half were classified as deep incisional SSIs. (Huotari 
et al., 2007b.) 
For an SSI to develop, a microbial contamination of the surgical site, either by 
endogenous or exogenous pathogens has to occur. Traditionally, it has been assumed 
that the risk for SSI is significantly increased if the surgical site is contaminated with 
>105 microorganisms per gram of tissue (Krizek & Robson, 1975). However, the 
number of contaminating microbes needed to produce an infection may be much 
lower if foreign material (such as a joint replacement) is introduced to the surgical 
site (Zimmerli et al., 1982). 
During the development of a PJI, after microbial colonization of the joint 
replacement, the dividing microbes produce a biofilm. It is a polymeric matrix that 
protects the microbes from host defense responses and antimicrobial agents. 
Furthermore, the microbes in the biofilm may enter a stationary growth phase, 
making them more resistant to antimicrobials that affect cell division. (Zimmerli et 
al., 2004) Because of these factors, antimicrobial treatment on its own is usually not 
sufficient in the treatment of PJIs, and a removal of the infected joint replacement 
is usually needed. 
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2.2 Definition and diagnostics of periprosthetic joint infection 
2.2.1 Diagnostic tests 
There is not a single diagnostic test to identify a PJI, but many different methods 
have been used in clinical practice and studied, either alone or in combination with 
other tests. In clinical practice, a step-wise approach to diagnosing PJIs is 
recommended, starting with clinical examination and serologic markers before 
moving on to more invasive examinations (Abdel Karim et al., 2019; Della Valle et 
al., 2011). 
The most common symptom that raises a suspicion of a PJI is persistent pain in 
the joint. Early infections can also present with induration or edema, a draining 
wound, surgical site erythema and effusion. (Kapadia et al., 2016a; Osmon et al., 
2013; Zmistowski et al., 2014.) Pain is not a specific symptom for infection, however, 
but can be caused by other reasons as well. A more specific finding is a sinus tract 
from the skin to the joint, and it has been considered to be enough on its own for a 
diagnosis of a PJI (Zmistowski et al., 2014). 
Once a suspicion of a PJI has been raised, a number of diagnostic tests can be 
applied, these are outlined below. Sensitivities and specificities of various diagnostic 
tests are given in Table 1. There is great variation in these, mainly because the cut-
off values and reference standards vary considerably between studies. 
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Table 1.  Sensitivities and specificities of various diagnostic tests in identifying a PJI (from 
previously published studies and review papers) 
Diagnostic test Sensitivity Specificity 
Serology *   
C-reactive protein (CRP)  0.86 – 0.96 0.20 – 0.92 
Erythrocyte sedimentation rate (ESR) 0.75 – 0.97 0.33 – 0.89 
CRP and ESR in combination 0.75 – 0.95 0.29 – 0.89 
White blood cell count 0.20 – 0.70 0.60 – 0.96 
Interleukin-6 0.87 – 0.95 0.87 – 0.90 
Procalcitonin 0.33 0.98 
Synovial fluid and tissue samples †   
Culture of synovial fluid  0.56 – 0.86 0.88 – 1.00 
Culture of periprosthetic tissue 0.61 – 0.94 0.92 – 1.00 
Culture of sonicate-fluid 0.73 – 0.97 0.90 – 1.00 
Polymerase chain reaction testing of synovial fluid, periprosthetic 
tissue or sonicate-fluid 
0.67 – 0.96 0.12 – 1.00 
Synovial fluid white blood cell count 0.36 – 0.94 0.80 – 0.99 
Synovial fluid polymorphonuclear neutrophil percentage 0.84 – 1.00  0.82 – 0.98 
Histopathology of periprosthetic tissue 0.73 – 0.94 0.94 – 0.98 
Synovial fluid leucocyte esterase 0.29 – 1.00 0.64 – 1.00 
Synovial fluid α-defensin 0.63 – 1.00 0.95 – 1.00 
Synovial fluid CRP 0.82 – 0.92 0.88 – 1.00 
Next-generation sequencing of periprosthetic tissue or synovial 
fluid 
0.89 0.73 
Imaging techniques ‡   
Bone scintigraphy 0.68 – 1.00 0.15 – 0.90 
Gallium scintigraphy 0.37 – 0.95 1.00 
Leucocyte labeled scintigraphy 0.50 – 1.00 0.45 – 1.00 
18F-fluorodeoxyglucose positron emission tomography 0.64 – 1.00 0.67 – 0.97 
*, (Berbari et al., 2010b; Bottner et al., 2007; Cipriano et al., 2012; Gallo et al., 2018; Ghanem et al., 2009; 
Johnson et al., 2011; Schinsky et al., 2008); †, (Atkins et al., 1998; Barrack & Harris, 1993; Cipriano et al., 2012; 
De Vecchi et al., 2016; Deirmengian et al., 2014; Dinneen et al., 2013; Gallo et al., 2018; Ghanem et al., 2008; 
Lee et al., 2017; Liu et al., 2017; Lonner et al., 1996; Melendez et al., 2014; Mitchell et al., 2017; Parvizi et al., 
2011a; Portillo et al., 2012; Rothenberg et al., 2017; Schinsky et al., 2008; Spangehl et al., 1999; Tarabichi et 
al., 2018a; Trampuz et al., 2004; Trampuz et al., 2007; Yan et al., 2018); ‡,  (Diaz-Ledezma et al., 2015; 
Palestro, 2014) 
2.2.1.1 Serology 
Traditional inflammatory markers, C-reactive protein (CRP) and erythrocyte 
sedimentation rate (ESR), can be used as screening tools in the diagnosis of PJI and 
have been widely studied (Berbari et al., 2010b; Bottner et al., 2007; Cipriano et al., 
2012; Ghanem et al., 2008; Johnson et al., 2011; Schinsky et al., 2008). Their use is 
also recommended by the international consensus statement from 2018 (Barrack et 
al., 2019). CRP and ESR have a poor specificity, but are usually elevated in cases of 
PJI (Table 1), even though there are reports of PJIs with normal CRP and ESR values 
(McArthur et al., 2015). ESR value higher than 30 millimeters per hour and CRP 
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value more than 10 milligrams per liter are generally used as cut-off values suggestive 
of a PJI, except in the immediate post-operative period (<6 weeks), when higher cut-
off values are recommended (Zmistowski et al., 2014).  
Novel serum inflammatory markers, such as interleukin-6 (IL-6) and 
procalcitonin, have also been studied with respect to PJIs (Barrack et al., 2019; 
Bottner et al., 2007). Especially IL-6 has shown a good sensitivity and specificity 
when compared to more traditional serology testing, but as the number of studies is 
still fairly small, it has not been adopted to routine use (Berbari et al., 2010b; Xie et 
al., 2017). 
2.2.1.2 Synovial fluid and tissue samples 
A microbial culture from the affected joint, either from a synovial fluid aspirate or 
from a tissue or synovial fluid sample taken intraoperatively, has been a traditional 
method to identify the presence or absence of infection (Bauer et al., 2006). There 
are problems associated with this, however. A positive bacterial culture can be the 
result of a contamination, especially in the case of skin commensals, such as 
coagulase-negative staphylococci (CoNS), corynebacteria or Cutibacterium acnes 
(Atkins et al., 1998; Barrack & Harris, 1993; Lonner et al., 1996). On the other hand, 
a PJI can be culture-negative, for example due to prior use of antibiotics (Berbari et 
al., 2007; Klement et al., 2018; Malekzadeh et al., 2010). In addition, the optimal 
number of samples that should be obtained for culture to accurately diagnose a PJI 
has been under debate. Earlier studies recommended obtaining five or six samples 
in order to gain optimal diagnostic accuracy (Atkins et al., 1998), but more recent 
studies have shown that four samples might be the optimal number (Bemer et al., 
2016; Gandhi et al., 2017; Peel et al., 2016). 
 In order to improve the sensitivity of microbial cultures, different techniques 
have been applied. These include experimental techniques, such as extracting the 
pathogens from the tissue samples using a beadmill technique (Bemer et al., 2016; 
Roux et al., 2011) or, more commonly, using sonication to break the biofilm and 
dislodge pathogens from the surface of the prosthesis and culturing the resulting 
sonicate-fluid (Liu et al., 2017; Rothenberg et al., 2017; Trampuz et al., 2007).  
The use of polymerase chain reaction (PCR) analysis, either from synovial fluid, 
tissue samples or sonicate-fluid, has been examined with varying results (Table 1) 
(Gallo et al., 2008; Jacovides et al., 2012; Melendez et al., 2014; Portillo et al., 2012). 
In general, it has been problematic to find a balance in the PCR technique between 
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optimal sensitivity and specificity without the other suffering too much (Mitchell et 
al., 2017). 
In addition to culture samples and PCR, synovial fluid can be used for many other 
analyses. Among the most commonly used are the white blood cell (WBC) count 
and the polymorphonuclear neutrophil (PMN) percentage. There has been a 
problem in defining universally accepted cut-off values for these, however. Studies 
have proposed cut-off values with high sensitivity and specificity ranging from 
1100/μl to 3450/μl for WBC count and from 64% to 78% for the PMN percentage 
(Cipriano et al., 2012; Dinneen et al., 2013; Ghanem et al., 2008; Trampuz et al., 
2004). On the other hand, the international consensus meeting guidelines from 2013 
suggest much higher cut-off values: WBC count >10 000 for early infections and >3 
000 for delayed and late infections and PMN% >90% for early infections and >80% 
for delayed and late infections (Zmistowski et al., 2014). 
There has been a wish to obtain results from the synovial fluid analysis faster, and 
to this end, the use of leucocyte esterase (LE) strip test has been proposed. LE is an 
enzyme secreted by neutrophils at the site of infection and has been commonly used 
in the diagnosis of urinary tract infections (Parvizi et al., 2011a). It can be used for 
point-of-care analysis of the synovial fluid, but again, when used alone to diagnose 
PJIs, it has shown varying sensitivity and specificity (Table 1). 
Histopathological analysis of intraoperative tissue samples can also be indicative 
of a PJI, especially if a systematic analysis on the number of PMNs per high-power 
field is used, but this requires a pathologist experienced in interpreting periprosthetic 
tissue (Tsaras et al., 2012a). 
2.2.1.3 Imaging techniques 
Imaging techniques that can aid in the diagnosis of a PJI either do not require radio-
isotopes [plain radiographs, ultrasonography, computed tomography (CT) scanning 
or magnetic resonance imaging (MRI)] or do require them (bone scintigraphy, 
gallium scintigraphy, leucocyte labeled scintigraphy or FDG-PET/CT) (Arvieux & 
Common, 2018; Palestro, 2014; Palestro & Love, 2017). None of these methods 
have a fixed role in the diagnostic process of a PJI, however, and they have not been 
included in the diagnostic criteria proposed by the international consensus meeting 
in 2013 (Zmistowski et al., 2014). 
Patients with a PJI often have normal plain radiographs and thus they are not 
very useful in diagnosing a PJI (Tigges et al., 1994). They are still recommended as a 
first-line imaging modality when suspecting a PJI and are routinely used, especially 
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because they can be used to identify other reasons for joint failure (Kapadia et al., 
2016a; Osmon et al., 2013). CT scans or MRI can provide additional information, 
and they can show signs suggestive of a PJI, such as joint effusion, local edema, bone 
destruction and reactive lymphadenopathy, but these are usually not enough to 
confirm the diagnosis, as they are non-specific findings (Fritz et al., 2014). 
In recent years, several radionuclide imaging techniques have been applied to the 
diagnosis of PJIs. Older techniques, such as bone scintigraphy with technetium-99m 
labeled diphosphonate and gallium scintigraphy, have been mostly replaced by newer 
ones (Palestro, 2014). These include leucocyte labeled scintigraphy with or without 
a bone scan or bone marrow imaging and FDG-PET, often combined with a CT 
scan. These have both shown similar sensitivities and specificities (Table 1). 
However, there has been a debate as to which one of these methods should be the 
imaging technique of choice when diagnosing a PJI (Kwee et al., 2017; Palestro, 
2014). Furthermore, there has been a concern that the radionuclide imaging 
techniques might not offer any additional benefit in the diagnosis of a PJI when 
compared to other diagnostic modalities, and should therefore be reserved only to a 
selected group patients with difficult to diagnose infections (Diaz-Ledezma et al., 
2015; Osmon et al., 2013). 
2.2.1.4 Future possibilities 
As PCR techniques have not shown great advantages over traditional culture in 
diagnosing PJI (Melendez et al., 2014; Mitchell et al., 2017), studies have recently 
focused on next-generation sequencing (NGS) and other molecular technologies as 
a an aid to diagnose PJIs and to identify pathogens causing them (Tarabichi et al., 
2018a; Tarabichi et al., 2018b; Thoendel et al., 2018). These methods have shown 
high sensitivity, but specificity has not been optimal and a high number of false 
positive cases have been reported (Tarabichi et al., 2018a; Thoendel et al., 2018). 
Even though molecular technologies have shown promise in identifying pathogens 
in culture-negative PJIs, the cost and slow processing time limit these methods from 
being adopted to routine use at the moment (Thoendel et al., 2018). 
There has also been great interest in different synovial fluid markers in the 
diagnosis of PJI, some being more promising than others (Deirmengian et al., 2014; 
Lee et al., 2017; Mitchell et al., 2017). A wide range has been studied (e.g. CRP, IL-
6 and α-defensin), and some studies have even shown 100% sensitivity and 
specificity to markers such as α-defensin (Deirmengian et al., 2014). Nevertheless, 
none of these markers have shown superiority over others and none of them can be 
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used as a single test to diagnose a PJI. Furthermore, they cannot be used to identify 
the causing pathogen. 
In the field of radionuclide imaging, there has been interest towards the 
development of infection-specific tracers, such as antimicrobial peptides, and the use 
of other imaging techniques, such as single-photon emission computed tomography-
CT (SPECT/CT) (Palestro, 2014). Their role in the diagnosis of PJI remains to be 
determined. 
2.2.2 Diagnostic criteria 
A universal definition or diagnostic criteria for PJI are lacking. Different diagnostic 
criteria have been used in clinical practice, clinical studies and surveillance programs 
(Parvizi et al., 2011b). Most of these criteria are based on different combinations of 
microbiological cultures, histology, laboratory parameters and the intraoperative 
appearance of the affected joint (Parvizi et al., 2006; Parvizi et al., 2008; Schinsky et 
al., 2008; Spangehl et al., 1999; Trampuz et al., 2007). In SSI surveillance programs, 
PJIs have been defined according to the CDC criteria from the year 1992 (Horan et 
al., 1992). These include a diagnosis of infection by the treating clinician as one of 
the diagnostic criteria (Table 2). 
Due to the lack of consensus on the definition of PJI, a new, more objective, set 
of criteria was proposed in 2011 by the Musculoskeletal Infection Society (MSIS) 
(Parvizi et al., 2011c). These were further modified in the international consensus 
meeting in 2013, where a new set of criteria was introduced. These two sets of criteria 
are compared with the old CDC criteria from 1992 in Table 2. The most notable 
difference between the old criteria and new ones is the removal of the clinician’s 
diagnosis from the criteria set and the addition of specific laboratory tests in the 
minor criteria. The criteria from 2013 have also been adopted by the CDC (Centers 
for Disease Control 2019). 
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Table 2.  Different diagnostic criteria for periprosthetic joint infection (Horan et al., 1992; Parvizi 
et al., 2011c; Zmistowski et al., 2014) 
Centers for Disease Control 
criteria from 1992 
Musculoskeletal Infection 
Society criteria from 2011 
Consensus meeting criteria 
from 2013 
Infection involves any part of the 
anatomy (e.g., organs or spaces), 
other than the incision, which was 
opened or manipulated during an 
operation 
There is a sinus tract 
communicating with the prosthesis 
A sinus tract communicating with 
the joint 
 OR OR 
 A pathogen is isolated by culture 
from at least two separate tissue or 
fluid samples obtained from the 
affected prosthetic joint 
Two positive periprosthetic 
cultures with phenotypically 
identical organisms 
AND OR OR 
Patient has at least one of the 
following: 
Four of the following six criteria 
exist: 
Having three of the following minor 
criteria: 
Purulent drainage from a drain that 
is placed through a stab wound 
into the organ/space 
Elevated serum erythrocyte 
sedimentation rate and C-reactive 
protein concentration 
Elevated serum C-reactive protein 
and erythrocyte sedimentation rate 
* 
Organisms isolated from an 
aseptically obtained culture of fluid 
or tissue in the organ/space 
Elevated synovial leukocyte count Elevated synovial fluid white blood 
cell count or change on leukocyte 
esterase test strip † 
An abscess or other evidence of 
infection involving the organ/space 
that is found on direct examination, 
during reoperation, or by 
histopathologic or radiologic 
examination 
Elevated synovial neutrophil 
percentage 
Elevated synovial fluid 
polymorphonuclear cell 
percentage ‡ 
Diagnosis of an organ/space 
surgical site infection by a surgeon 
or attending physician 
Isolation of a microorganism in one 
culture of periprosthetic tissue or 
fluid 
A single positive culture 
 Greater than five neutrophils per 
high-power field in five high-power 
fields observed from histologic 
analysis of periprosthetic tissue at 
x 400 magnification 
Positive histological analysis of 
periprosthetic tissue 
 Presence of purulence in the 
affected joint 
 
*, Cut-off values for CRP >100 for early infections (less than 6 weeks from previous operation) and >10 for 
delayed/late infections (over 6 weeks from previous operation), cut-off value for ESR >30 (delayed/late 
infections, ESR does not apply for early infections); †, Cut-off value for synovial fluid WBC count >10 000 for 
early infections and >3 000 for delayed/late infections; ‡, Cut-off value for PMN% >90% for early infections and 
>80% for delayed/late infections 
In the 2011 MSIS criteria, the presence of purulence in the affected joint is one of 
the minor criteria in defining a PJI (Parvizi et al., 2011c). The Infectious Diseases 
Society of America (IDSA) guideline on PJI also states that purulence without any 
other apparent reason is definitive proof of a PJI (Osmon et al., 2013). Interestingly, 
this criterion was removed from the 2013 definition of PJI, as purulence has also 
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been found in cases of adverse local tissue reaction to metal-on-metal hip implants  
and determining its presence is subjective (Zmistowski et al., 2014). 
In an attempt to formulate a validated set of diagnostic criteria for PJI, Parvizi et 
al. developed yet another set of criteria in 2018, as the previous criteria were based 
on expert opinion and not validated (Parvizi et al., 2018). These criteria were further 
revised and presented in the international consensus meeting in 2018 (Shohat et al., 
2019). This set of criteria is more complex than the previous ones, and different 
diagnostic tests have different weights (Table 3). It also incorporates novel diagnostic 
tests for PJI, such as serum D-dimer and synovial fluid α-defensin. Interestingly, 
purulence in the affected joint is one of the minor criteria for infection, as it was 
removed from the previous consensus meeting criteria set. However, these criteria 
reached only a weak consensus in the consensus meeting in 2018 and have not been 
endorsed by larger organizations, so their role in the diagnosis of PJI remains to be 
established. 
Table 3.  The diagnostic criteria for PJI proposed in 2018 (Parvizi et al., 2018; Shohat et al., 
2019) 
Major criteria (at least one of the following) 
Two positive cultures of the same organism 
Sinus tract with evidence of communication to the joint or visualization of the prosthesis 
Decision 
Infected 
Minor criteria Threshold Score  
Acute* Chronic Combined minor 
criteria score: 
≥ 6 Infected 
3–5 Inconclusive† 
<3 Not infected 
Elevated serum C-reactive protein (mg/l) 
or  
D-Dimer (μg/l) 
100 
 
Unknown 
10 
 
860 
2 
 
Elevated erythrocyte sedimentation rate (mm/hour) 
 
No role 
 
30 
 
1 
 
Elevated synovial white blood cell count (/μl) 
or  
leukocyte esterase 
 
10 000 
 
++ 
 
3 000 
 
++ 
 
3 
or  
positive α-defensin (signal/cutoff) 
 
1.0 
 
1.0 
 
 
Elevated synovial polymorphonuclear cell 
percentage 
 
90 
 
70 
 
2 
 
Single positive culture 
 
- 
 
- 
 
2 
 
Positive histology 
 
- 
 
- 
 
3 
 
Positive purulence‡ 
 
- 
 
- 
 
3 
*, Criteria not validated for acute infections; †, Consider further molecular diagnostics such as next-generation 
sequencing; ‡ Not applicable in suspected adverse local tissue reaction 
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2.3 Surveillance and epidemiology of periprosthetic joint 
infections 
2.3.1 Surveillance programs 
Due to the considerable morbidity and costs, SSIs following joint replacement 
surgery, especially PJIs, are part of most SSI surveillance programs (Grammatico-
Guillon et al., 2015b). In Finland, surveillance data is gathered by hospitals 
participating in the Finnish Hospital Infection Program (SIRO) of the National 
Institute of Health and Welfare. The program was established in 1999 and 
orthopedic operations were among the first surgical procedures under surveillance. 
(Huotari et al., 2007b.) In validation studies of the SIRO program, sensitivities of 
36–75% and a specificity of 100% have been reported for orthopedic SSIs (Huotari 
et al., 2010; Huotari et al., 2007b). Currently, of the 14 hospitals participating in the 
surveillance program, 12 hospitals report SSIs following hip replacement surgery and 
11 hospitals following knee replacement surgery (Leikkausalueen sairaalainfektiot - 
julkinen raporttitiiviste). 
The SSI surveillance programs are based on active and prospective infection 
surveillance. In order to gather reliable and comparable data, uniform definitions for 
SSIs should be used. Most surveillance programs are based on the National 
Nosocomial Infections Surveillance (NNIS) methodology and CDC definitions 
from the 1990s (Horan et al., 1992), but there are considerable differences nationally 
and internationally in the length of follow-up, the use of post-discharge surveillance, 
how the data is collected and reported and how feedback is given to the participating 
hospitals (Grammatico-Guillon et al., 2015b). The use of post-discharge surveillance, 
or the lack of it, is especially problematic in terms of comparing data from different 
centers and countries, as it can affect the incidence numbers greatly (Huotari et al.,  
2006). 
Organized infection surveillance is important, as it has been shown to reduce the 
incidence of SSIs and to be cost-effective (Gastmeier et al., 2002; Haley et al., 1985; 
Wilson et al., 2006). Furthermore, reliable surveillance data can be used to assess 
quality of care, and it can also be used in benchmarking. 
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2.3.2 Epidemiology 
The number of primary hip and knee replacements is continually rising, both globally 
(Ferguson et al., 2018; Price et al., 2018) and nationally in Finland (Järvelin et al., 
2018). In 2018, there were 9 632 primary hip replacements and 12 092 primary knee 
replacements in Finland, and the number of primary joint replacement surgeries has 
more than doubled when compared to the year 2000. However, the number of 
revision joint replacements has not increased in the recent years. There were 1 537 
revision hip replacements and 913 revision knee replacements in Finland in 2018. 
(Kovanen et al., 2019.) 
The occurrence of a PJI after joint replacement surgery is fairly rare, occurring in 
approximately 1% of the cases. The incidences of PJI after primary hip and knee 
replacements in recent studies are presented in Tables 4 and 5. Overall, the incidence 
of PJI is higher for knee replacements than for hip replacements. The variation 
between studies in incidence numbers for PJI is mostly due to differences in follow-
up times and definition of infection. Slightly different rates have also been found in 
single-center and national register-based studies, as national registers have a tendency 
to underestimate the incidence of infection (Jämsen et al., 2009b).  
The incidence of PJI is higher after revision joint arthroplasty than after primary 
joint replacement (Kurtz et al., 2008; Poss et al., 1984). PJI rates up to 8% for hips 
and 15% for knees have been described for revision joint replacement (Kurtz et al., 
2008) and the risk for PJI is more than doubled after revision joint replacement 
surgery when compared with primary joint replacements (Kunutsor et al., 2016). 
Even though the incidence of PJI has decreased from the early years of joint 
replacement surgery due to the adoption of effective preventive measures 
(Schmalzried et al., 1992), there have been conflicting reports on the incidence 
numbers during recent years. Some studies have reported an increasing incidence for 
PJI after primary joint replacement surgery (Dale et al., 2012; Grammatico-Guillon 
et al., 2015a), while others have reported stable (Gundtoft et al., 2017a; Phillips et 
al., 2006) or decreasing incidences (Wang et al., 2018). In a large study, Kurtz et al. 
reported a significant rise in the incidence of PJI during 1990–2004, but this was 
only for revision surgeries. The incidence of PJI after primary joint replacements 
actually decreased during the study period. (Kurtz et al., 2008.) Nevertheless, the 
number of very late PJIs, occurring after five years from primary surgery, seems to 
be increasing (Huotari et al., 2015). This is probably due to the fact that the number 
of replaced joints is increasing and thus also the number of joints at risk for 
developing a PJI is increasing.  
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Table 4.  The incidence of periprosthetic joint infection (PJI) for primary hip replacements in 
different studies* 
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Table 5.  The incidence of periprosthetic joint infection (PJI) for primary knee replacements in 
different studies* 
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Most of the PJIs appear during the first postoperative year, with the incidence rate 
falling during the second and third year and then remaining stable or slightly 
decreasing over the years (Huotari et al., 2015; Kurtz et al., 2010; Ong et al., 2009; 
Tsaras et al., 2012b). It has been estimated that 25–47% of the PJIs after primary hip 
or knee replacement occur during the first three postoperative months, 17–23% 
during 3–12 months after surgery and 29–52% after one year (Grammatico-Guillon 
et al., 2015a; Huotari et al., 2015; Phillips et al., 2006; Pulido et al., 2008; Triffault-
Fillit et al., 2018; Wang et al., 2018). However, when comparing these numbers, it 
should be taken into account that the proportion of late PJIs increases with longer 
follow-up times. 
2.4 Types and microbiology of periprosthetic joint infections 
PJIs have traditionally been classified as early (occurring within 3 months from 
prosthetic joint replacement surgery), delayed (occurring within 3–12 months) or late 
hematogenous infections (occurring after one year) (Coventry, 1975; Kapadia et al., 
2016a). However, this division is somewhat arbitrary, as for example hematogenous 
infections can occur at any time after joint replacement surgery (Rodriguez et al., 
2010; Stefánsdóttir et al., 2009). 
Early and delayed infections are caused by direct contamination of the prosthesis 
during surgery or soon after it. Early infections present with an acute onset of 
symptoms, whereas delayed infections have a longer period of symptom 
development. Traditionally, early infections are postulated to be caused by virulent 
pathogens such as S.aureus or gram-negative bacteria, and delayed infections by more 
non-virulent pathogens such as CoNS that take time to proliferate sufficiently to 
cause symptoms. (Kapadia et al., 2016a; Zimmerli et al., 2004.) However, in a study 
by Stefánsdóttir et al., CoNS were the most common pathogen in both early and 
delayed PJIs (Stefánsdóttir et al., 2009), whereas in another study by Pulido et. al, 
S.aureus was most commonly found in early and delayed PJIs (Pulido et al., 2008). 
The source of hematogenous PJIs can be from the skin and soft tissues, urinary 
tract, dental sources (Maderazo et al., 1988; Zeller et al., 2018), cardiovascular system 
(Rakow et al., 2019), lungs (Cook et al., 2007) or the gastrointestinal tract (Uçkay et 
al., 2009). They are most often caused by S.aureus, followed by streptococci and 
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gram-negative bacteria (Rodriguez et al., 2010; Stefánsdóttir et al., 2009; Swan et al., 
2011; Triffault-Fillit et al., 2018; Zeller et al., 2018). 
The proportion of culture-negative PJIs has varied from 1% to 12% in different 
studies (Berbari et al., 1998; Peel et al., 2012; Tsaras et al., 2012b; Zeller et al., 2018). 
This variation is partly explained by the different number of samples from individual 
study patients used in different studies. 
2.5 Risk factors for periprosthetic joint infection 
Over the years, several studies have examined possible risk factors for PJI with 
varying results, with some factors associated with an increased risk for infection 
consistently and some with conflicting results across studies (Kunutsor et al., 2016; 
Zhu et al., 2015). Overall, the risk factors can be divided into patient-related 
preoperative factors, operation-related perioperative factors and patient- and joint-
related postoperative factors. Patient-wise, the overall risk for PJI is a combination 
of several factors, and therefore the risk scores used for assessing the individual’s 
risk for infection, such as the NNIS System surgical patient risk index score, are a 
combination of different types of factors (Berbari et al., 1998). 
It is possible that risk factors for PJI, especially those related to postoperative 
wound healing, differ between hip and knee replacements, as has been suggested by 
Peel et al. (Peel et al., 2011). This can be mostly explained by the anatomical 
differences between the sites. 
2.5.1 Preoperative factors 
2.5.1.1 Chronic comorbidities 
Several chronic comorbidities have been shown to increase the risk for developing 
a PJI, and the risk is especially high for patients with multiple comorbidities (Kurtz 
et al., 2010; Ong et al., 2009). The American Society of Anesthesiologists (ASA) 
score is a measure of the patients’ overall condition, and higher ASA scores (i.e. 
patients with more comorbidities) have been associated with an increased risk for 
developing a PJI (Huotari et al., 2007a; Jämsen et al., 2010b; Lenguerrand et al., 2018; 
Lenguerrand et al., 2019; Pulido et al., 2008). 
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Rheumatic disease, especially as an indication for joint replacement surgery, has 
been shown to increase the risk for PJI (Bozic et al., 2012b; Jämsen et al., 2009a; 
Lenguerrand et al., 2018). The effect of other comorbidities has been varied in 
different studies. For example, in a large, but older study by Berbari et al., systemic 
malignancy was the only chronic comorbidity independently associated with an 
increased risk for PJI (Berbari et al., 1998), whereas in a more recent study by 
Grammatico-Guillon et al., liver disease was the only independent risk factor for PJI 
among comorbidities (Grammatico-Guillon et al., 2015a). On the other hand, Bozic 
et al. evaluated the effect of 29 different comorbidities and patient-related risk factors 
for PJI, and found that besides rheumatic disease, coagulopathy and preoperative 
anemia were independently associated with an increased risk for PJI for hip 
replacements (Bozic et al., 2012b) and congestive heart failure, chronic pulmonary 
disease, preoperative anemia, diabetes, depression, renal disease, pulmonary 
circulation disorders, obesity, psychoses, metastatic tumor, peripheral vascular 
disease, and valvular disease for knee replacements (Bozic et al., 2012a). Finally, in a 
very large cohort study consisting of 623 253 primary hip replacements, Lenguerrand 
et al. showed that chronic pulmonary disease, diabetes, liver disease and congestive 
heart failure increased the risk for PJI (Lenguerrand et al., 2018), with similar results 
reported for knee replacements in another large cohort study (Lenguerrand et al., 
2019). 
The effect of diabetes on the risk for PJI has been divergent between studies, 
even though two large meta-analyses have demonstrated a significant association 
between diabetes and the risk for PJI (Kunutsor et al., 2016; Zhu et al., 2015). Jämsen 
et al. also showed diabetes to be an independent risk factor for PJI, even when 
potential confounding factors, such as obesity, were taken into account (Jämsen et 
al., 2012) On the other hand, in a study by Kremers et al., the effect of diabetes on 
the risk for PJI was nonsignificant in a multivariable analysis that included, among 
other variables, also body mass index (BMI) (Kremers et al., 2015). Nevertheless, 
hyperglycemia has been shown to be an independent risk factor for PJI (Jämsen et 
al., 2010a), thus suggesting that it is likely that poorly controlled diabetes increases 
the risk for PJI whereas well-controlled diabetes may not have such a significant 
effect. This is also reflected in the most recent international consensus statement, 
where severely uncontrolled diabetes is suggested to be a contraindication for joint 
replacement surgery (Cizmic et al., 2019). 
Obesity has been shown to be a significant risk factor for PJI in many studies 
(Bozic et al., 2012b; Grammatico-Guillon et al., 2015a; Jämsen et al., 2010b; 
Lenguerrand et al., 2018; Lübbeke et al., 2016; Pulido et al., 2008), even though not 
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all studies have found this association (Berbari et al., 1998). However, the definition 
of obesity differs between studies, thus making direct comparisons difficult. Others 
have used different cut-offs for BMI, such as 30 (Lenguerrand et al., 2018) or 40 
(Pulido et al., 2008), while others have used it as a continuous variable (Jämsen et al., 
2010b). In a prospective cohort study, Lübbeke et al. discovered that BMI ≥35 
seemed to be a cut-off for the increased risk for PJI (Lübbeke et al., 2016). On the 
other hand, also undernutrition may increase the risk for infection (Grammatico-
Guillon et al., 2015a). 
2.5.1.2 Preoperative acute infections 
It is generally accepted that active local cutaneous, subcutaneous or deep tissue 
infection at the joint replacement site preoperatively is a risk factor for subsequent 
PJI (Aggarwal et al., 2014; Cizmic et al., 2019), usually resulting in postponement of 
the surgery. Furthermore, dermatophyte infections of the feet might predispose the 
patient to a PJI postoperatively (Kimyai-Asadi et al., 1999), and they are usually 
screened and treated preoperatively, even though there is no data to support this 
practice. 
Patients with an elective joint replacement have traditionally been screened 
preoperatively for bacteriuria (David & Vrahas, 2000; Rajamanickam et al., 2007), 
even though this practice has been questioned (Lamb et al., 2016; Mayne et al., 2016). 
Thus, the association between preoperative asymptomatic bacteriuria (ASB) and 
subsequent PJI is not clear. The prevalence of ASB in patients undergoing elective 
joint replacement surgery has varied between 3.2% and 36% (Bouvet et al., 2014; 
Cordero-Ampuero et al., 2013; Glynn & Sheehan, 1984; Martinez-Velez et al., 2016; 
Sousa et al., 2014; Weale et al., 2019). On the other hand, ASB is common in the 
overall population, especially in older women (Nicolle et al., 2005; Rodhe et al., 2008) 
and its treatment is not recommended in the general population (Nicolle et al., 2005). 
Earlier retrospective studies have not shown an association between preoperative 
bacteriuria and PJI (Berbari et al., 1998; Glynn & Sheehan, 1984; Koulouvaris et al., 
2009; Ritter & Fechtman, 1987), but only during the last decade have there been 
prospective studies on the subject. An increased risk for postoperative infection 
complications in patients with preoperative ASB has been reported in some studies 
(Ollivere et al., 2009; Sousa et al., 2014; Weale et al., 2019), but direct seeding to the 
replaced joint has not been shown. 
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2.5.1.3 Other patient-related factors 
Even though usually the majority of patients undergoing joint replacement surgery 
are female, male gender has been shown in several studies to increase the risk for PJI 
(Grammatico-Guillon et al., 2015a; Jämsen et al., 2010b; Jämsen et al., 2009a; Kurtz 
et al., 2010; Lenguerrand et al., 2018; Ong et al., 2009; Tayton et al., 2016). Older age 
has also been proposed to be an independent risk factor for PJI, but in fact, in many 
studies its effect has not been statistically significant (Grammatico-Guillon et al., 
2015a; Jämsen et al., 2010b; Jämsen et al., 2009a; Kurtz et al., 2010; Lenguerrand et 
al., 2018; Ong et al., 2009). In addition, smoking has been shown to increase the risk 
for PJI, probably due to the many unfavorable cardiovascular effects of smoking that 
can lead to poor wound healing and other complications (Cizmic et al., 2019). 
Previous surgery of the joint that is to be replaced is also a risk factor for PJI 
(Kunutsor et al., 2016), even though arthroscopic surgery has not been associated 
with an increased risk (Aalirezaie et al., 2019b). In addition, revision joint 
replacement surgery has also been shown to be an independent risk factor of PJI 
(Kunutsor et al., 2016). Possibly the reasons for this are the increased scar tissue and 
dead space in the joint caused by previous surgery. 
In a retrospective study to develop a risk score for identifying patients at risk for 
developing a PJI, Everhart et al. found that a history of staphylococcal septicemia 
was an independent risk factor for PJI (Everhart et al., 2016). The mechanism for 
this lasting effect could not be identified by the researchers, however, nor was it 
known whether the subsequent PJIs of the patients with staphylococcal septicemias 
were caused by staphylococci or other bacteria. Perhaps this result reflects the 
patients’ susceptibility to infection in general, as lower extremity osteomyelitis or 
septic arthritis were also independent risk factors for PJI in the same study (Everhart 
et al., 2016). 
Staphylococcal nasal and skin carriage are common among patients undergoing 
elective joint replacement surgery. Stefánsdóttir et al. showed that in preoperative 
samples taken from patients coming for primary joint replacement, 95% had CoNS 
in the groin and 77% in the nose (Stefánsdóttir et al., 2013). In addition, studies have 
found S.aureus colonization rates of 27–28% for the nares and 7% for the inguinal 
area among patients planned for joint replacement surgery (Kalmeijer et al., 2000; 
Stefansdottir et al., 2013). Furthermore, S.aureus carriage has been shown to be an 
independent risk factor for developing an SSI, and the only independent risk factor 
for SSIs caused by S.aureus (Kalmeijer et al., 2000). 
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2.5.2 Perioperative factors 
The impact of several operation-related factors on the risk for PJI have been 
examined. The duration of surgery has been shown to have an effect on the risk for 
PJI (Anis et al., 2018; Huotari et al., 2007a; Jämsen et al., 2010b; Kurtz et al., 2010). 
The reason for this could be that more difficult anatomic and operative conditions 
might predispose to longer operative times and thus also to postoperative 
complications. There might also be longer wound exposure to airborne bacteria in 
longer operations.  In addition, obesity is associated with longer operative times and 
this might explain part of the increased risk as well (Liabaud et al., 2013). 
In their large study, Lenguerrand et al. showed that surgical techniques have an 
impact on the risk for PJI, whereas different forms of anesthesia do not 
(Lenguerrand et al., 2018). The experience of the surgeon does not seem to have an 
effect on the risk for PJI (Berbari et al., 1998; Lenguerrand et al., 2018). 
The need for allogenic blood transfusion has been shown to increase the risk for 
PJI (Pulido et al., 2008). This is possibly caused by the immunomodulatory effects 
of the transfusion. 
2.5.3 Postoperative factors 
2.5.3.1 Wound infection 
The development of a superficial SSI postoperatively is a major risk factor for 
developing a PJI afterwards (Berbari et al., 1998; Peel et al., 2011). Berbari et al. 
showed that other factors related to poor wound healing (e.g. wound drainage, 
hematoma and dehiscence) were also associated with an increased risk for PJI in a 
univariate analysis. However, their effect was not significant in a multivariable 
analysis. (Berbari et al., 1998) On the other hand, in a study by Peel et al., wound 
discharge was an independent risk factor for PJI (Peel et al., 2011). 
2.5.3.2 Other immediate postoperative complications 
Postoperative complications following joint replacement surgery, such as atrial 
fibrillation and acute myocardial infarction, may also increase the risk for developing 
a PJI (Pulido et al., 2008). It is possible that this is due to the comorbidities 
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predisposing patients to these complications or due to the need for aggressive 
anticoagulation involved in these conditions. 
2.5.3.3 Other infections and hematogenous spread 
After joint replacement, the patient is at a permanent risk of developing a 
hematogenous PJI from other infectious sources. It has been shown that 25–40% of 
patients with S.aureus-bacteremia (SAB) and a joint replacement develop a 
hematogenous PJI (Lalani et al., 2008; Makki et al., 2017; Murdoch et al., 2001; Sendi 
et al., 2011; Tande et al., 2016). The risk for developing a PJI as a consequence of 
bacteremia caused by other pathogens is unclear, because most reports on PJIs 
during bacteremia have been case studies (Chodos & Johnson, 2009; Law et al., 2017; 
Pepke, Lehner et al., 2013; Reboli et al., 1989). In their study, Uçkay et al. reported 
a PJI rate of 6% (5/81) in patients with any bacteremia, but the small number of 
infections precludes making any conclusions on the risk for PJI for different 
pathogens (Uçkay et al., 2009). 
Hematogenous seeding from a remote infection to the joint replacement has been 
reported for various types of infection: skin and soft tissue infections, dental 
infections (Maderazo et al., 1988; Rakow et al., 2019; Zeller et al., 2018), urinary tract 
infections (UTIs) (Cordero-Ampuero & de Dios, 2010; Pepke et al., 2013; Poss et 
al., 1984; Wymenga et al., 1992), gastrointestinal infections (Rakow et al., 2019; 
Uçkay et al., 2009; Zeller et al., 2018), cardiovascular infections (Rakow et al., 2019) 
and respiratory tract infections (Cook et al., 2007). The most common source for 
hematogenous PJIs has varied between studies. 
There are two studies that have assessed the rate of remote infections in patients 
with joint replacements and the subsequent risk for developing a PJI, both with a 
mean follow-up period of about six years. The rate of remote infections in these 
studies is shown in Table 6. In the study by Ainscow et al., recurrent skin infections 
were a risk factor for PJI, with 7.5% (3/40) of patients with skin infections 
developing a PJI (Ainscow & Denham, 1984). On the other hand, in the study by 
Uçkay et al., the incidence of PJI for skin infections was 2.7% (1/37), whereas it was 
7.5% (4/53) for infections from the gastrointestinal tract (Uçkay et al., 2009). None 
of the patients in either study with UTIs or respiratory tract infections developed a 
PJI.  
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Table 6.  The incidence of remote infections in patients with a joint replacement 
Study Number 
of 
patients 
Urinary tract 
infection 
Respiratory 
tract infection 
Skin 
infection 
Gastroinfestinal 
infection 
Other 
n n % n % n % n % n % 
Ainscow et 
al. 1984 
1 000 109 11 120 12 40 4 NA NA 68 7 
Uçkay et al. 
2009 
5 122 271 5 128 2 37 0.7 53 1 41 0.8 
Risk factors, other than the type of primary infection, for developing a 
hematogenous PJI are not clear and have not been studied extensively. Tande et al. 
showed that the presence of three or more joint replacements increased the risk for 
PJI during SAB (Tande et al., 2016), but other patient-related risk factors for 
developing a PJI during bacteremia have not been found. In one study with a fairly 
small sample size, patients’ age, gender, diabetes and rheumatic disease did not affect 
the risk for developing a PJI during SAB (Sendi et al., 2011). There are no studies on 
risk factors for developing a PJI during any bacteremia. 
Patients who develop cellulitis with a joint replacement in situ, are at risk for 
developing a PJI due to contiguous spread of the infection to the prosthesis. The 
risk is especially high if the joint replacement is recent and if the infection is located 
near the replaced joint. (Wouthuyzen-Bakker et al., 2018.) 
2.5.3.4 Other surgical procedures 
The risk for developing a PJI after a surgical procedure other than procedures 
involving the joint replacement seems to be low, even though there are case reports 
of PJIs occurring after genitourinary (Dabasia et al., 2009; Pepke et al., 2013) and 
gastrointestinal procedures (Cornelius et al., 2003; Schlaeffer et al., 1996; Triesenberg 
et al., 1992; Vanderhooft & Robinson, 1994).  
In an older study, Ainscow et al. reported that of their cohort of 1 000 patients 
with a hip or knee replacement, 224 patients underwent a dental or other surgical 
procedure after the joint replacement, and none developed a PJI subsequently. None 
of these patients received antibiotic prophylaxis before the procedure. (Ainscow & 
Denham, 1984.) In addition, in a prospective case-control study, Gupta et al. showed 
that genitourinary procedures did not increase the risk for PJI (Gupta et al., 2015). 
In another study from the same study group, esophago-gastro-duodenoscopy with 
biopsy was associated with an increased risk for PJI, but other gastrointestinal 
procedures were not. Moreover, most of the PJIs were caused by pathogens not 
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associated with the gastrointestinal tract, and there was no difference in the 
microbiology of the PJIs between patients who had undergone a gastrointestinal 
procedure and those who had not. (Coelho-Prabhu et al., 2013.) 
2.6 Prevention of periprosthetic joint infections 
The measures used to prevent PJIs can be divided into different categories with 
respect to the timing of the surgery, similarly to the risk factors for PJI (Table 7). 
Preoperative measures are aimed at optimizing the patient’s condition prior to 
surgery, peri- and intraoperative measures aim to prevent contamination of the 
wound and joint replacement, and postoperative measures are directed to prevent 
wound infection and improve wound healing. In addition, postoperative measures 
include prevention of hematogenous spreading from remote infections to the joint 
replacement.  
The evidence to support the use of different preventive measures is varied, and 
the use of some preventive measures is under debate. In the most recent guideline 
on the prevention of SSIs, the CDC identified six key topics related specifically for 
the prevention of PJIs that were deemed unresolved and for which no 
recommendations could be made. These included blood transfusion, systemic 
immunosuppressive therapy, intra-articular corticosteroid injection, anticoagulation, 
orthopedic surgical space suit, postoperative antimicrobial prophylaxis duration with 
drain use and biofilm. (Berrios-Torres et al., 2017.) Other unresolved topics 
considered in the guideline development process but not included as priority 
guideline research topics were anesthesia, operating room environment and S. aureus 
nasal screening and decolonization (Berbari et al., 2017). 
As the PJI rates have decreased thanks to effective peri- and intraoperative 
preventive methods, there has been a special interest to identify patient-related risk 
factors for PJI and to focus research on the prevention of PJIs to patient-
optimization. This is especially important as the patients undergoing joint 
replacement surgery are more obese and have more comorbidities than before (Singh 
& Lewallen, 2014). However, it is unclear whether comprehensive risk-factor 
modifications would lead to decreased rates of PJIs  (Everhart et al., 2016). 
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Table 7.  Measures currently used to prevent periprosthetic joint infections with varying 
evidence base* 
Preoperative measures Perioperative 
measures 
Intraoperative 
measures 
Postoperative 
measures 
Dental screening Antibiotic prophylaxis Antibiotic-impregnated 
cement 
Avoidance of 
unnecessary blood 
transfusions 
Glycemic control Perioperative skin 
preparation with an 
alcohol-based 
antiseptic agent 
Changing the scalpel 
after the skin incision 
Minimizing the length of 
hospital stay 
S.aureus nasal screening 
and decolonization 
 Keeping the duration 
of surgery to a 
minimum 
Prevention of hematoma 
formation 
Smoking cessation 4 weeks 
preoperatively 
 Laminar airflow Use of antibiotic 
prophylaxis before 
(surgical) procedures 
Treatment of active 
infections (especially in the 
operation area) 
 Maintenance of 
normothermia 
 
Weight loss (deferral of 
surgery for patients with BMI 
>40) 
 No extra personnel in 
the operating room 
 
Withholding 
immunosuppressive 
medication 
 Protective gear of the 
operating staff and use 
of body exhaust 
systems 
 
*, (Alaee et al., 2019; Berrios-Torres et al., 2017; Cizmic et al., 2019; Mangram et al., 1999; Marculescu et al.,  
2016; Rezapoor & Parvizi, 2015; Workgroup of the American Association of Hip and Knee Surgeons Evidence 
Based Committee, 2013) 
2.6.1 Preoperative measures 
Many of the preoperative measures to prevent PJIs are focused on modifiable 
patient-related risk factors, such as hyperglycemia and obesity (Rezapoor & Parvizi, 
2015) and smoking cessation (Cizmic et al., 2019). These are based on variable levels 
of evidence, however, and well-conducted prospective studies are often lacking 
(Berbari et al., 2017). For example, the CDC has made a strong recommendation to 
control blood glucose levels preoperatively to prevent SSIs, but the recommendation 
is based on low quality evidence (Mangram et al., 1999). Furthermore, in an update 
to the CDC guidelines for the prevention of SSIs, no recommendation could be 
made on the optimal level for preoperative hemoglobin A1C, as no randomized 
studies exist on the topic (Berrios-Torres et al., 2017). On the other hand, guidelines 
suggest weight loss to obese patients to reduce the risk for developing a PJI, but the 
optimal method for preoperative weight loss is not known (Cizmic et al., 2019). In 
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addition, the American Association of Hip and Knee Surgeons recommends 
deferring joint replacement surgery for patients with BMI >40 (Workgroup of the 
American Association of Hip and Knee Surgeons Evidence Based Committee, 
2013). 
Treatment of active infections, including skin infections and UTIs, is 
recommended preoperatively to prevent subsequent PJIs (Cizmic et al., 2019). 
However, treatment of preoperative ASB with antibiotics has not been effective in 
preventing PJIs (Cordero-Ampuero et al., 2013; Lamb et al., 2016; Martinez-Velez 
et al., 2016; R. Sousa et al., 2014). 
Currently, routine preoperative dental screening is recommended only for certain 
high-risk groups (e.g. patients with diabetes or rheumatic diseases, smokers, drinkers 
of carbonated beverages and those at a lower socioeconomic level) in the recent 
international consensus statement, as there are no prospective studies evaluating the 
effect of preoperative dental screening in reducing PJIs (Ares et al., 2019). On the 
other hand, the incidence of dental pathology in patients planned to undergo elective 
joint replacement surgery is fairly high, up to 23–29% (Barrington & Barrington, 
2011; Vuorinen et al., 2018). 
There is some controversy regarding preoperative nasal screening for S.aureus 
carriage and decolonization. As S.aureus carriage has been shown to be a risk factor 
for SSIs, it has been proposed that even in the absence of active infection, 
preoperative staphylococcal decolonization could reduce the incidence of SSIs 
caused by S.aureus (Chen et al., 2013; Schweizer et al., 2013; Stambough et al., 2017; 
Weiser & Moucha, 2015). However, it is not clear whether a universal decolonization 
regimen or a so-called “screen and treat” approach would be better, nor is the 
optimal decolonization method known. 
Chen et al. showed a reduction in SSI rates for decolonization programs in a large 
meta-analysis. The studies included in the analysis were very heterogeneous, 
however, as some of the decolonization programs used only nasal mupirocin and 
some used nasal mupirocin in combination with chlorhexidine showers. 
Furthermore, some studies had universal decolonization programs, whereas in 
others, only patients screened positive for S.aureus carriage were decolonized. (Chen 
et al., 2013.) There have been studies that favor universal decolonization over 
“screen and treat” protocols in terms of efficiency and cost-effectiveness 
(Stambough et al., 2017). However, there have been concerns of increased antibiotic 
resistance following widespread use of mupirocin in the decolonization regimen. 
Thus no consensus on the decolonization regimens could be reached in the recent 
international consensus meeting (Akesson et al., 2019). 
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Oral antibiotics can reduce the carriage of S.aureus (Kumar et al., 2015), but the 
concentrations of oral antibiotics in the nares are not sufficient for effective 
decolonization (Peterson et al., 1990; Strausbaugh et al., 1992). Thus they are 
recommended to be used only in conjunction with topical agents in the 
decolonization of methicillin-resistant S.aureus (MRSA) (McConeghy et al., 2009; 
Simor et al., 2007). In addition, the routine use of oral antibiotics in MRSA 
decolonization regimens is discouraged by the IDSA due to concerns regarding 
increased antibiotic resistance (Liu et al., 2011). The use of oral antibiotics in 
decolonization regimens prior to joint replacement surgery has not been studied. 
2.6.2 Peri- and intraoperative measures 
One of the most effective methods to prevent PJIs is the use of perioperative 
antibiotic prophylaxis, and the number needed to treat (NNT) value for 
perioperative antibiotic prophylaxis in the prevention of SSIs for joint replacement 
surgery is low (AlBuhairan et al., 2008). An early study on antibiotic prophylaxis in 
joint replacement surgery showed a significant decrease in the incidence of deep 
infection from 3.3% to 0.9% when cefazolin was compared to placebo (Hill et al., 
1981). The use of perioperative antibiotic prophylaxis has a well-established role in 
the prevention of PJIs and is recommended by the international consensus meeting 
and the American Academy of Orthopaedic Surgeons (Aboltins et al., 2019; 
American Academy of Orthopaedic Surgeons, 2014; Hansen et al., 2014). The key 
to successful administration of antibiotic prophylaxis is optimal timing and correct 
choice of antibiotics (van Kasteren et al., 2007). Currently, first or second generation 
cephalosporins are recommended (Hansen et al., 2014). There are concerns, 
however, of their efficacy if the carriage rate of resistant staphylococci in the 
population increases. 
In addition to perioperative antibiotics, perioperative skin preparation is 
universally accepted as a means to prevent PJIs (Atkins et al., 2019; Berrios-Torres 
et al., 2017). The most effective antiseptic agent is not known, as studies have not 
managed to show superiority of one agent over others. The most commonly studied 
agents are povidone-iodine and chlorhexidine gluconate, either with or without 
isopropyl alcohol. The existing guidelines recommend the use of alcohol-based 
solutions unless contraindicated. (Atkins et al., 2019; Berrios-Torres et al., 2017.) 
In a classic study, Hill et al. interestingly showed that the effect of perioperative 
antibiotics was nonsignificant if the intraoperative conditions were optimized (Hill 
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et al., 1981). Furthermore, the importance of intraoperative methods to reduce the 
risk for PJI was dramatically illustrated in another classic study by Charnley, where 
the incidence of PJI fell from 7% to 0,5% purely as a result of intraoperative methods 
to prevent contamination of the wound and joint replacement. The most important 
method was deemed to be the use of laminar airflow ventilation, but also the use of 
improved protective gear of the operating staff and improved methods of wound 
closure were assumed to play a role. (Charnley, 1972.) However, the results of these 
older studies may not apply in a modern day context, and  in fact, there are more 
recent studies that have not shown any benefit in using laminar airflow ventilation 
or body exhaust systems in reducing the incidence of PJI (Breier et al., 2011). 
Furthermore, there are two studies from New Zealand that show an association 
between the use of laminar airflow ventilation and an increased risk for PJI (Hooper 
et al., 2011; Tayton et al., 2016). Yet, there is considerable variation in laminar airflow 
technologies used in different studies, and this might affect the results. 
Prophylactic antibiotics can also be administered via the use of antibiotic-
impregnated cement. Most commonly, vancomycin or aminoglycosides, such as 
tobramycin and gentamycin, are used. Again, the evidence supporting this practice 
is varied and no consensus could be reached in the international consensus meeting, 
even though the practice is widely used in many countries.  (Fillingham et al., 2019.)  
On the other hand, in a study by Tayton et al., the use of antibiotic-impregnated 
cement was associated with a higher risk for PJI, but the results could have been 
confounded by the fact that antibiotic-cement may have been reserved for patients 
already at a higher risk for infection (Tayton et al., 2016). Thus, based on the lack of 
definitive evidence for the benefit of using antibiotic-impregnated cement in primary 
joint replacement surgery, it was suggested in the consensus statement that its use 
might be most justified in surgeries with a high risk for infection. 
Other well-established methods to decrease the risk of contamination of the 
wound or the joint replacement include changing the scalpel after the skin incision 
and keeping the operating time to a minimum. Some of the more experimental 
methods include the use of antibiotic coatings on implants, but large-scale studies 
on these are lacking. (Alaee et al., 2019.) In addition to operating room conditions, 
also the maintenance of optimal patient condition is important, especially the 
maintenance of normothermia (Aalirezaie et al., 2019a). 
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2.6.3 Postoperative measures 
Postoperative methods to decrease the risk for PJI in the immediate postoperative 
period are aimed at prevention of wound contamination/infection and improving 
wound healing. These include keeping the wound covered and dry for 48 hours 
postoperatively. There is also some evidence that the type of dressing used to cover 
the wound could have an effect on the risk for SSI and PJI, but more studies are 
needed, especially to evaluate the cost-effectiveness of using special dressings, such 
as ones with antiseptic or antimicrobial properties. (Al-Houraibi et al., 2019.) 
In the long term, postoperative methods to prevent PJIs are aimed at preventing 
hematogenous spread from distant infectious foci to the replaced joint. These are 
mainly focused on the prevention of bacteremia, especially related to dental or other 
surgical procedures. 
The need for subsequent antibiotic prophylaxis before dental procedures for 
patients with joint replacements has been under debate. Even though there are 
reports with PJIs caused by pathogens from the oral flora (Bartzokas et al., 1994; 
LaPorte et al., 1999), giving antibiotic prophylaxis before dental procedures for 
patients with joint replacements in order to prevent PJIs has not been effective in 
other studies (Ainscow & Denham, 1984; Berbari et al., 2010a; Kao et al., 2017), and 
therefore it is not routinely recommended by the American Dental Association 
(Sollecito et al., 2015) or the international consensus statement on PJIs (Arnold et 
al., 2019). However, maintaining good oral hygiene is recommended for patients with 
prosthetic joints (Arnold et al., 2019). 
The issue of antibiotic prophylaxis before other surgical procedures not involving 
the joint replacement is not clear. There are few studies on the topic, and they are 
underpowered. Gupta et al. showed that prophylactic antibiotics before 
genitourinary procedures did not decrease the risk for PJI (Gupta et al., 2015). 
However, it should be noted that in that study, the proportion of patients receiving 
antibiotic prophylaxis was very low (2%), thus making definite conclusions on the 
efficacy of antibiotic prophylaxis difficult. Also, even though Coelho-Prabhu et al. 
showed an increased risk for PJI after esophago-gastro-duodenoscopy with biopsy, 
only 1% of the study patients had received prophylactic antibiotics before their 
gastrointestinal procedure and thus no conclusions on the efficacy of the prophylaxis 
could be made (Coelho-Prabhu et al., 2013). Therefore, giving antibiotic prophylaxis 
for patients with joint replacements before genitourinary or gastrointestinal 
procedures is not recommended by the recent international consensus statement 
(Arnold et al., 2019; Bravo et al., 2019) or by the American Society for 
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Gastrointestinal Endoscopy (ASGE Standards of Practice Committee et al., 2015). 
The American Urology Association does not recommend routine antibiotic 
prophylaxis for patients with joint replacements before urologic procedures, but they 
do recommend giving it for certain high-risk groups (such as during the first two 
years after joint replacement surgery and for immunocompromised patients) (Wolf 
et al., 2008). 
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3 AIMS OF THE STUDY 
The aims of the present study were: 
1) To compare the old CDC diagnostic criteria for PJI with the consensus meeting 
criteria from 2013 in patients with a suspected PJI and to examine possible reasons 
for discordance between the criteria sets (Study I) 
2) To assess the effect of preoperative bacteriuria on the risk for PJI in a one-year follow-
up (Study II) 
3) To assess the effect of preoperative oral antibiotic use on the risk for PJI in a one-
year follow-up (Study III) 
4) To examine the risk for developing a PJI during an episode of bacteremia and to 
identify possible risk factors leading to it (Study IV) 
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4 SUBJECTS AND METHODS 
4.1 Overview of the study 
The retrospective study was conducted in the Coxa Hospital for Joint Replacement, 
Tampere, Finland. It is a publicly funded tertiary hospital dedicated to joint 
replacement surgery with a population base of ca. 500 000. It was founded in 
September 2002 and approximately 2 000–3 000 joint replacement surgeries are 
performed there annually (Järvelin et al., 2018). It is also a referral center for 
complications related to joint replacement surgery. 
For Study I, patients from the Pirkanmaa Hospital District treated for a PJI of 
the hip or knee in the Coxa Hospital between 2002 and 2014 and with previous joint 
replacement surgery in 2013 or earlier (with no time limit) were identified. The 
primary joint replacements of the PJI patients could have been done in Coxa or in 
other hospitals.  Time periods were chosen to have at least one year of follow-up for 
each joint replacement. Only patients with total joint replacements were considered.  
Patient material in Studies II and III consisted of all patients undergoing a primary 
total hip or knee replacement in the Coxa hospital between September 2002 and 
December 2013. Study IV included patients from the Pirkanmaa Hospital District 
with a primary total hip or knee replacement performed in the Coxa hospital between 
September 2002 and December 2013. Each joint replacement was considered 
separately for patients with multiple primary joint replacements.  
Follow-up periods were one year in Studies II and III and from 0 to 12 years in 
Study IV. An overview of the patient material used in the studies and study settings 
is given in Table 8.  
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Table 8.  Overview of the study patients and settings 
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4.2 Data sources 
4.2.1 Identification of periprosthetic joint infection cases 
In order to identify as many PJI cases as possible for Study I, six different data 
sources were used to identify possible cases of infection. Descriptions of each data 
source and how the data was combined are given below. As data for the whole study 
period (2002–2014) could not be gathered from all data sources, time periods for 
available data are given for each source. The same combined data of infection cases 
was also used in Study IV, except that PJIs occurring in joints not previously 
operated in the Coxa hospital were excluded. 
For Studies II and III, all SSIs (including superficial and deep incisional infections 
and PJIs) were identified from the local healthcare-associated infection register of 
the Tampere University Hospital. 
4.2.1.1 Finnish Hospital Infection Program 
The Coxa hospital participates in the Finnish Hospital Infection Program (SIRO) of 
the National Institute for Health and Welfare. Data is prospectively collected from 
the participating hospitals according to the NNIS standards modified for Finland 
(Huotari et al., 2007b). SSI cases are classified according to the CDC criteria from 
1992 (Horan et al., 1992). The follow-up time for each patient is one year post-
operatively. 
In order to identify SSI cases that occur after discharge, patients are given a 
questionnaire form where they can report problems related to wound healing. In 
previous studies from the Coxa hospital, it was shown that annual response rate of 
the questionnaires ranged from 71 to 83% (Jämsen, 2009). In addition, an infection 
control nurse is employed to identify SSIs that are treated in the Coxa Hospital. 
PJI cases from the Coxa hospital in the Finnish Hospital Infection Program from 
2005–2010 and 2012–2013 were identified. The Coxa hospital joined the surveillance 
program in 2005. The year 2011 is missing due to technical problems in data transfer. 
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4.2.1.2 Local healthcare-associated infection register of the Tampere University 
Hospital 
Data gathered as part of the infection surveillance for the SIRO program is also 
recorded in the local healthcare-associated infection register of the Tampere 
University Hospital (SAI). The register is run by a team of infection control nurses 
and lead by a specialist in infectious diseases. PJI cases recorded in the register in 
2002–2014 were identified. 
SSI (including superficial, deep incisional infections and PJIs) cases recorded in 
the register within one year from primary surgery in 2002–2014 for patients with a 
primary knee or hip joint replacement performed in the Coxa hospital in 2002–2013 
were identified for Studies II and III. 
4.2.1.3 Microbial cultures from joint samples 
Positive microbial cultures from synovial fluid or tissue samples taken in the Coxa 
hospital in 2002–2014 were retrieved from the electronic records of the 
microbiological laboratory (see Section 4.2.3 for more details). 
4.2.1.4 Hospital discharge records 
Information on patients requiring overnight treatment in the hospital is recorded in 
the hospital discharge records, including diagnosis codes. Patients in the Coxa 
hospital with a diagnosis code related to a PJI [ICD-10 diagnosis code T84.5 
(Infection and inflammatory reaction due to internal joint prosthesis) or T81.4 
(Infection following a procedure, not elsewhere classified)] in 2002–2014 were 
identified from the discharge records. 
4.2.1.5 Local prospective joint replacement database 
All revision joint replacements that were performed because of an infection in the 
Coxa Hospital, as recorded by the operating surgeon between 2002–2014, were 
identified from the local joint replacement database (TEKOSET). 
The database is an electronic recording system designed to collect operative and 
outcome data on joint replacement surgery. Data is collected prospectively, and the 
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database covers preoperative, operative and postoperative data, including indications 
for surgery. (Jämsen, 2009.) 
4.2.1.6 Hospital infection register 
The Coxa Hospital has its own infection register that was established in 2012 for 
clinical purposes and to prospectively collect data on the quality of care. Data is 
recorded in the register by a dedicated nurse; however, it is not collected according 
to any official infection surveillance guidelines, but more on a case-by-case basis. All 
PJI cases recorded in the register in 2012–2014 were identified. 
4.2.1.7 Combining the data and case verification 
After all possible cases of PJI (n=1 425) were identified from the six different data 
sources, patient charts of each patient were reviewed by the author of this thesis 
(MH). Unclear cases (n=67) were also reviewed by two infectious diseases specialists. 
Patients from outside of the Pirkanmaa Hospital District area (n=403) were excluded 
immediately. Patient exclusion based on other reasons was done after reviewing the 
patient charts. The most common reasons for exclusion were superficial wound 
infections (recorded as such in the SSI surveillance and verified from the patient 
charts, n=218) and cases mistakenly recorded as infections in the hospital discharge 
records (n=177). Positive bacterial cultures (n=60) without infection were defined 
as a single positive bacterial culture without any other diagnostic criteria for 
infection, including the treating physician’s opinion. In addition, early PJIs previously 
operated in another hospital (n=4) and cases outside the study period (n=27) were 
excluded. Other reasons for exclusion are shown in Figure 1.  
An overview of the combined data is shown in Figure 1. It was verified from the 
patient charts that all included cases fulfilled at least one set of diagnostic criteria 
studied. 
 58 
 
Figure 1.  Overview of the patient data used in Study I 
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4.2.2 Drug registries of the Social Insurance Institution of Finland (Studies 
II – IV) 
4.2.2.1 Drug reimbursement data 
In Finland, patients with certain chronic illnesses are entitled to drug 
reimbursements for their medication. In order to receive reimbursements, the 
patient requires a certificate from the treating doctor. The right to reimbursements 
is granted based on specific diagnostic criteria for each disease, and with some 
diseases (e.g. hypertension) these criteria might differ from the criteria used to 
determine whether or not medication should be initiated. The Social Insurance 
Institution of Finland maintains a national drug reimbursement register, where 
special reimbursement codes and dates of entitlement are recorded for each person. 
Patients with a valid right to reimbursement for diabetes, rheumatic diseases, 
hypertension, chronic heart failure, chronic coronary disease, arrhythmias, chronic 
lung disease, Parkinson's disease, epilepsy, Alzheimer's disease, psychotic disorders, 
hematological and solid malignancies at the time of their primary joint replacement 
surgery were identified from the national register. Chronic heart failure, chronic 
coronary disease and arrhythmias were grouped together for the analyses, as were 
Parkinson’s disease, epilepsy, Alzheimer’s disease and psychotic disorders. Data on 
comorbidities was used in Studies II–IV. 
4.2.2.2 Preoperative oral antibiotics 
Antibiotics are not available in Finland without a prescription from a doctor and all 
antibiotic purchases are recorded in a nationwide prescription register run by the 
Social Insurance Institution of Finland. It is commonly used for research purposes, 
as information on drug purchases can be easily retrieved. However, drugs given for 
in-patients are not recorded in the register. (Furu et al., 2010.) 
The courses of antibiotics purchased by the patients within 90 days before the 
joint replacement surgery were identified from the prescription register for Studies 
II and III. The antibiotics were identified based on their Anatomical Therapeutic 
Chemical Classification System (ATC) codes (WHO list of ATC codes), and the type 
of antibiotic, number of packages and the date of purchase were recorded. 
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4.2.3 Microbiological data 
All microbiological data was retrieved from the electronic records of the accredited 
microbiological laboratory of the Tampere University Hospital. 
Positive microbial cultures from synovial fluid or tissue samples taken in the Coxa 
hospital in 2002–2014 that were used in Study I to identify PJI cases were also used 
in Studies II–IV to evaluate the causative pathogens for PJIs.  
The results of preoperative urine samples taken within 90 days before elective 
joint replacement surgery were obtained (Study II). From positive samples, the 
species of bacteria found and their antibiotic susceptibility data were recorded. The 
sample taken closest to the date of operation was used in the analyses, if more than 
one sample was taken. All bacterial growth in the urine was considered significant, 
except when mixed bacterial flora was reported. If more than one bacterium was 
reported in the sample, they were all recorded. 
Positive blood culture results of the study patients occurring after the first joint 
replacement surgery until December 2014 were obtained (Study IV). Positive blood 
cultures caused by low-virulence bacteria (i.e. CoNS, corynebacteria, micrococci or 
Cutibacterium species) were considered to be contaminants, unless there was growth 
on two blood culture bottles. Positive blood cultures by other pathogens were always 
considered significant. 
4.2.4 Other data 
Additional patient-related data was retrieved from the local hospital database 
(TEKOSET). This data included preoperative information (municipality of 
residence, the weight and the height of patients and the indication for surgery), 
operative information (use of antibiotic-impregnated cement in the operation) and 
postoperative information (revision surgeries and date of death). The data on weights 
and heights was used to calculate BMIs. 
The official database of carriers of multidrug resistant microbes in Pirkanmaa 
Hospital District was used to identify MRSA carriers. 
Prophylactic intravenous antibiotics were administered perioperatively prior to 
incision in all joint replacement surgeries, a single dose of 3 grams of cefuroxime was 
used unless contraindicated. If this was the case, then 900 milligrams of clindamycin 
or one gram of vancomycin was used. Known MRSA carriers were given cefuroxime 
and vancomycin. If cement was used in the operation, it was gentamicin-
impregnated. 
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4.3 Definition of outcome 
In Study I, each case of PJI was checked to see, which diagnostic criteria they fulfilled 
from the old CDC criteria for PJIs (Horan et al., 1992) and from the diagnostic 
criteria set defined in the international consensus statement from 2013 (Zmistowski 
et al., 2014). Either the day when the new criteria set were met or, if that did not 
happen, the day when treatment was started (usually the day of revision joint 
replacement) was defined as the date of the occurrence of infection. Data was 
collected on an electronic data collection form. 
The primary outcome in Studies II and III was the occurrence of a PJI, identified 
from the local healthcare-associated infection register. The occurrence of any SSI 
(superficial, deep incisional or PJI) was considered to be a secondary outcome. 
In Study IV, the primary outcome was a PJI as a consequence of bacteremia. This 
was identified, if the same organism was cultured from blood and from the affected 
joint, unless the PJI was determined to be the source of the bacteremia. The latter 
definition was based on the timing of symptom onset. For culture-negative PJIs in 
patients with bacteremia, patient charts were reviewed to find out if the PJI was 
determined by the treating clinician to be caused by the pathogen identified in the 
blood culture. In addition, if there was a duration of more than seven days between 
the positive blood culture and identification of the PJI, patient charts were checked 
to verify the association. 
4.4 Statistical methods 
Frequencies for different variables were calculated and cross tables formed to 
compare the different diagnostic criteria in the whole study material and in different 
clinical subgroups (Study I). Incidence rates (per 1 000 person-years) were calculated 
for bacteremias and PJIs in Study IV. 
Means and standard deviations (SD) were calculated for continuous variables 
with a normal distribution and medians and range for variables with a skew 
distribution. Categorical variables were compared using χ2 test and continuous 
variables with Student's independent-samples t-test. 
To examine the association between positive urine cultures (Study II) and 
preoperative oral antibiotic use (Study III) and the outcome (PJIs and all SSIs 
separately), binary logistic regression with univariate analysis was used and ORs 
(odds ratios) and 95% CIs (confidence intervals) were calculated. Then, a 
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multivariable model was developed to account for confounding factors. Variables in 
the model included patients’ gender, operated joint, age, BMI (only Study III), use 
of cement in the operation (only Study III), indication for surgery (osteoarthritis, 
rheumatic disease, previous trauma and other reasons) (only Study III) and chronic 
diseases (chronic heart disease, chronic lung disease, diabetes, hypertension, 
malignancy, neurological or psychiatric disorder and rheumatic disease). In Study III, 
a separate analysis was also performed for patients with antibiotics with potential 
activity against staphylococci (amoxicillin-clavulanate, cephalosporins, clindamycin, 
flucloxacillin, fluoroquinolones, macrolides, tetracyclines, trimethoprim and 
trimethoprim/sulfamethoxazole). 
Binary logistic regression with univariate analysis was also used to examine the 
association between potential risk factors (number of bacteremias, BMI, male 
gender, knee location, time since previous joint replacement surgery, age, indication 
for joint replacement surgery, use of cement in the operation and chronic diseases) 
and the development of a PJI as a consequence of bacteremia in Study IV. 
For Study III, variables associated with preoperative antibiotic use were used to 
calculate propensity scores. Patient matching was performed using nearest neighbour 
matching with caliper width 0.02 (0.2 of the standard deviation of the logit of the 
propensity score). This resulted in 4 106 matched pairs. A logistic regression analysis 
was performed in the matched patient population. 
In all studies, a p-value <0.05 was considered statistically significant. All statistical 
analyses were performed using SPSS for Windows statistical software package 
versions 23.0 (Studies I–III) or 25.0 (Study IV). 
4.5 Ethical considerations 
Informed patient consent was not required according to the Finnish national 
legislation, as all data was retrospectively gathered from patient charts and registers. 
Permission to review patient charts was acquired from the heads of the Science 
Centre of the Pirkanmaa Hospital District and Coxa Hospital. A statement from the 
Ethical Review Board of the Pirkanmaa Hospital District was acquired. 
All data analyses were performed using pseudonymized data and patient-
identifiers were stored in a secure drive of the Pirkanmaa Hospital District. 
Good clinical practice and the Helsinki Declaration were followed during the 
conduction of the study. The aims of the study were clinically relevant, and the study 
methods used were validated and well-known to the researchers. 
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5 SUMMARY OF THE RESULTS 
The incidence of PJI was 0.68% (158/23 171 joint replacements) in a one-year 
follow-up after primary hip or knee replacement surgery (Studies II and III). For hip 
replacements, the incidence was 0.57% (58/10 200) and for knee replacements 
0.77% (100/12 971). In total, there were 490 SSIs (2.11%), when also the superficial 
and deep incisional infections were included. 
In the longer follow-up period (up to 12 years, Study IV) the incidence of PJI 
after primary joint replacement surgery was 1.50% (288/19 262) and the incidence 
rate was 3.3 per 1 000 person-years. Of these PJIs, 131 (45%) occurred within 90 
days from previous surgery, 53 (18%) occurred within 3–12 months and 104 (36%) 
occurred after one year. The distribution of PJIs over time is shown in Figure 2. 
 
 
Figure 2.  The distribution of periprosthetic joint infections over time 
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5.1 Concordance between diagnostic criteria for periprosthetic 
joint infections (Study I) 
There was a notable difference in the incidence of PJI when two different sets of 
diagnostic criteria were used. Of the 405 PJI cases identified, 73 (18%) met only the 
old CDC criteria, but not the new consensus meeting criteria (Table 9). On the other 
hand, only one case (0.2%) fulfilled only the new set of criteria. The proportions of 
cases meeting the old and new criteria were similar when examined in different 
patient-related (gender and age), joint-related (location and previous operation) and 
infection-related (infection type and year of diagnosis) subgroups (Table 10). Ninety-
one percent of patients with positive bacterial cultures met both sets of diagnostic 
criteria, as bacterial cultures are part of both sets of criteria. 
Table 9.  Number of cases meeting the old and new diagnostic criteria for periprosthetic joint 
infection 
 N % of all cases 
CDC criteria from 1992   
Purulent drainage from a drain that is placed through a stab wound into the 
organ/space 0 0 
Organisms isolated from an aseptically obtained culture of fluid or tissue in the 
organ/space 327 81 
An abscess or other evidence of infection involving the organ/space that is found 
on direct examination, during reoperation, or by histopathologic or radiologic 
examination 38 9 
Diagnosis of an organ/space SSI by a surgeon or attending physician 400 99 
Total 404 100 
Consensus meeting criteria from 2013   
Major criteria   
Two positive periprosthetic cultures with phenotypically identical organisms 239 59 
A sinus tract communicating with the joint 82 20 
Minor criteria   
Any three minor criteria 106 26 
Elevated serum CRP and ESR* 199 49 
Elevated synovial fluid WBC count or change on leukocyte esterase test strip† 192 47 
Elevated synovial fluid PMN percentage‡ 178 44 
A single positive culture 88 22 
Positive histological analysis of periprosthetic tissue 11 3 
Total 332 82 
*, CRP was measured from 402 patients, ESR from 152 patients and both from 152 patients. Early infections 
with an elevated CRP were considered to be fulfilling this criterion; †, Synovial fluid WBC was measured from 
209 patients, leukocyte esterase test strips were not in use; ‡, Synovial fluid PMN% was measured from 198 
patients 
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Table 10.  Number of cases meeting the old and new diagnostic criteria for periprosthetic joint 
infection in different clinical subgroups 
Subgroup Cases Cases fulfilling 
only the old CDC 
criteria 
Cases fulfilling only 
the new consensus 
meeting criteria 
Cases fulfilling 
both sets of 
criteria 
 n n % n % n % 
All cases 405 73 18 1 0.2 331 82 
Patient-related        
Gender        
Men 177 28 16 0 0 149 84 
Women 228 45 20 1 0.4 182 80 
Age        
≤70 195 37 19 0 0 158 81 
>70 210 36 17 1 0.5 173 82 
Joint-related        
Joints        
Hips 167 32 19 1 0.6 134 80 
Knees 238 41 17 0 0 197 83 
Previous operation        
Primary arthroplasty 285 48 17 1 0.4 236 83 
Revision arthroplasty 120 25 21 0 0 95 79 
Infection-related        
Infection type        
Early 151 24 16 1 0.7 126 83 
Delayed 63 15 24 0 0 48 76 
Late 191 34 18 0 0 157 82 
Bacterial culture        
Positive 327 28 9 0 0 299 91 
Negative 78 45 58 1 1.3 32 41 
Infections diagnosed in        
2002–2006 97 29 30 0 0 68 70 
2007–2010 165 20 12 0 0 145 88 
2011–2014 143 24 17 1 0.7 118 83 
When possible reasons for the discordance between the diagnostic criteria sets were 
examined, it was discovered that of the patients who did not fulfil the new criteria, 
39 (53%) had their diagnosis based solely on the clinician’s opinion. Fifteen (39%) 
of these patients fulfilled two of the minor criteria from the new criteria set. 16 (41%) 
had an increased number of leucocytes in the joint aspirate, 16 (41%) an increased 
number of polymorphonuclear cells, 13 (33%) had an elevated CRP and ESR value 
and 30 (77%) had an increased CRP value. 
ESR was measured in 152 (38%) cases with a suspected PJI. If patients with a 
delayed or late PJI with an elevated CRP value, but whose ESR was not measured, 
were assumed to have an increased ESR, 169 patients would fulfil three or more 
minor criteria of the consensus meeting criteria. However, only 17 new infectious 
cases would be identified in total, as most of these patients also fulfilled either one 
of the main criteria. Of these new cases, 13 did not meet any other CDC criteria 
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besides the clinician’s diagnosis. If they were considered to have a PJI according to 
the new criteria, there are still 26 (6%) cases in the whole study population, where 
the clinician’s diagnosis is the only basis for the diagnosis of PJI. 
There were 78 culture-negative cases. Of these, 58% (45/78) did not meet the 
new consensus meeting criteria for PJI. However, 38 (49%) fulfilled two minor 
criteria from the new criteria set. 38 (49%) had an increased number of leucocytes, 
37 (47%) an increased number of polymorphonuclear cells in the joint aspirate, CRP 
and ESR were elevated in 38 (49%) of the patients and CRP was elevated in 58 
(74%). Even though the number of intraoperative tissue samples taken increased 
over time, the proportion of culture-positive cases did not. Forty-nine (63%) of the 
culture-negative cases had four or more intraoperative samples. 
5.2 Microbiology of periprosthetic joint infections 
5.2.1 Early and delayed periprosthetic joint infections 
The most common causative pathogens for PJIs during the first year after primary 
joint replacement surgery were S.aureus and CoNS (Table 11), with a slightly higher 
proportion of S.aureus during the first 3 months and a slightly higher proportion of 
CoNS 3–12 months after surgery. Streptococci were more common for delayed PJIs 
than for early infections. Gram-negative bacteria were found only in polymicrobial 
infections, most of which were early infections. Overall, 19% of the PJIs were 
culture-negative. 
Table 11.  The distribution of pathogens causing periprosthetic joint infections after primary joint 
replacement in a one-year follow-up 
Pathogen Early infections* (n=88) Delayed infections† (n=70) 
 n % n % 
Gram-positive bacteria     
Staphylococcus aureus 26 30 17 24 
Coagulase-negative staphylococci 22 25 20 29 
Streptococci 7 8.0 11 16 
Enterococci 1 1.1 0 0 
Other gram-positive 2 2.3 2 2.9 
Polymicrobial 15 17 1 1.4 
Culture-negative 12 14 18 26 
No cultures taken 3 3.4 1 1.4 
*, Periprosthetic joint infections occurring within 3 months from surgery; †, Periprosthetic joint infections 
occurring 3–12 months from surgery 
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5.2.2 Periprosthetic joint infections as a consequence of bacteremia (Study 
IV) 
There were 542 patients (out of 14 378, 3.8%) with at least one episode of bacteremia 
during the study period. Eighty-five (0.6%) patients had more than one bacteremia. 
Overall, there were 643 separate episodes of bacteremia. They occurred 3–4 285 days 
after the first joint replacement (median 1 460 days), and 85 (13%) occurred within 
one year. E.coli was the most common pathogen causing the bacteremias (241/643, 
37% of bacteremias), followed by S.aureus (105, 16%), beta-hemolytic streptococci 
(58, 9%), Streptococcus pneumoniae (43, 7%), CoNS (28, 4%) and enterococci (28, 4%). 
Seven percent (46/643) of the bacteremias resulted in a PJI, one of these was a 
bilateral knee infection. The development of a PJI as a consequence of bacteremia 
was most common for beta-hemolytic streptococci (21%, 12/58), S.aureus (20%, 
21/105) and viridans group streptococci (16%, 4/25), but rare for gram-negative 
bacteria (1.3%, 4/314) (Figure 3). There were no PJIs related to bacteremias caused 
by CoNS. 
 
 
Figure 3.  The risk for developing a periprosthetic joint infection (PJI) during bacteremia caused by 
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5.3 Risk factors for periprosthetic joint infection (Study II, Study 
III, Study IV) 
The distribution of characteristics of patients with primary joint replacement surgery 
and with and without PJI in a one-year follow-up is shown in Table 12. From the 
overall population, 62% (14 901/23 171) were female, 56% (12 971/23 171) had a 
knee replacement and the indication for surgery was osteoarthritis for 91% of the 
patients (21 005/23 171). 
Table 12.  The characteristics of patients with primary joint replacement surgery with and without 
periprosthetic joint infection (PJI) 
Patient characteristic Patients with PJI (n=158) Patients without PJI (n=23 013) 
n % n % 
Gender     
Male 86 54 8 724 38 
Female 72 46 14 289 62 
Replaced joint     
Hip 58 37 10 142 44 
Knee 100 63 12 871 56 
Indication for surgery     
Osteoarthritis 135 85 20 870 91 
Rheumatoid arthritis 9 6 803 3 
Trauma 10 6 742 3 
Other 4 3 526 2 
Unknown 0 0 72 0.3 
Use of cement in the operation 123 78 17 827 77 
Age, mean (SD) 69 11 67 11 
Known MRSA-carrier* 1 0.6 61 0.2 
Rural living location 26 17 3 116 14 
Chronic comorbidities     
Chronic heart disease† 13 8 2 357 10 
Chronic lung disease 11 7 1 504 7 
Diabetes 20 13 1 857 8 
Hypertension 35 22 6 281 27 
Malignancy 3 2 804 3 
Neurological or psychiatric disease‡ 6 4 861 4 
Rheumatic disease 5 3 1 207 5 
*, Methicillin-resistant Staphylococcus aureus; †, Chronic heart failure, chronic coronary disease and 
arrhythmias; ‡, Parkinson’s disease, epilepsy, Alzheimer’s disease and psychotic disorders 
5.3.1 Preoperative factors 
Male gender, older age and diabetes were associated with an increased risk for PJI in 
a one-year follow-up in a univariate analysis (Table 13). Knee replacement also 
seemed to increase the risk, but this was not statistically significant. In the 
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multivariable analysis, male gender, knee replacement and older age were associated 
with an increased risk for PJI, the effect of diabetes was also almost statistically 
significant (Table 13). On the other hand, besides diabetes, other chronic 
comorbidities were not associated with an increased risk for PJI (Table 13). 
The same preoperative risk factors that increased the risk for PJI also increased 
the overall risk for developing an SSI in the multivariable analysis: male gender (OR 
1.45, 95% CI 1.19–1.77), knee replacement (OR 1.58, 95% CI 1.29–1.94) and older 
age (OR 1.01, 1.00–1.02). Diabetes, however, was not associated with an increased 
risk for SSI in the multivariable analysis (OR 1.09, 0.78–1.52). 
Table 13.  The effect of preoperative factors on the risk for periprosthetic joint infection 
Factor Univariate analysis Multivariable analysis 
 OR 95% CI OR 95% CI 
Male gender 1.96 1.43–2.68 2.21 1.56–3.11 
Knee replacement 1.36 0.98–1.88 1.43 1.01–2.04 
Age 1.01 1.00–1.03 1.03 1.01–1.05 
Positive urine culture 0.72 0.34–1.54 0.82 0.38–1.77 
Chronic comorbidities     
Chronic heart disease 0.78 0.55–1.10 0.58 0.28–1.21 
Chronic lung disease 1.07 0.58–1.98 1.04 0.53–2.05 
Diabetes 1.65 1.03–2.65 1.64 0.99–2.73 
Hypertension 0.76 0.52–1.11 1.09 0.50–2.38 
Malignancy 0.54 0.17–1.68 0.55 0.17–1.72 
Neurological or psychiatric disease† 1.02 0.45–2.30 1.15 0.51–2.63 
Rheumatic disease 0.59 0.23–1.44 0.61 0.23–1.67 
*, Chronic heart failure, chronic coronary disease and arrhythmias; †, Parkinson’s disease, epilepsy, Alzheimer’s 
disease and psychotic disorders 
5.3.1.1 Preoperative bacteriuria 
A preoperative urine sample was available in 87% (20 226/23 171) of primary joint 
replacement operations. Positive urine cultures were found in 1 378 samples (6.8%), 
1 237 (90%) of these from women. Positive urine cultures were more common in 
older patients: mean age was 73 years (SD 10 years) for patients with bacteriuria and 
67 years (SD 11 years) for patients without bacteriuria. Patients with positive urine 
cultures also had more chronic diseases than patients with negative urine cultures 
(Table 14). 
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Table 14.  Comparison of chronic diseases in patients with positive and negative preoperative 
urine cultures 
Chronic disease Positive urine culture 
(n=1 378) 
Negative urine culture 
(n=18 848) 
 
 n % n % p-value 
Hypertension 491 36 5 138 27 <0.001 
Diabetes 160 12 1 508 8 <0.001 
Chronic heart disease* 159 12 1 947 10 0.16 
Chronic lung disease 116 8 1 215 6 0.004 
Rheumatic disease 97 7 959 5 0.002 
Neurological or psychiatric disease† 85 6  662 4 <0.001 
Malignancy 62 5 599 3 0.008 
*, Chronic heart failure, chronic coronary disease and arrhythmias; †, Parkinson’s disease, epilepsy, Alzheimer’s 
disease and psychotic disorders 
The incidence of PJI was 0.51% (7/1 378) for patients with a positive urine culture 
and 0.71% (133/18 848) for patients with a negative urine culture. Bacteriuria was 
not associated with an increased risk for PJI in the univariate or multivariable analysis 
(Table 13). In addition, there was no correlation between pathogens found in the 
preoperative urine samples and those causing the PJIs (Table 15). There was also no 
connection between bacteria found in the urine and those causing the superficial or 
deep wound infections. 
Table 15.  Description of patients with preoperative bacteriuria and periprosthetic joint infection 
 Age Gender Joint Time 
between 
urine 
sample 
and 
surgery 
(days) 
Time 
between 
surgery 
and 
infection 
(days) 
Treatment 
of 
bacteriuria 
with 
effective 
antibiotics 
Pathogen 
found in 
urine 
Pathogen 
causing PJI 
1 81 Female Hip 36 16 No Enterococcus 
faecalis 
Staphylococcus 
aureus 
2 76 Female Knee 9 16 Yes Escherichia coli NA* 
3 76 Male Knee 31 18 No Enterococcus 
faecalis 
Coagulase-
negative 
staphylococcus 
4 63 Female Knee 11 36 No Klebsiella 
pneumoniae 
Staphylococcus 
aureus 
5 81 Female Knee 64 85 No Escherichia coli Coagulase-
negative 
staphylococcus 
6 75 Female Knee 0 142 No Escherichia coli NA* 
7 79 Male Knee 29 258 No Coagulase-
negative 
staphylococcus 
Staphylococcus 
epidermidis† 
*, Culture-negative PJI; †, Different antibiogram from the strain found in the urine 
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Among the 2 945 patients with a missing urine sample, there were 18 cases of PJI 
(0.61%). The overall incidence of SSI was 1.8% (53/2 945). These incidences were 
similar to the incidences in the whole study population. In the 11 cases where the 
pathogen causing the PJI could be identified (S.aureus, Corynebacterium species and 
CoNS), no typical urinary tract pathogens were found. 
5.3.2 Risk factors for hematogenous periprosthetic joint infections 
Chronic comorbidities, gender or obesity did not affect the risk for developing a PJI 
during bacteremia (Table 16). Older age was associated with a lower risk for 
developing a PJI, but when the effect of E.coli bacteremias was examined in a 
multivariable analysis, this was no longer statistically significant (OR 0.97, 95% CI 
0.95–1.00). There were also no joint-related factors (indication for primary surgery, 
joint location, time since previous surgery or use of cement in the primary operation) 
that affected the risk for developing a PJI during bacteremia. 
On the other hand, having several bacteremias during the study period increased 
the risk for developing a PJI as a consequence of bacteremia (Table 16). 
Furthermore, the risk for developing a PJI was higher for bacteremias occurring 
within a year from previous surgery than for bacteremias occurring later. 
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Table 16.  Potential risk factors for developing a periprosthetic joint infection (PJI) as a 
consequence of bacteremia 
Risk factor Joints with PJI 
(n=47) 
Joints without PJI 
(n=672) 
  
 n (%) n (%) OR 95% CI 
Patient characteristics     
Age at the time of bacteremia, 
y, mean (standard deviation)* 
71 (11) 76 (10) 0.97 0.94–0.99 
Body mass index ≥25 38 (81) 473 (70) 1.82 0.70–4.72 
Chronic heart disease 6 (13) 72 (11) 1.22 0.50–2.97 
Chronic lung disease 3 (6) 33 (5) 1.32 0.39–4.48 
Diabetes 5 (11) 103 (15) 0.66 0.25–1.70 
Male gender 21 (45) 276 (41) 1.16 0.64–2.10 
Rheumatic disease 3 (6) 59 (9) 0.71 0.21–2.35 
Joint-related     
Osteoarthritis as indication for 
primary operation 
43 (92) 588 (88) 0.65 0.23–1.86 
Knee location 29 (62) 398 (59) 1.11 0.60–2.04 
Time since previous joint 
replacement (years)* 
    
<1 17 (36) 94 (12) 1.00  
1–10 28 (60) 672 (85) 0.23 0.12–0.44 
>10 2 (4) 24 (3) 0.46 0.10–2.13 
Use of cement in the primary 
operation 
35 (74) 555 (83) 0.59 0.30–1.17 
Other     
Number of bacteremias ≥2 13 (28) 96 (14) 2.29 1.17–4.50 
*, Calculated for each bacteremia and joint (n=837) separately 
5.4 Prevention of periprosthetic joint infections 
5.4.1 Treatment of preoperative bacteriuria (Study II) 
Twenty-five percent (344/1 378) of the patients with preoperative bacteriuria 
received antibiotics after the urine sample was taken. Of these, the prescribed 
antibiotic was not effective against the pathogen found in the urine in 51 cases. Thus, 
293 (21%) patients with bacteriuria received effective antibiotic treatment. 
One patient (0.34%) with effective antibiotic treatment for bacteriuria had a PJI 
in a one-year follow-up, whereas six patients out of 1 085 (0.55%) with bacteriuria, 
but no (effective) antibiotic treatment, had a PJI. Treating preoperative bacteriuria 
with effective antibiotics did not affect the risk for developing a PJI (OR 0.62, 95% 
CI 0.07–5.14). 
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5.4.2 Preoperative antibiotic use (Study III) 
Overall, 18% (4 106/23 171) of the primary joint replacement operations were 
preceded by at least one course of antibiotics within 90 days before the operation. 
In 4.3% (989) operations there was more than one course of antibiotics. The 
distribution of time difference between the surgery and the purchase of the antibiotic 
course closest to the surgery is shown in Figure 4, the median number of days was 
30. 
 
 
Figure 4.  The distribution of time (in days) between the joint replacement and the purchase of 
antibiotics (the antibiotic course closest to the surgery) 
First-generation cephalosporins, penicillin and pivmecillinam were the most 
commonly prescribed antibiotics (Table 17). Overall, the number of preoperatively 
purchased packages of antibiotics was 5 741, and the average antibiotic consumption 
was 2.75 packages per 1 000 patients per day. 
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Table 17.  The most commonly used groups of antibiotics before elective joint replacement 
surgery 
Antibiotic group Number of operations preceded by antibiotic 
 n % (of all operations) 
First-generation cephalosporins 984 4.2 
Penicillin 693 3.0 
Pivmecillinam 571 2.5 
Amoxicillin 544 2.3 
Fluoroquinolones 500 2.2 
Tetracyclines 424 1.8 
Macrolides 374 1.6 
Trimethoprim 303 1.3 
Amoxicillin-clavulanate 182 0.8 
Clindamycin 146 0.6 
For patients with preoperative oral antibiotic use, the incidence of PJI was 0.29% 
(12/4 106), and for patients without antibiotic use, the incidence was 0.77% (146/19 
065). The use of oral antibiotics within 30 days and 90 days before joint replacement 
surgery was associated with a lower risk for subsequent PJI in a univariate analysis 
(Table 18). The results remained statistically significant also in the multivariable 
analysis for antibiotic use 30 days preoperatively (OR 0.24, 95% CI 0.08–0.77) and 
90 days preoperatively (OR 0.40, 95% CI 0.22–0.73). No individual antibiotic or 
antibiotic group decreased the risk statistically significantly (Table 18). The risk for 
PJI was statistically significantly decreased for patients with the use of anti-
staphylococcal antibiotics (OR 0.34, 95% CI 0.16–0.72), when compared to patients 
without preoperative antibiotics, but not for patients with the use of other antibiotics 
(OR 0.46, 95% CI 0.19–1.13). 
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Table 18.  The effect of preoperative oral antibiotic use on the risk for developing a periprosthetic 
joint infection (PJI) 
Antibiotic use Univariate analysis 
 OR 95% CI 
Antibiotic use 30 days preoperatively 0.26 0.10–0.71 
Antibiotic use 90 days preoperatively 0.38 0.21–0.69 
The effect of individual antibiotic groups   
Amoxicillin 0.53 0.13–2.15 
Amoxicillin-clavulanate NA* NA* 
Clindamycin 1.01 0.14–7.23 
First-generation cephalosporins 0.29 0.07–1.16 
Fluoroquinolones 0.58 0.14–2.35 
Macrolides 0.78 0.19–3.16 
Penicillin 0.41 0.10–1.67 
Pivmecillinam 0.51 0.13–2.05 
Tetracyclines NA* NA* 
Trimethoprim NA* NA* 
*, There were no PJIs in this group 
The use of preoperative oral antibiotics decreased the risk for PJI in different 
subgroup analyses as well. Results were similar when the operated joint (hip joint 
OR 0.36, 95% CI 0.13–1.00, knee joint OR 0.38, 95% CI 0.19–0.79), use of cement 
in the operation (cement used OR 0.40, 95% CI 0.21–0.77, cement not used or not 
known OR 0.29, 95% CI 0.07–1.22) and indication for surgery (osteoarthritis OR 
0.37, 95% CI 0.17–0.70, other indications OR 0.47, 95% CI 0.11–1.99) were 
considered. However, due to insufficient statistical power, the results were not 
statistically significant in some subgroups. 
The use of preoperative antibiotics 90 days preoperatively did not have an effect 
on the overall risk for SSI. The incidence of SSI was 1.90% (78/4 106) for patients 
with antibiotics and 2.16% (412/19 065) for patients without antibiotics (OR 0.88, 
95% CI 0.69–1.12). 
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6 DISCUSSION 
6.1 Diagnostic criteria for periprosthetic joint infection 
There was notable discordance between the old CDC criteria and the consensus 
meeting diagnostic criteria for PJI from 2013 in Study I: one fifth of the PJI cases 
were identified as such only by the old criteria, but not the newer ones. Mainly the 
reason for this was that many of the cases identified as PJIs only by the treating 
clinician failed to meet the new, more objective, diagnostic criteria. Thus, different 
numbers of PJIs are identified by the different sets of criteria and the incidence of 
PJI is slightly lower when the new criteria are used. 
The new diagnostic criteria were created in 2013 as an attempt to provide a gold 
standard for the diagnosis of PJI that could be used in research work and infection 
surveillance. However, they have not been validated, and neither have there been 
any previous studies comparing the old and new sets of criteria. The results of Study 
I raise two important points. Firstly, there is a possibility that some PJI cases could 
be missed by the new diagnostic criteria, as such a large proportion of patients with 
PJIs according to the old criteria did not meet them. It is possible that unnecessarily 
strict diagnostic criteria could miss some PJI cases if the diagnostic resources used 
in clinical work are not sufficient in a hospital. Secondly, it is possible that some of 
the PJIs identified by the old criteria were in fact not infected. These questions are 
important to keep in mind when assessing surveillance numbers, especially from 
different time periods. 
Even though it can be questioned whether the 10% of the PJI cases where the 
diagnosis was based solely on the clinician’s opinion were truly infected, it is likely 
that at least some of these cases are nevertheless true PJIs. In some of these cases, 
the failure to meet three minor criteria from the new criteria set was because ESR 
was not measured, as CRP is generally the preferred inflammatory marker in Finland. 
In fact, the utility of measuring both CRP and ESR as markers of PJI is not clear. 
Ghanem et al. showed a lower sensitivity of using CRP and ESR in combination as 
a marker for PJI, when compared to using either one alone (Ghanem et al., 2009). 
Furthermore, Johnson et al. showed that the same sensitivity was obtained when 
CRP alone or CRP and ESR in combination were used to diagnose PJI of the knee, 
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but the combination resulted in a significant increase in the number of false negative 
cases (from 5.3% to 11.1%) (Johnson et al., 2011). Cases of PJIs with normal CRP 
and ESR have also been reported (McArthur et al., 2015). Thus, requiring both CRP 
and ESR for the diagnosis of PJI is likely not needed and this is indeed reflected in 
the newest set of proposed diagnostic criteria, where they are included separately and 
also given different weights (Parvizi et al., 2018; Shohat et al., 2019). 
Another reason for failing to meet the new diagnostic criteria could be the cut-
off levels for synovial fluid leucocytes and polymorphonuclear cells. The accuracy of 
the determined cut-off levels can be questioned, as they are based on a small number 
of studies that have variable results (Zmistowski et al., 2014). Furthermore, high 
sensitivity and specificity for lower cut-off values, ranging from 1 100–3 450 for 
leucocytes and 64%–78% for PMN%, have been reported (Cipriano et al., 2012; 
Dinneen et al., 2013; Ghanem et al., 2008; Trampuz et al., 2004). Using lower cut-
off values would have probably resulted in more patients being identified as having 
a PJI according to the new criteria as well. 
Nevertheless, it is likely that some of the cases reported as PJIs according to the 
clinician’s opinion were not truly infected, but could have for example represented 
adverse reactions to metal debris from metal-on-metal hip replacements (Judd & 
Noiseux, 2011; Mikhael et al., 2009; Wyles et al., 2013). These cases have been 
erroneously diagnosed as PJI, before the phenomenon was recognized. 
Unfortunately, in the study population of Study I, the types of joint replacements 
were not recorded and thus the number of metal-on-metal joint replacements is not 
known. 
The results of Study I also show the importance of a positive bacterial culture in 
the diagnosis of a PJI. In total, about 80% of patients had at least one positive 
bacterial culture and almost 60% had at least two. This was also the most commonly 
fulfilled part of the new consensus meeting criteria. Indeed, bacterial cultures have a 
well-established role in the diagnosis of a PJI, and two positive cultures with the 
same organism is enough to make a diagnosis of a PJI also according to the newest 
set of diagnostic criteria (Parvizi et al., 2018). There has still been some debate about 
the optimal number of samples that should be taken and also about the number of 
positive samples required for the diagnosis of a PJI. Even though most recent studies 
have shown that four samples might be the optimal number in terms of sensitivity 
and specificity (Bemer et al., 2016; Gandhi et al., 2017; Peel et al., 2016), almost two 
thirds of the culture negative cases in Study I had four or more samples taken. 
The importance of positive bacterial cultures in the diagnostic criteria for PJI is 
also shown by the fact that almost two thirds of the culture negative patients in Study 
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I met only the old CDC criteria. However, it is possible that some true culture 
negative PJIs were missed by the new criteria, as almost half of the culture negative 
cases met two other minor criteria. Thus, with a single positive bacterial culture, 
these patients would have been diagnosed as having a PJI also according to the new 
consensus meeting criteria. One possible reason for false negative bacterial cultures 
in PJI cases can be preceding antibiotic use (Berbari et al., 2007; Malekzadeh et al., 
2010), but unfortunately this information could not be attained for the study 
population in Study I. 
It should be acknowledged that the old CDC criteria were intended to be used 
for surveillance programs for a limited time period postoperatively, but Study I 
included patients that had been operated several years before. However, the number 
of patients identified by the two sets of diagnostic criteria were similar irrespective 
of the type of infection (early, delayed or late), suggesting that both criteria can also 
be applied for the diagnosis of late PJIs. 
There is a shift, especially in terms of research and surveillance purposes, from a 
subjective diagnosis of a PJI relying only on the clinician’s opinion to a diagnosis 
that is based on objective measurements. However, in clinical work, the diagnosis 
made by the clinician is still important and the new diagnostic criteria are not 
intended for clinical work as such. Nevertheless, a need for objective and uniform 
diagnostic criteria for PJI that can be used both in research and surveillance 
programs still remains. 
6.2 Risk factors for periprosthetic joint infection 
6.2.1 Preoperative bacteriuria 
Study II shows that there is no association between preoperative bacteriuria and 
subsequent SSI or PJI, even with the effect of chronic diseases taken into account. 
In addition, there was no connection between pathogens found in the preoperative 
urine samples and pathogens causing postoperative SSIs. 
The results of Study II are in line with many earlier studies (Berbari et al., 1998; 
Glynn & Sheehan, 1984; Ritter & Fechtman, 1987). In the classic study by Glynn 
and Sheehan (Glynn & Sheehan, 1984), preoperative bacteriuria was not associated 
with an increased risk for PJI, but the sample size of the study was very small and 
the follow-up period only three months. In fact, there were no PJIs in the whole 
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study population regardless of whether they had bacteriuria or not, thus making any 
definite conclusions impossible. A more recent study has also shown the lack of 
association between preoperative bacteriuria and subsequent PJI for hip joint 
replacements, but its reliability is again limited by a small sample size (Cordero-
Ampuero et al., 2013). In addition, none of the above-mentioned studies have taken 
into account the possible confounding effect of chronic diseases. 
There are other studies, however, where an association between preoperative 
bacteriuria and subsequent PJI has been found, even though no direct seeding from 
preoperative bacteriuria to the replaced joint has been reported (Ollivere et al., 2009; 
Sousa et al., 2014; Weale et al., 2019). Of these, studies by Sousa et al. and Weale et 
al. have larger sample sizes than other studies, but they are still considerably smaller 
than Study II, and especially the number of PJIs is considerably lower (Figure 5). 
Only in the study by Sousa et al. is there an attempt to take into account the effect 
of chronic diseases using a multivariable analysis, but this is not done very 
extensively, as only diabetes and obesity were included, in addition to the ASA score. 
Figure 5.  The results of studies on the effect of preoperative bacteriuria on the risk for periprosthetic 
joint infection (including Study II) (Cordero-Ampuero et al., 2013; Garcia-Nuno et al., 2017; 
Glynn & Sheehan, 1984; Martinez-Velez et al., 2016; Ritter & Fechtman, 1987; Sousa et 
al., 2014; Weale et al., 2019) 
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Since the publication of Study II, two meta-analyses have been published on the 
effect of preoperative bacteriuria on the risk for SSI and PJI (Gomez-Ochoa et al., 
2019; Sousa et al., 2019). Interestingly, both of these show an increased risk for 
infection in patients with bacteriuria. However, there is moderate heterogeneity 
among the studies included in the analyses, reflecting the conflicting results found in 
different studies. This can also be seen in Figure 5, which includes the studies in the 
meta-analysis by Sousa et al., but with corrected numbers. Sousa et al. have 
misinterpreted the results of the study by Glynn and Sheehan, as this older study 
does not have any PJIs in either group, but Sousa et al. report two PJIs in the 
bacteriuria group. In addition, the ORs for individual studies reported in the meta-
analysis by Sousa et al. are not correct, even though the overall OR has been 
calculated correctly. Despite the results of these meta-analyses, they both conclude 
that preoperative bacteriuria is probably a surrogate marker for some other unknown 
factor that is associated with an increased risk for PJI. On the other hand, it can be 
stated that the effect of possible confounding factors is taken into account most 
extensively in Study II when compared to the other studies and that patients with 
positive urine cultures have more chronic diseases than patients with negative ones.  
Finally, screening for preoperative bacteriuria before joint replacement surgery is 
not recommended by the most recent consensus meeting statement either (Ares et 
al., 2019), even though the varied results of different studies are acknowledged. The 
results of Study II are also referred to and can be seen to validate this conclusion 
even further. 
6.2.2 Risk factors for hematogenous periprosthetic joint infections 
The overall rate of developing a PJI as a consequence of bacteremia in Study IV, 
seven percent, corresponds with the results of Uçkay et al. In their study, 6% of 
bacteremias lead to the development of a PJI (Uçkay et al., 2009), but the overall 
number of bacteremias (n=81) was considerably lower than in Study IV. There are 
no other studies evaluating the rate of PJIs during bacteremia, except for SAB. 
Previous studies focusing on the risk of PJI during SAB have reported somewhat 
higher rates than in Study IV (Lalani et al., 2008; Murdoch et al., 2001; Sendi et al., 
2011). 
The most important factor influencing the risk for developing a PJI as a 
consequence of bacteremia in Study IV seemed to be the pathogen causing the 
bacteremia. There have not been any studies examining this previously. It can be 
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calculated from the results of Uçkay et al. that in their small study, the rate of PJI 
was 2.9% for bacteremia caused by E.coli, 14% for S.aureus and 40% for anaerobes. 
But as the number of PJIs as a consequence of bacteremia was only five, it is 
impossible to make any relevant conclusions from their results. The high risk related 
to SAB has been known before, but interestingly, the risk was as high for beta-
hemolytic streptococci as well in Study IV. Nevertheless, this can be expected, as 
beta-hemolytic streptococci have been reported to be important pathogens causing 
late hematogenous PJIs (Ainscow & Denham, 1984; Rodriguez et al., 2010; 
Stefánsdóttir et al., 2009). On the other hand, even though coagulase-negative 
staphylococci are important pathogens causing PJIs, surprisingly there were no PJIs 
during bacteremias caused by them in Study IV. There is evidence that nosocomial 
SABs are not associated with PJIs (Sendi et al., 2011; Tande et al., 2016), and as 
CoNS bacteremias are mostly nosocomial (Hitzenbichler et al., 2017), it is probable 
that these are not associated with PJIs either. Unfortunately, it was not possible to 
differentiate between nosocomial and community-acquired bacteremias in Study IV. 
Even though E.coli was the most common pathogen causing bacteremias in Study 
IV by far, particularly in the oldest age groups, the development of a PJI as a 
consequence of E.coli bacterermia was rare. Hence, such particular attention with 
regards to the development of a PJI does not need to be paid to patients with 
bacteremias caused by gram-negative bacteria when compared to SABs or 
bacteremias by beta-hemolytic streptococci. 
Different chronic diseases did not affect the risk of developing a hematogenous 
PJI in Study IV. Patient-related risk factors for hematogenous PJIs have not been 
identified in previous studies either (Sendi et al., 2011; Uçkay et al., 2009). Yet, 
multiple episodes of bacteremia were associated with an increased risk of PJI in Study 
IV, suggesting that there could be some unidentified factor predisposing the patients 
to infections in general. Nevertheless, rheumatic diseases or diabetes were not 
associated with an increased risk of developing a PJI during bacteremia. 
Importantly, the risk of developing a PJI during bacteremia was highest during 
the first year after previous surgery. Often, early PJIs have been categorically 
classified as non-hematogenous, but Study IV shows that even very early PJIs can 
be the result of a bacteremia and not vice versa, as most of the pathogens in these 
cases were not typical bacteria causing primary PJIs. Thus, the increased risk for PJI 
during the first two years after surgery, observed in previous large studies (Kurtz et 
al., 2010; Ong et al., 2009; Pulido et al., 2008), is possibly partly due to the increased 
risk for hematogenous PJIs. Still, there are studies such as the one by Rakow et al., 
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where most of the hematogenous PJIs occurred at a later occasion (Rakow et al., 
2019).  
6.3 Prevention of periprosthetic joint infections 
6.3.1 Treatment of preoperative bacteriuria 
Study II shows that treating preoperative bacteriuria with effective antibiotics does 
not have an effect on the risk for subsequent PJI. Other studies have not found any 
benefit in treating preoperative bacteriuria either, but the number of patients in many 
of the studies is very low (Table 19) (Cordero-Ampuero et al., 2013; Martinez-Velez 
et al., 2016; Sousa et al., 2014). It is interesting that even though Sousa et al. found a 
significant association between preoperative bacteriuria and risk for PJI, treating the 
bacteriuria did not have an effect on the risk for infection (Sousa et al., 2014). This 
seems to further support the assumption that preoperative bacteriuria is indeed a 
surrogate marker for some other factor related to the increased risk for PJI. 
Table 19.  The effect of treating preoperative bacteriuria on the risk for periprosthetic joint 
infection (PJI) (Cordero-Ampuero et al., 2013; Martinez-Velez et al., 2016; Sousa et al., 2014) 
Study PJI/treated bacteriuria PJI/untreated 
bacteriuria 
Effect of treatment 
Number % Number % OR 95% CI 
Cordero-Ampuero et al. 1/26 3.8 0/20 0 2.41 0.09–62.39 
Sousa et al. 6/154 3.9 7/149 4.7 0.82 0.27–2.51 
Martinez-Velez et al. 1/4 25 0/7 0 6.43 0.21–201.07 
Honkanen et al. (Study II) 1/293 0.3 6/1 085 0.6 0.62 0.07–5.14 
An interventional study by Lamb et al. showed that implementing a policy of not 
routinely screening preoperative urine samples led to a substantial decrease in the 
number of antibiotic prescriptions for preoperative bacteriuria as well, with no 
significant increase in the intervention period PJI rates (Lamb et al., 2016). This 
further supports the evidence that treatment of ASB preoperatively is not necessary, 
even though the study is limited by the remarkably low baseline PJI rate and the fact 
that outpatient antibiotic use could not be assessed. 
Based on the evidence found in previous studies, including Study II, the recent 
international consensus meeting statement advices against treatment of preoperative 
asymptomatic bacteriuria (Ares et al., 2019). It can be seen in Table 20 that the 
patient material in Study II is the largest one to support this recommendation. It 
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should be noted that even though treatment of preoperative bacteriuria was 
supposedly routine practice at the time of the study period, only about one fifth of 
the patients with bacteriuria received effective antibiotics targeted to the pathogen 
found in the urine. 
6.3.2 Preoperative antibiotic use 
The overall use of oral antibiotics before elective joint replacement surgery has not 
really been studied before. In a Swedish study evaluating the bacterial colonization 
of patients planned for elective joint replacement surgery, it was found that 25% of 
the study patients had received antibiotics within six months before surgery 
(Stefánsdóttir et al., 2013). This is similar to the results of Study III, where almost 
one fifth of the patients had received at least one course of antibiotics within three 
months before surgery. In fact, the results seem to indicate that patients coming for 
elective joint replacement surgery receive more antibiotics than the general 
population. The antibiotic consumption of the study patients in Study III was 2.75 
packages per 1 000 patients per day, whereas in recent years it has been about 2 
packages per 1 000 patients per day in the overall population in Finland (Summary 
of the latest data on antibiotic consumption in the European Union, 2016). 
Another, and perhaps more significant, finding of Study III is the association 
between preoperative oral antibiotic use and a decreased risk for subsequent PJI. 
This topic has not been studied before and therefore it is a novel finding. Possible 
explanations for the association are not completely clear. Even though treatment of 
active preoperative infections is generally accepted, and even recommended, as a 
means to prevent PJIs (Aggarwal et al., 2014), it should not offer any additional 
prophylactic protection against PJIs. In addition, active infections would probably 
lead to postponement of surgery. 
As the use of antibiotics with activity against staphylococci seemed to be mostly 
responsible for the reduction in the incidence of PJI, it can be speculated that 
perhaps it had an effect on the frequency of S.aureus carriage. Nasal carriage of 
S.aureus is common: 25% to 40% of the general population are carriers (Kumar et 
al., 2015; Weiser & Moucha, 2015) and the situation is similar among patients 
planned for elective joint replacement surgery (Chen et al., 2013; Stefánsdóttir et al., 
2013). On the other hand, nasal carriage of S.aureus is an independent risk factor for 
developing a SSI after joint replacement surgery (Kalmeijer et al., 2000) and thus 
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different decolonization programs have been proposed, but these use only topical 
agents (Akesson et al., 2019).  
The use of oral antibiotics in decolonization programs preoperatively has not 
been studied, however. It is known that they can reduce the carriage of S.aureus 
(Kumar et al., 2015), but they should be combined with topical agents in 
decolonization programs for MRSA as they do not reach sufficient nasal 
concentrations for effective decolonization (McConeghy et al., 2009; Simor et al., 
2007). In addition, it is not known how long the potential decolonizing effect of oral 
antibiotics lasts. There is one study conducted among children colonized with 
S.aureus and with skin infections, where oral antibiotics reduced the carriage rate of 
S.aureus by half up to 50 days (Hogan et al., 2018). 
On the other hand, there is for example a small randomized controlled trial by 
Sousa et al., where reducing S.aureus carriage rate with decolonization did not lead to 
a decreased incidence of PJI (Sousa et al., 2016). Hence it is also possible that the 
effect of preoperative oral antibiotics could be caused by some other mechanism. 
Perhaps the patients with preoperative antibiotic use had some unidentified active 
infections that were treated with the antibiotics. This seems unlikely, though, as the 
patients are rigorously screened preoperatively for possible infections. 
Even if oral antibiotics could be used to reduce the PJI rate, for example through 
S.aureus decolonization, their widespread use for this reason cannot be 
recommended. Firstly, in Study III the NNT value for preoperative oral antibiotics 
to prevent one PJI was high (211). Secondly, there are concerns for potential harms 
of indiscriminate use of antibiotics, such as the increased risk for Clostridioides difficile 
infection and an increase in the incidence of resistant bacteria. It has been shown 
that the use of non-MRSA antibiotics leads to increased rates of MRSA carriage 
(Cheng et al., 2008). 
6.3.3 Late periprosthetic joint infections 
There is an effort to prevent late hematogenous PJIs with different antimicrobial 
prophylaxis regimens before various surgical or dental procedures. The data to 
support recommendations on the prophylactic regimens is varied. 
Study IV shows that the risk of developing a PJI as a result of bacteremia caused 
by gram-negative bacteria is very low. Still, the American Urological Association 
recommends antibiotic prophylaxis before certain genitourinary procedures for 
patients with recent (less than two years old) joint replacements or 
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immunocompromised patients (Wolf et al., 2008). Based on the results of Study IV, 
this recommendation probably leads to overuse of antibiotics, and should perhaps 
be modified. 
Unfortunately, it was not possible to make any definite conclusions on the 
usefulness of antibiotic prophylaxis before dental procedures based on the results of 
Study IV. The study shows that bacteremias by viridans group streptococci lead to 
PJIs fairly often, even though the absolute numbers were low. It is known that these 
bacteria are mainly associated with dental or gastrointestinal sources (Aas et al., 2005; 
Shenep, 2000). However, the dental status or previous dental procedures of the study 
patients could not be evaluated nor the sources of bacteremias caused by viridans 
group streptococci, and thus no conclusions could be made on the risk for PJI after 
dental procedures. 
The relatively high risk of developing a PJI as a consequence of bacteremia caused 
by beta-hemolytic streptococci and S.aureus reported in Study IV highlights the 
importance of good skin care in patients with joint replacements to prevent PJIs, as 
most of these bacteremias originate from the skin. In addition, good skin care is 
important in the prevention of erysipelas caused by beta-hemolytic streptococci, as 
contiguous spread from the infected skin to the joint replacement has been reported 
(Wouthuyzen-Bakker et al., 2018). 
6.4 Strengths and weaknesses of the study 
The biggest strengths of Studies II and III were the very large sample size and the 
availability of extensive register-based data on possible confounding factors. Even 
though the study setting was retrospective, the large sample size and prospective data 
collection compensate for this. In addition, there has been an estimation that the 
study population would have to be 50 000 patients in each study arm in order to 
reliably estimate the effect of screening and treating preoperative bacteriuria in a 
randomized controlled trial (Bouvet et al., 2014). In reality, this is not feasible and 
thus previous prospective studies on preoperative bacteriuria have been 
insufficiently powered (Cordero-Ampuero et al., 2013; Martinez-Velez et al., 2016; 
Ollivere et al., 2009; Sousa et al., 2014). In fact, Study II is the largest study conducted 
on the effect of preoperative bacteriuria on the risk for PJI to date (Gomez-Ochoa 
et al., 2019; Sousa et al., 2019).  
Another major strength in Studies II and III was the use of data from the Social 
Insurance Institution of Finland. With the use of the national drug reimbursement 
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register, the chronic diseases of the study patients could be evaluated fairly reliably 
and extensively, despite the large patient population. However, the drug 
reimbursement criteria pose some limitations, as there are certain diseases (such as 
hypertension) where reimbursements are granted only to patients with more serious 
forms of the disease and so their prevalence in the study population could have been 
underestimated. Nevertheless, it is likely that these milder forms of the disease do 
not have an effect on the risk for PJI or bacteriuria, and thus the effect on the results 
was probably not significant. On the other hand, there are other diseases, such as 
chronic liver disease, where reimbursements for medications are not granted and 
thus their prevalence could not be evaluated. Yet, the fairly extensive evaluation of 
the effect of chronic diseases could also be used to rule out a so-called “healthy 
patient bias” in Study III, i.e. a situation where healthier patients are more likely to 
take care of themselves and thus more likely to seek medical attention, therefore 
perhaps receiving antibiotics more readily than others. This seems unlikely in the 
study population of Study III, as the patients with and without preoperative 
antibiotics were similar with respect to chronic diseases. 
The use of preoperative antibiotics in general and in the treatment of bacteriuria 
could also be evaluated extensively using data from the prescription register of the 
Social Insurance Institution of Finland, as all antibiotic purchases in Finland are 
recorded in the register. However, due to the nature of the register, in-patient use of 
antibiotics could not be identified. Nevertheless, it can be assumed that this was 
negligible, as a serious infection requiring treatment in a hospital setting would have 
likely resulted in postponement of surgery. Information on indication for the 
antibiotics or who had prescribed them was also not available from the register data, 
nor were the dosages of the antibiotics. Thus, consumption rates in defined daily 
dosages could not be examined, but as the number of pills purchased was available, 
some calculations on consumption rates could be made. 
The retrospective nature of the study imposed some limitations. This was seen 
for example in Study I where some of the parameters required for the different 
diagnostic criteria were not available for all patients (e.g. ESR or synovial fluid 
samples). Had it been possible to influence the diagnostic tests performed for the 
study patients, the results could have been different. Also, in Study II, the 
retrospective setting influenced some aspects of data collection: the timing of the 
urine samples could not be affected, even though most samples were collected close 
to the time of surgery. In addition, the urine sample was missing from 13% of the 
operations. However, this probably did not affect the results, as none of the PJIs in 
patients with no urine samples were caused by typical urinary tract pathogens and 
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the incidence of PJI was similar in patients with or without preoperative urine 
samples. 
The lack of a gold standard for the diagnosis of a PJI also had an effect on the 
studies. In Study I, it was not possible to test the accuracy of either of the diagnostic 
criteria and thus it could not be used as a validation study for the new consensus 
meeting criteria. On the other hand, the PJI cases in Studies II and III were identified 
from prospectively collected infection surveillance data. Even though this type of 
data has been shown to be fairly reliable, it is known that some cases are inevitably 
missed (Huotari et al., 2010; Huotari et al., 2007b). To avoid this, multiple data 
sources were used in Studies I and IV, especially to identify late PJIs that are not 
found in routine PJI surveillance. 
There were also other limitations with respect to data collection. It was not 
possible to differentiate between ASB and symptomatic UTI due to the lack of 
clinical data in Study II. In addition, information on preoperative creatinine levels or 
urinary tract diseases was not obtained. It is also possible that there is some yet 
unidentified confounding factor responsible for the association between 
preoperative oral antibiotic use and the decreased risk for PJI observed in Study III. 
Nevertheless, the effect of several known possible confounding factors was taken 
into account and the results were the same also in the propensity score-matched 
patient population. In Study IV, the sources of bacteremia could not be investigated. 
In addition, it was not possible to determine with absolute certainty whether all of 
the PJIs caused by bacteremias were truly so or vice versa, even though patient charts 
were reviewed to eliminate this error. Finally, as the study period in Study IV was 
limited (up to 12 years), some very late PJIs were inevitably missed, but it can be 
assumed that their numbers were fairly low and did not affect the results significantly. 
6.5 Future considerations 
Despite the attempts to formulate uniform diagnostic criteria for PJIs, there still 
remains the lack of a gold standard that could be used both in research and 
surveillance work, and applied perhaps to clinical work as well. There is a shift 
towards more objective criteria that is, in light of the results of Study I, probably a 
shift towards more comparable incidence numbers in benchmarking or research 
studies. More studies are needed to validate the proposed diagnostic criteria, 
however, as they are mainly based on expert opinion at the moment. 
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As the number of joint replacement surgeries is continually rising, the prevention 
of PJIs continues to be crucial as well. On the other hand, ineffective prevention 
methods should be discontinued, as they only lead to unnecessary costs and perhaps 
increased harm to the patients. Study II shows that screening for preoperative 
bacteriuria is not necessary in the prevention of PJIs and this has for example been 
discontinued in the Coxa Hospital leading to significant savings. The same policy 
should be adopted both nationally and internationally as well, especially to avoid 
unnecessary antibiotic prescriptions to patients. International recommendations to 
this effect have already been made (Ares et al., 2019), based partly on the results of 
Study II, but their implementation is still in process. 
Other methods to prevent PJIs still require more research. The interesting finding 
of a decreased risk for PJI with preoperative oral antibiotic use in Study III needs 
further validation in a larger patient population. It is not yet known, whether any 
studies on the topic have been initiated, but hopefully more data will be available on 
the topic in the future. 
Not only is the number of joint replacement surgeries performed on the rise, also 
the number of people living with replaced joints continues to increase as the 
population is getting older. Thus, more people are continually at risk of developing 
a late PJI as well, making prevention of late hematogenous PJIs of high importance 
as well. Unfortunately, no specific patient-related risk factors for the development 
of hematogenous PJIs could be identified in Study IV, but perhaps in the future 
more efforts should be focused on the prevention of bacteremias caused by 
pathogens that are associated with a high risk of developing a hematogenous PJI, 
such as S.aureus and beta-hemolytic streptococci. 
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7 SUMMARY AND CONCLUSIONS 
The main findings of this study are summarized as follows: 
1) Fewer patients fulfil the new, more objective diagnostic criteria for PJI than 
the old criteria. A large proportion of the cases where the diagnosis was 
based solely on the opinion of the treating clinician failed to meet the new 
criteria. It is crucial to take into account the differences between the 
diagnostic criteria used when benchmarking or examining the results of 
surveillance or clinical studies. 
2) Preoperative bacteriuria is not associated with an increased risk for PJI and 
therefore urine screening should not be performed preoperatively on 
asymptomatic patients before elective joint replacement surgery. 
Furthermore, treating preoperative bacteriuria does not have an effect on 
the risk for PJI. Thus, asymptomatic patients with preoperative bacteriuria 
should not be treated with antibiotics. 
3) The use of oral antibiotics before joint replacement surgery is more common 
than in the general population. It is associated with a decreased risk for PJI, 
possibly due to a reduced rate of S.aureus carriage, but the significance of this 
novel result is yet to be determined. At the moment, indiscriminate use of 
oral antibiotics before joint replacement surgery cannot be recommended, 
even though active infections should be treated in order to prevent 
subsequent SSIs. 
4) The development of a PJI as a consequence of bacteremia is mostly 
dependent on the pathogen causing the bacteremia. The risk is the highest 
for S.aureus and beta-hemolytic streptococci, but very low for gram-negative 
bacteria and coagulase-negative staphylococci. Repeated episodes of 
bacteremia increase the risk for developing a PJI during bacteremia, but no 
other patient-related risk factors could be found. The risk for the 
development of a PJI is the highest for bacteremias occurring within one 
year from previous surgery. Thus, when evaluating the risk of PJI in a patient 
with bacteremia, the pathogen, timing of the infection with respect to 
previous surgery and the history of the patient should be taken into account. 
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portion of the cases diagnosed as infection by the treating 
clinician, did not fulﬁl the new diagnostic criteria.
Keywords Prosthetic joint infection ·  
Healthcare-associated infections · Surveillance ·  
Diagnosis
Introduction
Due to the considerable morbidity and high costs of 
periprosthetic joint infections (PJIs), they are part of most 
surgical site infection surveillance programs [1], and indeed 
surveillance seems to reduce infection incidence and it is 
cost-effective [2–4]. However, there has been no uniform 
deﬁnition of PJI in clinical studies and several diagnostic 
criteria have been used both in clinical work and in epide-
miological studies [5–8]. On the other hand, the deﬁnition 
of PJI is dependent on the purpose of use, e.g., whether it is 
used for surveillance, clinical diagnosis making, or clinical 
research.
To receive reliable epidemiological data, it is crucial 
that the deﬁnition of surgical site infections is uniform in 
the organizations participating in the surveillance. In sur-
gical site infection surveillance programs, PJIs have been 
identiﬁed according to the Centers for Disease Control and 
Prevention (CDC) criteria from the year 1992 (Table 1) 
[9]. Due to the variability in the diagnostic criteria of PJI, 
there has been an international attempt to formulate a set 
of diagnostic criteria that could be widely adopted [10]. In 
2013, an international consensus meeting on PJI produced 
a new set of diagnostic criteria (Table 1) [11], which were 
adapted from the criteria originally suggested by the Mus-
culoskeletal Infection Society in 2011 [10], and which have 
been later adopted by CDC [12]. The new criteria are more 
Abstract 
Purpose There is no uniform deﬁnition for periprosthetic 
joint infection (PJI). New diagnostic criteria were formu-
lated in an international consensus meeting in 2013 and 
adopted by Centers for Disease Control (CDC) in 2016. 
The purpose of this study is to compare the new diagnostic 
criteria with the old CDC criteria from the year 1992.
Methods Patients, who had been treated for PJI of hip or 
knee from 2002 to 2014, in a tertiary care hospital, were 
identiﬁed. Patient records were reviewed by a physician 
to identify PJI cases fulﬁlling the old or new CDC crite-
ria and to record data concerning the diagnostic criteria. PJI 
frequencies were calculated for the two diagnostic criteria 
sets. Cross tables were formed to compare the concordance 
between the two sets of criteria in the whole material and in 
different clinical subgroups.
Results Overall 405 cases fulﬁlling either or both sets of 
criteria for PJI were identiﬁed. 73 (18%) of the patients 
fulﬁlled only the old criteria, whereas only one (0.2%) ful-
ﬁlled only the new criteria. Of the patients who did not ful-
ﬁl the new criteria, in 39 (53%) the diagnosis was based 
solely on the clinician’s opinion.
Conclusions The number of PJIs is notably lower when 
using the new, more objective, diagnostic criteria. A large 
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detailed and are based more on laboratory testing. In addi-
tion, a diagnosis of PJI by the treating clinician alone is no 
longer considered sufﬁcient to make the diagnosis.
The purpose of this study was to compare the old CDC 
criteria for diagnosing PJI with the new consensus meet-
ing criteria from 2013 in patients with suspected PJI. Fur-
thermore, the reasons for potential discordance between the 
two criteria were investigated.
Methods
This is a retrospective study of patients treated for PJI of 
hip or knee from September 2002 until December 2014 in 
the Coxa Hospital for Joint Replacement, Tampere, Fin-
land. The hospital is a public funded tertiary hospital and is 
responsible for providing prosthetic joint surgery within the 
Pirkanmaa Hospital District (population-base ca. 500,000 
inhabitants). It is also the referral centre for complications 
involving prosthetic joints. Approximately 3000 arthroplas-
ties are performed there annually. All included patients had 
a previous hip or knee arthroplasty operation in 2013 or 
earlier (with no time limit, in Coxa or in other hospitals) 
to have at least a 1-year follow-up period for the operated 
joints.
To identify all possible PJIs from the study period, data 
were gathered from six different sources: (1) prospec-
tive surveillance data following the National Nosocomial 
Infections Surveillance standards gathered in the national 
Finnish Hospital Infection Program (SIRO) (2005–2010, 
2012–2013) of the National Institute of Health and Welfare 
[13, 14], (2) cases identiﬁed by active post-discharge sur-
veillance conducted by infection control nurse according 
to the old CDC criteria (2002–2014), (3) positive bacterial 
cultures of joint aspirates or tissue cultures from samples 
taken in the Coxa hospital, identiﬁed from the electronic 
records of the microbiological laboratory, which is an 
accredited laboratory of the Tampere University Hospital 
(2002–2014), (4) all patients with a prosthetic joint opera-
tion done because of an infection (ICD-10 diagnosis code 
T84.5 or T81.4) that had been recorded in the hospital dis-
charge records (2002–2014), (5) all revision arthroplasties 
performed because of an infection and recorded in the local 
hospital database, where operative data are gathered pro-
spectively (2002–2014), and (6) cases recorded in the hos-
pital’s own infection register, which was created for clini-
cal purposes and for collecting data on the quality of care 
(2012–2014).
Patient records of all possible infection cases identiﬁed 
from the above-mentioned six sources were thoroughly 
reviewed by one of the authors (M.H.), a specialist reg-
istrar in infectious diseases, to identify PJI cases fulﬁll-
ing the old or new criteria and to record data concerning 
the diagnostic criteria to compare them. Cases that were 
difﬁcult to deﬁne (n = 67) were reviewed also by two 
infectious diseases specialists (J.S., M.K.). Cases were 
excluded from the study: (1) if the infection was classiﬁed 
as a superﬁcial or deep wound infection, (2) if the infected 
prosthesis was a hemi endoprosthesis implanted for the 
treatment of hip fracture, (3) if the infection was related to 
osteosynthesis material, temporary spacer or native joint or 
to a joint other than knee or hip, or (4) if the case was not 
an infection at all (e.g., a positive bacterial culture, which 
had been deemed to be a contamination and left untreated, 
or if the recorded procedure was done for some other rea-
son, but mistakenly recorded as an infection) (Fig. 1).
For each identiﬁed PJI case, it was determined sepa-
rately if the case fulﬁlled the old [9] or the new [11] diag-
nostic criteria. The date of the occurrence of infection 
was determined to be either the day when the new criteria 
Table 1  The old CDC and the new consensus meeting criteria for prosthetic joint infection [9, 11]
a
 Cut-off values for CRP >100 for early infections (less than 6 weeks from previous operation) and >10 for delayed/late infections (over 
6 weeks from previous operation), cut-off value for ESR >30 (delayed/late infections, ESR does not apply for early infections)
b
 Cut-off value for synovial ﬂuid WBC count >10,000 for early infections and >3000 for delayed/late infections
c
 Cut-off value for PMN% >90% for early infections and >80% for delayed/late infections
Deﬁnition of PJI according to the 1992 CDC criteria Deﬁnition of PJI proposed by the consensus meeting 2013
Infection involves any part of the anatomy (e.g., organs or spaces), other 
than the incision, which was opened or manipulated during an operation 
AND patient has at least one of the following:
 Purulent drainage from a drain that is placed through a stab wound into 
the organ/space
 Organisms isolated from an aseptically obtained culture of ﬂuid or tissue 
in the organ/space
 An abscess or other evidence of infection involving the organ/space that 
is found on direct examination, during reoperation, or by histopatho-
logic or radiologic examination
 Diagnosis of an organ/space SSI by a surgeon or attending physician
Two positive periprosthetic cultures with phenotypically identical 
organisms OR a sinus tract communicating with the joint OR hav-
ing three of the following minor criteria:
 Elevated serum C-reactive protein (CRP) and erythrocyte sedimen-
tation rate (ESR)a
 Elevated synovial ﬂuid white blood cell (WBC) count or change on 
leucocyte esterase test  stripb
 Elevated synovial ﬂuid polymorphonuclear neutrophil percentage 
(PMN%)c
 Positive histological analysis of periprosthetic tissue
 A single positive culture
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were met or, if that did not occur, the day when treatment 
was started (i.e., usually the day of revision arthroplasty). 
The PJIs were classiﬁed as early, if they occurred within 
3 months after the previous operation, delayed, if they 
occurred within 3–12 months and late, if they occurred 
after 1 year [7, 15]. Cut-off values for different laboratory 
tests were determined according the consensus meeting 
suggestions [11].
Statistical methods
Frequencies were calculated and cross tables were formed 
to compare the concordance between the two sets of criteria 
in the whole material and in different clinical subgroups. 
Cases, which fulﬁlled only the old CDC criteria and where 
the diagnosis was based on the clinician’s opinion alone, 
and culture negative cases, were examined separately.
All data analyses and management were performed 
using SPSS for Windows 23.0 statistical software package.
Results
Overall 405 cases fulﬁlling either or both sets of criteria 
for PJI were identiﬁed. 73 out of 405 cases (18%) met 
only the old CDC criteria, but not the new consensus 
meeting criteria, whereas only one (0.2%) of the cases 
fulﬁlled only the new criteria (Table 2).
The distribution of cases fulﬁlling either or both diag-
nostic criteria sets according to clinical subgroups is 
shown in Table 2. The distribution of cases was similar 
when analysed separately for hip prostheses, knee pros-
theses, primary and revision arthroplasties, according 
to gender, age and different infection types. As positive 
bacterial culture belongs to both diagnostic criteria, most 
culture positive patients fulﬁlled both sets. The number 
of cases that met each speciﬁc diagnostic criterion in the 
old and new criteria sets is shown in Table 3.
Possible sources of discordance between the diagnos-
tic criteria sets were investigated, including the clini-
cian’s diagnosis, lack of ESR measurement and culture 
negative cases. Of the patients who did not fulﬁl the new 
criteria, in 39 (10% of the whole study population) the 
diagnosis was based solely on the clinician’s opinion. Of 
these patients, 16 (41%) had an increased number of leu-
cocytes in the joint aspirate and 16 (41%) an increased 
number of polymorphonuclear cells. Thirteen (33%) of 
these patients had an elevated CRP and ESR value, and 
30 (77%) had an increased CRP value. Fifteen (39%) ful-
ﬁlled two of the minor criteria from the new consensus 
meeting criteria set. If patients, who fulﬁlled only two 
minor criteria, were also considered to have PJI, 33 addi-
tional patients would fulﬁl the new consensus meeting 
criteria, leading to a total of 365 PJI cases identiﬁed by 
the new criteria.
ESR was measured in 152 (38%) cases in the whole 
patient population. There was only one delayed/late 
infection with an increased ESR value, but with nor-
mal CRP. If patients with a delayed or late infection and 
with an elevated CRP value, but whose ESR was not 
measured, were assumed to have an increased ESR, 169 
patients would fulﬁl three or more minor criteria of the 
new consensus meeting criteria. 17 new infectious cases 
would be identiﬁed in total, as most of these patients 
also fulﬁlled either one of the main criteria. Of these new 
cases, 13 cases did not meet any of the old CDC criteria, 
besides the clinician’s diagnosis. If they were considered 
to fulﬁl the new criteria, there are still 26 (6%) cases in 
the whole study population, who did not meet any other 
diagnostic criteria besides the clinician’s opinion.
Fig. 1  The number of suspected PJI cases identiﬁed from different 
data sources and the number of cases excluded from the study
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There were six cases of late haematogenous infections, 
where CRP was elevated, but ESR remained within nor-
mal range. All had positive blood cultures.
Of culture negative patients, 45/78 (58%) did not meet 
the new consensus meeting criteria for PJI (Table 2). How-
ever, 38 culture negative patients (49%) fulﬁlled two minor 
criteria from the new criteria set. 38 (49%) had an increased 
number of leucocytes and 37 (47%) an increased number 
of polymorphonuclear cells in the joint aspirate. CRP and 
ESR were elevated in 38 (49%) of the patients and CRP 
was elevated in 58 (74%). Despite an increase over time in 
the number of intraoperative tissue samples taken, the pro-
portion of culture positive cases did not increase over time. 
49 (63%) of the culture negative cases had four or more 
samples taken.
Discussion
This study indicates notable discordance between the old 
CDC criteria and the new consensus meeting criteria for 
PJI: one ﬁfth of the cases were identiﬁed as PJIs only by 
the old criteria, but not by the new ones. This was mainly 
because a large portion of the cases diagnosed as PJI by 
the treating clinician did not fulﬁl the new diagnostic crite-
ria. The discordance leads to different numbers of infected 
cases and the incidence of PJI is lower when using the new, 
more objective, diagnostic criteria.
The old and new criteria for PJI have not been compared 
before, and there has not been a study to validate the new set 
of diagnostic criteria. The new criteria were formed as an 
attempt to formulate a gold standard for the diagnosis of PJI. 
This study raises the question whether true PJI cases could 
be missed by the new criteria as such a large number of 
patients previously diagnosed as having a PJI did not fulﬁl 
them. On the other hand, it is likely that some of the patients 
diagnosed as having a PJI according to the old criteria, were 
in fact not infected. This is especially relevant when consid-
ering surveillance records and their accuracy. For example, 
if the resources for clinical diagnosis of PJI in a hospital are 
not sufﬁcient, there is a possibility that surveillance criteria 
that are too strict will fail to recognize PJIs.
Table 2  Number of cases 
fulﬁlling the different diagnostic 
criteria sets in different 
subgroups
Cases Cases fulﬁlling only 
the old CDC criteria
Cases fulﬁlling only 
the new consensus 
meeting criteria
Cases fulﬁlling both 
sets of criteria
n n (%) n (%) n (%)
All cases 405 73 (18) 1 (0.2) 331 (82)
Joints
 Hips 167 32 (19) 1 (0.6) 134 (80)
 Knees 238 41 (17) 0 197 (83)
Previous operation
 Primary arthroplasty 285 48 (17) 1 (0.4) 236 (83)
 Revision arthro-
plasty
120 25 (21) 0 95 (79)
Gender
 Men 177 28 (16) 0 49 (84)
 Women 228 45 (20) 1 (0.4) 182 (80)
Age
 ≤70 195 37 (19) 0 158 (81)
 >70 210 36 (17) 1 (0.5) 173 (82)
Bacterial culture
 Positive 327 28 (9) 0 299 (91)
 Negative 78 45 (58) 1 (1.3) 32 (41)
Infection type
 Early 151 24(16) 1 (0.7) 126 (83)
 Delayed 63 15 (24) 0 48 (76)
 Late 191 34 (18) 0 157 (82)
Infections diagnosed in
 2002–2006 97 29 (30) 0 68 (70)
 2007–2010 165 20 (12) 0 145 (88)
 2011–2014 143 24 (17) 1 (0.7) 118 (83)
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It is notable that in 10% of the cases the diagnosis was 
based solely on the clinician’s opinion and no other diag-
nostic criteria were fulﬁlled. It is possible that at least 
some of these cases are still true PJIs. Firstly, they did not 
fulﬁl three minor criteria of the new consensus meeting 
criteria, because ESR was not measured in many of these 
cases, as CRP is the preferred inﬂammatory marker used. 
The value of measuring both ESR and CRP as markers 
of PJI has been questioned. For example, Johnson et al. 
[16] showed that CRP alone and CRP and ESR in com-
bination had the same sensitivity when diagnosing PJI of 
the knee, but the number of false negative cases increased 
from 5.3 to 11.1% when they were used in combination. 
Additionally, Ghanem et al. [17] showed that using both 
CRP and ESR in combination resulted in lower sensitiv-
ity than using either one as a marker of PJI. There have 
also been reports of PJIs with normal CRP and ESR val-
ues [18]. Therefore, it is probably unnecessary to require 
both ESR and CRP for the diagnosis of PJI. Secondly, 
the cut-off values for leucocytes and polymorphonuclear 
cells are based on a small number of studies with large 
variation [11]. High sensitivity and speciﬁcity for cut-off 
values lower than those in the new criteria, ranging from 
1100 to 3450 for WBC and 64 to 78% for PMN%, have 
been reported [19–22]. If lower cut-off values had been 
used in this study, it is probable that more patients would 
have been identiﬁed as having PJI according to the new 
criteria.
On the other hand it is possible that some of the cases 
diagnosed as infections based on the clinician’s diagnosis 
may have represented reactions to metal debris from metal-
on-metal hip prostheses [23–25]. Before this phenomenon 
was recognized, such cases may have been mistakenly 
diagnosed as PJIs. Unfortunately the types of prosthetic 
joints in this study population were not recorded, so the 
possible number of metal-on-metal reactions falsely diag-
nosed as infections could not be evaluated.
A positive bacterial culture was important in the diagno-
sis of PJI in this material (Table 3). About 80% of patients 
had a positive bacterial culture, and 59% had at least two 
positive cultures, which was the most commonly met of 
part of the new consensus meeting criteria. Bacterial cul-
tures have had a well-established role in the diagnosis of 
PJI, even though there has been some debate about the 
number of positive samples required to make a deﬁnitive 
diagnosis. Some studies have shown that fewer than four 
samples obtained may decrease the sensitivity of the intra-
operative bacterial cultures [26, 27]. Nonetheless in this 
study almost two-thirds of the culture negative cases had 
four or more samples taken.
Almost two-thirds of the culture negative patients ful-
ﬁlled only the old CDC criteria, which again reﬂect the 
importance of a positive bacterial culture in the new con-
sensus meeting criteria. Nevertheless, there is a possibil-
ity that some true, but culture negative prosthetic joint 
infections were missed by the new criteria; almost half of 
Table 3  Number of cases fulﬁlling the different diagnostic criteria
a
 CRP was measured from 402 patients, ESR from 152 patients and both from 152 patients. Early infections with an elevated CRP were consid-
ered to be fulﬁlling this criterion
b
 Synovial ﬂuid WBC was measured from 209 patients
c
 Synovial ﬂuid PMN% was measured from 198 patients
Number % of all cases
Old CDC criteria
Total 404 100 
 Purulent drainage from a drain 0 0
 Organisms are identiﬁed from an aseptically obtained ﬂuid or tissue in the space by a culture 327 81
 An abscess or other evidence of infection involving the organ/space that is detected on gross anatomical or histo-
pathologic exam, or imaging test
38 9
 Diagnosis of a PJI by a surgeon or attending physician 400 99
New consensus meeting criteria
Total 332 82
 Two positive periprosthetic cultures with phenotypically identical organisms 239 59
 A sinus tract communicating with the joint 82 20
 Having three of the following minor criteria 106 26
  Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR)a 199 49
  Elevated synovial ﬂuid white blood cell  countb 192 47
  Elevated synovial ﬂuid polymorphonuclear neutrophil percentage (PMN%)c 178 44
  Positive histological analysis of periprosthetic tissue 11 3
  A single positive culture 88 22
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the culture negative patients fulﬁlled two other minor cri-
teria, and thus if they had had a single positive bacterial 
culture, they would have been diagnosed as having a PJI 
also by the new criteria. A history of antibiotic use before 
the diagnosis of infection could explain the negative bac-
terial cultures [28, 29], but this information could not be 
recorded in this study.
There are some limitations in this study. Firstly, some 
of the parameters, such as ESR or synovial ﬂuid sam-
ples, required by the different diagnostic criteria were not 
measured from all patients. Thus, it is possible that some 
patients could have fulﬁlled the new diagnostic criteria 
had these parameters been examined, making the two 
criteria more concordant. Since this was a retrospective 
study, it was not possible to inﬂuence which diagnostic 
tests were performed for each patient. Secondly, there is 
still no gold standard for diagnosing PJIs, so there was 
no method of testing the accuracy of either of the diag-
nostic criteria. For example, there is a possibility that the 
new criteria are not sufﬁcient to identify all the infec-
tious cases, especially those caused by low virulence 
organisms, as was suggested by Kapadia et al. [15] in a 
recent review. Thirdly, due to the large number of pros-
thetic joint operations in the study period, it was not pos-
sible to gather information regarding the different diag-
nostic criteria from the whole population, but only from 
those identiﬁed as infected by the different data sources. 
Thus, Cohen’s kappa estimate could not be used to com-
pare the different criteria. However, as the main purpose 
of this study was to compare cases identiﬁed as infected 
by the different criteria and their differences, this was not 
deemed necessary. Finally, it is acknowledged that sur-
gical site infection surveillance programs using the CDC 
deﬁnitions are limited to 90-day post-operative follow-up 
[12] whereas this study included patients who had been 
operated several years before. However, when comparing 
the different infection subgroups (early, delayed and late 
infections), the number of patients identiﬁed by the two 
sets of criteria were similar, suggesting that the same cri-
teria can also be used for the diagnosis of late PJIs.
In conclusion, fewer patients fulﬁl the new consensus 
meeting criteria for PJI than the old CDC criteria. A large 
portion of the cases diagnosed as PJI by the treating clini-
cian, did not fulﬁl the new diagnostic criteria. The two sets 
of diagnostic criteria examined in this study reﬂect a shift 
from a diagnosis relying only on the treating clinician’s 
opinion to a diagnosis based on objective measurements. In 
clinical work the diagnosis made by the treating clinician 
is important, but there is a need for uniform and objective 
diagnostic criteria for PJI in surveillance and benchmark-
ing. It is important to be aware of the differences between 
the diagnostic criteria when benchmarking or comparing 
the results of surveillance studies.
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Objectives: Patients who undergo elective joint replacement are traditionally screened and treated for
preoperative bacteriuria to prevent periprosthetic joint infection (PJI). More recently, this practice has
been questioned. The purpose of this study was to determine whether preoperative bacteriuria is
associated with an increased risk of PJI.
Methods: Patients who had undergone a primary hip or knee replacement in a tertiary care hospital
between September 2002 and December 2013 were identiﬁed from the hospital database (23 171 joint
replacements, 10 200 hips, and 12 971 knees). The results of urine cultures taken within 90 days before
the operation were obtained. Patients with subsequent PJI or superﬁcial wound infection in a 1-year
follow-up period were identiﬁed based on prospective infection surveillance. The association between
bacteriuria and PJI was examined using a multivariable logistic regression model that included infor-
mation on the operated joint, age, gender and the patients' chronic diseases.
Results: The incidence of PJI was 0.68% (n ¼ 158). Preoperative bacteriuria was not associated with an
increased risk of PJI either in the univariate (0.51% versus 0.71%, OR 0.72, 95% CI 0.34e1.54) or in the
multivariable (OR 0.82, 95% CI 0.38e1.77) analysis. There were no cases where PJI was caused by a
pathogen identiﬁed in the preoperative urine culture. Results were similar for superﬁcial infections.
Conclusions: There was no association between preoperative bacteriuria and postoperative surgical site
infection. Based on these results, it seems that the preoperative screening and treatment of asymp-
tomatic bacteriuria is not required. M. Honkanen, Clin Microbiol Infect 2018;24:376
© 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
To prevent postoperative infections, patients undergoing
elective joint replacement have traditionally been routinely
screened for bacteriuria [1,2]. The risk for haematogenous seed-
ing to a prosthetic joint from a postoperative urinary tract
infection has been reported [3e5]. However, the association be-
tween preoperative asymptomatic bacteriuria (ASB) and
periprosthetic joint infection (PJI) is less clear. Therefore, the ef-
ﬁcacy of the practice of routine urine cultures has been ques-
tioned in recent studies [6,7].
The relationship between preoperative ASB and PJI has previ-
ously been examined in small retrospective studies [8,9] and in one
large registry-based study [10]. However, only in the last decade
have there been prospective studies carried out on the subject
[7,11e15]. Some of these studies have shown an increased risk of
postoperative infection complications in patients with preoperative
ASB [11,14], but direct seeding to the prosthetic joint has not been
reported. Furthermore, treating preoperative ASB with antibiotics
has not been shown to be effective in preventing PJI [7,12,14,15].
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ASB is fairly common in the general population, especially in
older women. In people in their 70s, the estimated prevalence of
ASB is between 11% and 16% for women and between 4% and 19%
for men [16]. For women and men aged  80 years, the estimated
prevalence is 20% and 10%, respectively [17]. In patients undergoing
elective joint replacement, the prevalence of ASB varies from 3.5%
to 36% [8,12e15]. The unnecessary treatment of ASB with antibi-
otics has several drawbacks, such as the emergence of resistant
bacterial strains, the occurrence of Clostridium difﬁcile infection,
and increased costs [18,19], and is therefore not currently recom-
mended for the general population [16].
Guidelines concerning the screening of the preoperative urine
samples of asymptomatic patients undergoing elective joint
replacement surgery are conﬂicting. The British Orthopaedic As-
sociation recommends preoperative urine screening [6], whereas
the consensus statement from the International ConsensusMeeting
on Periprosthetic Joint Infection opposes it [20]. The current In-
fectious Diseases Society of America guideline gives no recom-
mendations on the matter [16], but lists urine screening before
joint replacement surgery as an important topic for future research
as does the International Consensus statement [20].
The purpose of this retrospective observational study with a 1-
year follow up was therefore to determine whether preoperative
bacteriuria before elective joint replacement increases the risk of
PJI or surgical site infection in a 1-year follow up.
Materials and methods
This retrospective study was performed at the Coxa Hospital for
Joint Replacement, Tampere, Finland, a publicly funded tertiary
orthopaedic hospital. Patients who had undergone primary hip or
knee replacement between September 2002 and December 2013
were identiﬁed from the local prospective joint replacement
database. According to the national legislation, patient consent is
not required in retrospective studies like this. If more than one
primary joint replacement was performed on a patient during the
study period, each joint replacement was considered separately.
With a few exceptions, the patients underwent surgery under
spinal anaesthesia. Unless contraindicated, a single dose of cefur-
oxime was used as antibiotic prophylaxis. Cemented prostheses
were ﬁxed with gentamicin-impregnated bone cement.
Urine cultures were part of the routine preoperative laboratory
testing for all patients. For this study, the results of urine cultures
taken within 90 days before the joint replacement were obtained
from the electronic records of a microbiology laboratory accredited
by Tampere University Hospital. The species of bacteria found in the
urine samples and their antibiotic susceptibility data were recor-
ded. If more than one urine sample was taken, the one taken closest
to the date of operation was used in the analyses. All bacterial
growth in the urine was considered signiﬁcant. If more than one
bacterium was reported in the sample, they were all recorded. The
outcomes with patients with missing urine samples are reported
separately.
Information regarding chronic diseases was gathered from the
drug reimbursement register of the Social Insurance Institution of
Finland. All permanent residents of Finland are covered by national
health insurance, which includes drug reimbursements. To receive
reimbursements, patients require a certiﬁcate issued by the treat-
ing doctor and the right to reimbursement is granted based on the
speciﬁc diagnostic criteria for each disease. Patients with a valid
entitlement to reimbursement for certain chronic diseases (dia-
betes, rheumatic diseases, hypertension, chronic heart failure,
chronic coronary disease, arrhythmias, chronic lung disease, Par-
kinson's disease, epilepsy, Alzheimer's disease, psychotic disorders,
haematological and solid malignancies) at the time of the joint
replacement were identiﬁed. For the analyses, chronic heart failure,
chronic coronary disease and arrhythmias were grouped together,
as were Parkinson's disease, epilepsy, Alzheimer's disease and
psychotic disorders.
Information on the antibiotics (identiﬁed based on their ATC
codes) purchased by the patients within 90 days before the joint
replacement was gathered from the prescription register of the
Social Insurance Institution of Finland. In Finland, antibiotics are
not available without a prescription and all purchases are recorded
in the national prescription register. The type of antibiotic and the
date of purchase were also recorded. Antibiotics for preoperative
bacteriuria were prescribed by orthopaedists at the operating
hospital, but other antibiotics could have been prescribed
elsewhere.
Cases of infection were identiﬁed from prospective post-
discharge surveillance data gathered by an infection control nurse
according to the Centers for Disease Control and Prevention criteria
[21] and National Nosocomial Infection Surveillance system
methodology adapted for Finland [22]. The primary outcome was
the occurrence of PJI. The occurrence of any surgical site infection
(superﬁcial or deep incisional infection or PJI) was analysed as a
secondary outcome. Microbiological data on the occurrence of PJI
were collected from the electronic records of the microbiology
laboratory. In order to have a 1-year follow-up period for all
operated joints, cases of infection recorded between September
2002 and December 2014 were identiﬁed.
Statistical analysis
All data analyses and management were performed using the
SPSS for Windows 23.0 statistical software package.
Categorical variables were compared with c2 test and contin-
uous variables (age) with Student's independent-samples t-test. A p
value <0.05 was considered statistically signiﬁcant.
The association between potential risk factors for infection and
the outcome (PJIs and all infections separately) was examined using
logistic regression with univariate analysis. A multivariable model
was developed that included all potential risk factors for infection
that were examined in the univariate analysis.
Results
In total, 23 171 primary joint replacements were performed in
17 562 people between September 2002 and December 2013. Of
these, 10 200 (44%) were primary hip and 12 971 (56%) primary
knee replacements, respectively. In addition, 1805 (8%) operations
Table 1
Bacteria found in the preoperative urine samples (some samples contained more
than one bacterium, these are recorded separately)
Bacterium species n (N¼1378) %
Gram-negative
Escherichia coli 822 59.7
Klebsiella 114 8.3
Proteus 36 2.6
Citrobacter 10 0.7
Morganella 4 0.3
Pseudomonas 23 1.7
Acinetobacter 8 0.6
Other 39 2.8
Gram-positive
Coagulase-negative staphylococci 63 4.6
Staphylococcus aureus 11 0.8
Streptococcus agalactiae 136 9.9
Enterococcus spp. 149 10.8
Other 8 0.6
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were simultaneous bilateral hip or knee replacements. From the
total number of operations, 14 361 (62%) were performed for
women and 8810 (38%) for men. The mean age at the time of
operation was 67 years (range 14 years to 109 years).
A preoperative urine sample was available in 20 226 operations
(87%), and 1378 (6.8%) of the urine cultures were positive. Most of
the samples were collected within 30 days before the surgery (see
Supplementary material, Fig. S1). The bacteria found in the urine
are listed in Table 1. Of the positive urine samples, 1237 (90%) were
inwomen. Patients with positive urine cultures were also older and
had more chronic diseases than patients with a negative urine
culture (see Supplementary material, Table S1). Positive urine cul-
tures weremore frequent in patients undergoing knee replacement
than hip replacement. A preoperative urine sample was missing in
2945 (12.7%) operations. There were more missing samples in men
than inwomen (16% versus 11%) and more before hip replacements
than before knee replacements (16% versus 10%). The mean age of
the patients with a missing urine sample was also lower (64 years
versus 68 years) and there were fewer patients suffering from
diabetes (7.1% versus 8.2%).
During the 1-year follow up, 490 surgical site infections (2.11% of
the study population) were identiﬁed. Of these, 158 were PJIs,
giving an incidence of 0.68% in the whole study population. The
incidence of PJI was 0.57% (58/10 200) for hip replacements and
0.77% (100/12 971) for knee replacements. In seven (4%) of the PJI
cases, the preoperative urine culture was positive, and in 133 (84%)
cases the culture was negative. In 18 (11%) PJI cases, the urine
sample was missing. In the PJI cases with a positive urine culture,
the pathogens found in the urine cultures and those identiﬁed from
the joint were not the same in any of the cases (Table 2). Further-
more, no evidence to link preoperative urine cultures to superﬁcial
or deep wound infections could be found (data not shown).
In patients with a positive urine culture, the incidence of PJI was
0.51% (7/1378), and 0.71% (133/18 848) in patients with a negative
culture. The incidence of all surgical site infections was 1.89% (26/
1378) in patients with a positive urine culture and 2.18% (411/
18 848) in those patients with a negative urine culture. No statis-
tically signiﬁcant association was found in univariate or multivar-
iable analysis between positive urine culture and PJI or all surgical
site infections (Table 3). The impact of other risk factors on the risk
of PJI is presented in Table 3.
Of the patients with preoperative bacteriuria, 344 (25%)
received antibiotics after the urine sample was taken. In 51 pa-
tients, the prescribed antibiotic was not effective against the
pathogen found in the urine, mostly because of the acquired or
natural resistance properties of the pathogen. Of the 293 patients
with effective antibiotic treatment, one (0.34%) had a subsequent
PJI, whereas of the 1085 patients with bacteriuria and no or no
effective antibiotics, six (0.55%) had a PJI. Treating the bacteriuria
with effective antibiotics did not affect the risk of PJI (OR 0.62, 95%
CI 0.07e5.14).
There were 18 PJI cases (incidence 0.61%) and 35 superﬁcial or
deep wound infections (incidence 1.19%) among the 2945 patients
without preoperative urine samples. These incidences were similar
to the overall incidence. In 11 PJI cases, the pathogens causing the
infection could be identiﬁed (Staphylococcus aureus, Corynebacte-
rium species and coagulase-negative staphylococci) and none were
typical urinary tract pathogens.
Discussion
The ﬁndings of this large retrospective study show that there is
no association between preoperative bacteriuria and subsequent
postoperative PJI after primary joint replacement when possible
confounding factors, such as chronic diseases, are taken into ac-
count. Furthermore, there were no postoperative infections caused
by the pathogens found in the preoperative urine samples and
treating the bacteriuria with effective antibiotics did not decrease
the incidence of PJI.
During the study, the inﬂuence of possible confounding factors,
especially chronic diseases, was taken into account extensively.
Furthermore, the data were based on prospective systematic sur-
veillance, which strengthens the reliability of this retrospective
study. It has been estimated that to conduct a reliable prospective
randomized controlled trial that compares the screening and
treatment of bacteriuria with no screening and treatment, it would
require a study population of 50 000 patients in each study arm,
which is not feasible [13]. Previous prospective studies [11,12,14,15]
have had small sample sizes, and so have been insufﬁciently
powered.
The incidence of PJI in this study (0.68%; 0.57% for hip and 0.77%
for knee replacements) is similar to the ﬁndings of previous
studies: 0.3%e0.6% for hip replacements [23,24] and 0.8%e1.1% for
knee replacements [23e25], with the exception of a study by Lamb
et al. [7], where the overall incidence of PJI was very low (0.02%).
The cases of infection in the present study were identiﬁed by
postoperative infection surveillance that has been shown to miss
some infections [22]. This should not, however, be seen to bias the
ﬁndings of this study. Male gender, age, knee replacement and
diabetes were all associatedwith an increased risk of PJI, which is in
line with previous studies [25,26]. Obesity has also been shown to
be a risk factor for PJI [26]; however, bodymass index datawere not
available for this study population.
The prevalence of preoperative bacteriuria was 6.8%, which is
similar to two earlier Spanish studies [12,15] and slightly lower
than in other studies [8,13,14]. There was no association between
preoperative bacteriuria and postoperative surgical site infection or
PJI. Furthermore, in the cases with preoperative bacteriuria and
Table 2
Comparison between pathogens found in the preoperative urine sample and postoperative prosthetic joint infection (PJI)
Case number Age Gender Operated joint Time between
urine sample and
surgery (days)
Time between
surgery and
infection (days)
Pathogen found in urine Pathogen causing PJI
1 81 Female Hip 36 16 Enterococcus faecalis Staphylococcus aureus
2 76 Female Knee 9 16 Escherichia coli NAa
3 76 Male Knee 31 18 Enterococcus faecalis Coagulase-negative staphylococcus
4 63 Female Knee 11 36 Klebsiella pneumoniae Staphylococcus aureus
5 81 Female Knee 64 85 Escherichia coli Coagulase-negative staphylococcus
6 75 Female Knee 0 142 Escherichia coli NAa
7 79 Male Knee 29 258 Coagulase-negative
staphylococcus
Staphylococcus epidermidisb
a Culture-negative PJI.
b Different antibiotic resistance pattern from the strain found in the urine.
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subsequent PJI, the pathogens were not the same. In addition,
treating the bacteriuria with antibiotics did not decrease the risk of
PJI. Previous studies have yielded variable results. Several studies,
such as the classic study by Glynn and Sheehan [8], have found no
association between preoperative bacteriuria and PJI. However, the
study by Glynn and Sheehan had a small sample size and a follow-
up period of only 3 months. In a more recent study, Cordero-
Ampuero et al. [12] found no association between preoperative
bacteriuria and postoperative infection following hip replacement,
and treating the bacteriuria with antibiotics had no effect on the
incidence of infection. The same research group reported similar
results for knee replacements [15]. Unlike earlier studies, the cur-
rent study takes into account the effect of both chronic diseases and
outpatient antibiotic use. Even so, the results are still in line with
those of the above-mentioned studies.
On the other hand, Sousa et al. [14] found that patients with
preoperative ASB had a statistically signiﬁcantly increased risk of
PJI, but the micro-organisms found in the urine and those causing
the PJI were different. Furthermore, there was no difference in the
incidence of PJI when comparing those patients who had received
antibiotics for the bacteriuria and those who had not. This suggests
that in patients with ASB there are some other factors that could
contribute to the risk of PJI. In fact, the current study shows that
patients with preoperative bacteriuria have more chronic diseases
than patients with negative urine cultures.
There were some limitations in this study. First, this was a
retrospective study, and therefore it was not possible to differen-
tiate between asymptomatic bacteriuria and symptomatic urinary
tract infection due to a lack of clinical data, and unfortunately the
concentration of bacterial growth in the urine samples could not be
retrieved from the laboratory data. Furthermore, the timing of
urine samples taken before the operation could not be inﬂuenced.
Most samples were, however, collected close to the surgery. Sec-
ond, a urine sample was not available in 13% of the operations.
However, none of the PJIs in patients with a missing urine sample
were caused by pathogens that typically cause urinary tract in-
fections. The incidence of PJI was not higher among patients with a
missing urine sample than in the overall study population. Third, it
was not possible to take into account all possible confounding
factors. The drug reimbursement data gives a fairly accurate esti-
mate of the prevalence of certain chronic diseases. However, due to
the nature of the reimbursement criteria, in certain diseases (such
as hypertension) patients who only have a mild form of the disease
receive no reimbursements, and so their prevalence may be
underestimated. These mild forms of diseases probably have less
effect on the risk of bacteriuria and should therefore not affect the
results. Furthermore, information on body mass index, serum
creatinine level or urinary tract diseases could not be obtained.
This study adds to the growing body of evidence that supports
the view that asymptomatic preoperative bacteriuria does not
cause PJI, and hence it should not be screened or treated. This
ﬁnding should be taken into account in future guidelines regarding
the screening and treatment of preoperative ASB before joint
replacement surgery.
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Objectives: Antibiotics are used for various reasons before elective joint replacement surgery. The aim of
this study was to investigate patients' use of oral antibiotics before joint replacement surgery and how
this affects the risk for periprosthetic joint infection (PJI).
Methods: Patients having a primary hip or knee replacement in a tertiary care hospital between
September 2002 and December 2013 were identiﬁed (n ¼ 23 171). Information on oral antibiotic courses
purchased 90 days preoperatively and patients' chronic diseases was gathered. Patients with a PJI in a 1-
year follow-up period were identiﬁed. The association between antibiotic use and PJI was examined
using a multivariable logistic regression model and propensity score matching.
Results: One hundred and ﬁfty-eight (0.68%) cases of PJI were identiﬁed. In total, 4106 (18%) joint
replacement operations were preceded by at least one course of antibiotics. The incidence of PJI for
patients with preoperative use of oral antibiotics was 0.29% (12/4106), whereas for patients without
antibiotic use it was 0.77% (146/19 065). A preoperative antibiotic course was associated with a reduced
risk for subsequent PJI in the multivariable model (OR 0.40, 95% CI 0.22e0.73). Similar results were found
in the propensity score matched material (OR 0.34, 95% CI 0.18e0.65).
Conclusions: The use of oral antibiotics before elective joint replacement surgery is common and has a
potential effect on the subsequent risk for PJI. Nevertheless, indiscriminate use of antibiotics before
elective joint replacement surgery cannot be recommended, even though treatment of active infections
remains an important way to prevent surgical site infections. M. Honkanen, Clin Microbiol Infect
2019;25:1021
© 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Periprosthetic joint infection (PJI) is a catastrophic complication
of joint replacement surgery [1]. Therefore, it is essential that
adequate preventive measures are taken before any elective joint
replacement operation.
Active infections, including skin and urinary tract infections, at
the time of operation are considered as potential risk factors for
subsequent surgical site infection (SSI), and their treatment is
therefore recommended [2]. Furthermore, active preoperative
screening and treatment of dental infections is recommended
[2e4].
Staphylococcal skin and nasal colonization is common among
patients before elective joint replacement [5,6]. Thus, evenwithout
the presence of active infection, preoperative decolonization may
reduce the incidence of SSIs caused by Staphylococcus aureus [6e9].
The use of oral antibiotics can reduce S. aureus carriage [10], but oral
antibiotics may not reach sufﬁcient nasal concentrations for effec-
tive decolonization. Therefore, they are recommended for decolo-
nization of methicillin-resistant S. aureus (MRSA) only in
conjunction with topical agents [11,12].
Although perioperative intravenous antibiotics have a well-
established role in the prevention of SSIs [13,14], no studies have
been conducted on the use of preoperative oral antibiotic before
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joint replacement surgery and its effect on the risk for subsequent
SSI or PJI. The aim of this study was to investigate how patients'
preoperative use of antibiotics affects the risk for PJI in a 1-year
follow-up.
Patients and methods
This retrospective study was performed in the Coxa Hospital for
Joint Replacement, Tampere, Finland. Patients, who had undergone
an elective primary hip or knee replacement between September
2002 and December 2013 were identiﬁed from the local prospec-
tive joint replacement database. Patient consent is not required in
retrospective studies like this, according to the Finnish national
legislation. In patients with multiple joint replacements during the
study period, each operationwas considered separately. Until 2007,
patients considered to have high risk for MRSA carriage were
screened for MRSA. From 2008 onwards all patients were screened
for MRSA on admission, but not for methicillin-sensitive S. aureus
[15]. Routine preoperative skin and nasal decolonization was not
used. All patients had preoperative clinical evaluation and labora-
tory tests at the operating hospital within 2 months before the
surgery. Preoperative urine samples were taken routinely and 25%
of the patients with bacteriuria received antibiotics [16]. A single
dose of cefuroxime was used as perioperative antibiotic prophy-
laxis. If this was contraindicated, clindamycin or vancomycin was
used. Known MRSA carriers received cefuroxime and vancomycin.
Cemented prostheses were ﬁxed with gentamicin-impregnated
bone cement.
The courses of antibiotics (identiﬁed based on their ATC codes
[17]; Table S1) purchased within 90 days before the joint replace-
ment were identiﬁed from the prescription register of the Social
Insurance Institution of Finland. The type of antibiotic and the date
of purchase were recorded. Antibiotics are not available without a
prescription in Finland and all purchases are recorded in this
nationwide prescription register. Antibiotics given for inpatients
could not be identiﬁed.
Patients with a valid entitlement to reimbursement for certain
chronic diseases (diabetes, rheumatic diseases, hypertension,
chronic heart failure, chronic coronary disease, arrhythmias,
chronic lung disease, Parkinson's disease, epilepsy, Alzheimer's
disease, psychotic disorders, haematological, and solid malig-
nancies) at the time of the joint replacement were identiﬁed from
the reimbursement register of the Social Insurance Institution of
Finland (see a more detailed description in a previous study of the
same study population [16]). For the analyses, chronic heart failure,
chronic coronary disease, and arrhythmias were grouped together,
as were Parkinson's disease, epilepsy, Alzheimer's disease, and
psychotic disorders.
Patients' weight and height were retrieved from the joint
replacement database to calculate body mass indexes (BMIs). The
data on the types of prostheses, municipality of residence and
indication of surgery was also gathered from the database. MRSA
carriers were identiﬁed from the ofﬁcial database of carriers of
multidrug resistant microbes in Pirkanmaa Hospital District.
The primary outcome was the occurrence of PJI. The occurrence
of any surgical site infection (superﬁcial or deep incisional infection
or PJI) was considered as a secondary outcome. These infections
were identiﬁed from prospective post-discharge surveillance data
gathered by an infection control nurse according to the Centers for
Disease Control and Prevention criteria [18] and National Nosoco-
mial Infection Surveillance system methodology adapted for
Finland [19]. The follow-up was 1 year for all operated joints.
Microbiological data on the pathogens causing PJIs were collected
from the electronic records of the microbiology laboratory.
Statistical analysis
All data analyses and management were performed using SPSS
forWindows 23.0 statistical software package. Categorical variables
were compared with chi-square test and continuous variables (age)
with Student's independent-samples t-test. A value of p <0.05 was
considered statistically signiﬁcant.
The association between preoperative antibiotic use and the
outcome (PJIs and all infections separately) was ﬁrst examined
using univariate logistic regression analysis, and odds ratios and
95% conﬁdence intervals (CI) were calculated. Then, a multivariable
model was developed to account for possible confounding factors.
Patients' gender, operated joint, age, BMI, use of cement in the
operation, indication for surgery (osteoarthritis, rheumatic disease,
previous trauma, and other reasons), and chronic diseases (chronic
heart disease, chronic lung disease, diabetes, hypertension, malig-
nancy, neurological or psychiatric disorder, and rheumatic disease)
were all included in the model. Patients with the use of antibiotics
with potential activity against staphylococcal species (i.e.
amoxicillineclavulanate, cephalosporins, clindamycin, ﬂuclox-
acillin, ﬂuoroquinolones, macrolides, tetracyclines, trimethoprim,
and trimethoprim/sulfamethoxazole) [20] were examined
separately.
Propensity scores were calculated using variables associated
with preoperative antibiotic use (p <0.05, Table 1). Patients were
matched using nearest neighbour matching with calliper width
0.02 (0.2 of the standard deviation of the logit of the propensity
score) resulting in 4106 matched pairs. A logistic regression anal-
ysis was performed also in the matched patient population.
Results
In total, there were 23 171 primary joint replacements per-
formed for 17 562 patients. Table 1 shows the general character-
istics of the study population. During the 1-year follow-up, 158 PJIs
occurred in the study population (incidence 0.68%). Overall, 490
surgical site infections (2.11%) were identiﬁed.
Table 1
Characteristics of patients with and without preoperative oral antibiotic use
Patient characteristic Patients with
antibiotic use
(n ¼ 4106)
Patients
without
antibiotic use
(n ¼ 19 065)
p
n % n %
Male gender 1324 32 7486 39 <0.001
Age, years, mean (SD) 66 (11) 67 (11) 0.20
Knee location 2383 58 10 588 56 0.003
BMI, mean (SD) 29.7 (5.3) 29.2 (5.1) 0.001
Known MRSA-carrier 16 0.4 46 0.2 0.10
Rural living location 493 12 2649 14 0.001
Chronic diseases
Chronic heart diseasea 1577 38 6241 33 <0.001
Chronic lung disease 375 9 1140 6 <0.001
Diabetes 414 10 1463 8 <0.001
Hypertension 1285 31 5031 26 <0.001
Malignancy 182 4 625 3 <0.001
Neurological or psychiatric
disorderb
180 4 687 4 0.02
Rheumatic disease 264 6 948 5 <0.001
Osteoarthritis as the indication
for operation
3740 91 17 265 91 0.29
Use of cement in the operation 3123 76 14 287 75 0.17
a Includes chronic heart failure, chronic coronary disease and arrhythmias.
b Includes Parkinson's disease, epilepsy, Alzheimer's disease and psychotic
disorders.
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In total, 4106 (18%) of the joint replacements were preceded by
one or more courses of oral antibiotics within 90 days before the
operation. In 989 (4.3% of the study population) cases, there were
two or more antibiotic courses. The median number of days be-
tween the joint replacement and the antibiotic course was 30
(Fig. 1). The most commonly used antibiotics were ﬁrst-generation
cephalosporins, penicillin, and pivmecillinam (Table 2). In total,
there were 5741 packages of antibiotics purchased preoperatively,
giving an antibiotic consumption of 2.75 packages per 1000 pa-
tients per day.
The incidence of PJI was 0.29% (12/4106) for patients with pre-
operative oral antibiotic use and 0.77% (146/19 065) for patients
without antibiotics. A preoperative oral antibiotic course was asso-
ciated with a decreased risk for subsequent PJI (Table 3). Also, in the
propensity matched patient population, the risk for PJI was also
lower for patients with antibiotic use (OR 0.34, 95% CI 0.18e0.65).
The results were similar when antibiotic use within 30 days was
considered: the incidence of PJI was 0.19% (4/2066) for patients with
antibiotic use and 0.73% (154/21 105) for those without.
Of the twelve cases of PJI with preoperative oral antibiotic
use, six were early infections, occurring within 30 days from the
joint replacement. Overall, 34% (54/158) of the PJIs were early
infections. The organism causing the PJI was identiﬁed in ﬁve
cases with preoperative antibiotic use: in two cases it was
Staphylococcus aureus, in two cases a coagulase-negative staph-
ylococcus and one case was polymicrobial (a coagulase-negative
staphylococcus and Enterococcus faecalis) (Table S2). The
remaining cases (7/12, 58%) were culture-negative. On the other
hand, 16% (23/146) of the PJIs in patients without antibiotic use
were culture-negative.
When superﬁcial infection cases were also included in the
analysis, preoperative antibiotic use did not affect the overall risk
for surgical site infection: the incidence was 1.90% (78/4106) for
patients with antibiotic use and 2.16% (412/19 065) for patients
without antibiotic use (OR 0.88, 95% CI 0.69e1.12).
No single antibiotic agent or antibiotic group reduced the risk
for PJI statistically signiﬁcantly (Table 2). However, when compared
with patients without antibiotic prescriptions, the risk for PJI was
lower for patients with anti-staphylococcal antibiotics (OR 0.34,
95% CI 0.16e0.72), but not for patients with the use of other anti-
biotics (OR 0.46, 95% CI 0.19e1.13).
A lower incidence of PJI for patients with antibiotic use was
observed also when the analyses were repeated in the subgroups of
hip and knee joint replacements, operations with and without the
use of cement, patients with osteoarthritis as the indication for
surgery, and the year of operation (Table S3). Statistically signiﬁcant
differences, however, were not always observed due to insufﬁcient
statistical power.
Fig. 1. The time difference (in days) between the joint replacement surgery and the date of purchase of the antibiotic course received closest to the surgery.
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Discussion
This large study shows that the use of oral antibiotics before
elective joint replacement surgery is common. Also, the use of
antibiotics preoperatively is associated with andmay have an effect
on the subsequent risk for periprosthetic joint infection.
In this study population, almost one ﬁfth of the patients had
received oral antibiotics within three months before surgery. The
use of oral antibiotics prior to joint replacement surgery has hardly
been studied. In a Swedish study [5], 25% of the patients coming for
elective joint replacement had received antibiotics within 6months
before surgery, a number similar to the present study. This study
indicates that patients having elective joint replacement seem to
receive more antibiotics than the general population. According to
European Centre for Disease Prevention and Control, the overall
antibiotic consumption in Finland has been about two packages per
1000 inhabitants per day in the recent years [21], whereas in this
study the number was 2.75 packages per 1000 patients per day.
The incidence of PJI was lower among patients with preopera-
tive oral antibiotic use than among patients without antibiotic use.
The effect of oral antibiotic use on the risk for PJI has not been
studied before and thus this is a novel ﬁnding. Treatment of active
infections before joint replacement surgery is recommended [2] to
prevent haematogenous spread to the replaced joint post-
operatively from non-treated infection sites. However, treatment of
active infections should decrease the risk for PJI to the level of the
general population, but not offer any additional prophylactic pro-
tection. Furthermore, active infections would probably lead to
delaying the surgery.
Preoperative oral antibiotic use could possibly reduce the fre-
quency of Staphylococcus aureus carriage. Supporting this view, the
current study indicates that especially the use of staphylococcal
antibiotics seemed to reduce the incidence for PJI. It has been
estimated that 25% to 40% of the population are nasal carriers of
Staphylococcus aureus [6,10], and similar numbers have been found
among patients with joint replacement surgery [5,8]. In addition,
nasal carriage of S. aureus is an independent risk factor for subse-
quent surgical site infection after joint replacement surgery [22]
and different preoperative decolonization regimens have been
proposed, including nasal mupirocin ointmentwith or without skin
decolonization [6]. In a systematic review, Chen et al. [8] found that
surgical site infection rates could be reduced by 13% to 200% with
decolonization programmes [8]. However, most of the studies
included in the review involved only patients, who screened pos-
itive for S. aureus. On the other hand, Sousa et al. found in a small
randomized controlled trial that decolonizationwas not effective in
reducing the rate of PJI [23], and the international consensus
statement on PJIs does not recommend universal screening and
decolonization of patients undergoing joint replacement surgery
[2]. Unfortunately, there is no information on the rate of S. aureus
carriage in the present study population and therefore the effect of
the use of oral antibiotics on the risk of PJI in relation to the carriage
rate could not be examined.
On the other hand, it has been proposed that oral antibiotics
may not reach sufﬁcient concentrations in the nares for adequate
decolonization [12]. Nevertheless, studies on MRSA colonization
have shown that carriage of S. aureus outside the nasopharynx is
also common [24,25], even though the role of oral antibiotics in
reducing carriage in non-nasal sites is unclear. Furthermore, it is
unclear how long the potential effect of oral antibiotics in S. aureus
decolonization could last. In a study conducted among children
with skin infections and S. aureus colonization, oral antibiotics
reduced the carriage rate by half for up to 50 days after the course of
antibiotics [26].
Another possible mechanism for action for the antibiotics could
be that the patients had ‘hidden’ infections that were treated, but
this seems unlikely. For example, treating bacteriuria with antibi-
otics has been shown to be ineffective in the prevention of PJI in the
same study population [16].
There are some limitations to this study. Firstly, the indications
for the antibiotics were not known, nor who had prescribed the
antibiotics. As the dosage of the antibiotics was not registered,
antibiotic consumption rates based on deﬁned daily doses could
not be evaluated, but information on the number of pills purchased
was available. Nevertheless, as all antibiotic purchases are recorded
in the national register, patients' use of antibiotics could be evalu-
ated comprehensively. Secondly, antibiotics given in hospitals
could not be identiﬁed. However, it can be assumed that this
number is fairly low, since the joint replacement surgery would
have been most likely postponed if the patient had required
treatment for an infection in a hospital setting. Thirdly, there could
be a so-called ‘healthy patient bias’, where healthier patients are
more prone to take care of themselves and perhaps seek medical
attention more readily, thus potentially receiving antibiotics more
easily than others. However, the characteristics and distribution of
chronic diseases of patients with and without antibiotic use were
similar, and the effect of chronic diseases could be considered
extensively. Finally, it is possible that the association between oral
antibiotic use and lower risk for PJI could be caused by some un-
known confounding factors that could not be identiﬁed in the
analysis. Nevertheless, the effect of many known risk factors for PJI
could be taken into account and the results remained the same also
in the propensity score-matched patient population.
While this study indicates that preoperative antibiotic use is
associated with a lower rate of PJI, the use of oral antibiotics as
prophylaxis cannot be recommended, unless there are active in-
fections, due to potential harms, such as the increased risk for
Clostridioides difﬁcile infections and incidence of resistant bacterial
strains. For example, Cheng et al. have shown that the use of non-
Table 2
The numbers of primary joint replacement operations preceded by different groups
of antibiotics 90 days before surgery and their effect on the risk for periprosthetic
joint infection (PJI)
Antibiotic group Number of operations
preceded by antibiotic
use
Effect of
antibiotic on the
risk for PJI in the
univariate
analysis
N % of all operations OR 95% CI
First-generation cephalosporins 984 4.2 0.29 0.07e1.16
Penicillin 693 3.0 0.41 0.10e1.67
Pivmecillinam 571 2.5 0.51 0.13e2.05
Amoxicillin 544 2.3 0.53 0.13e2.15
Fluoroquinolones 500 2.2 0.58 0.14e2.35
Tetracyclines 424 1.8 NAa NA
Macrolides 374 1.6 0.78 0.19e3.16
Trimethoprim 303 1.3 NAa NA
Amoxicillin-clavulanate 182 0.8 NAa NA
Clindamycin 146 0.6 1.01 0.14e7.23
a There were no PJIs in this group.
Table 3
The effect of preoperative oral antibiotic use on the risk for developing a PJI
Univariate
analysis
Multivariable
analysis
OR 95% CI OR 95% CI
Antibiotic use 30 days preoperatively 0.26 0.10e0.71 0.24 0.08e0.77
Antibiotic use 90 days preoperatively 0.38 0.21e0.69 0.40 0.22e0.73
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MRSA antibiotics increases the rate of nasal MRSA carriage [27]. In
addition, even if used, the current study shows that the number
needed to treat (NNT) with preoperative oral antibiotics to prevent
one case of PJI would be high (NNT 211).
In conclusion, the use of oral antibiotics before elective joint
replacement surgery is common and it may affect the subsequent
risk for PJI, perhaps due to a reduced rate of S. aureus carriage.
Further studies are needed in order to evaluate the signiﬁcance of
this novel result. Meanwhile, indiscriminate use of antibiotics
before elective joint replacement surgery cannot be recommended,
whereas treatment of active infections remains important in the
prevention of surgical site infections.
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Periprosthetic Joint Infections as a Consequence of 
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Background. The risk for developing a periprosthetic joint infection (PJI) during bacteremia is unclear, except for Staphylococcus 
aureus bacteremia. The aim of this study was to examine the risk for developing a PJI during bacteremia and to identify possible risk 
factors leading to it.
Methods. Patients with a primary knee or hip joint replacement performed in a tertiary care hospital between September 2002 
and December 2013 were identified (n = 14 378) and followed up until December 2014. Positive blood culture results during the 
study period and PJIs were recorded. PJIs associated with an episode of bacteremia were identified and confirmed from patient 
records. Potential risk factors for PJI among those with bacteremia were examined using univariate logistic regression.
Results. A total of 542 (3.8%) patients had at least 1 episode of bacteremia. Seven percent (47/643) of the bacteremias resulted 
in a PJI. Development of a PJI was most common for Staphylococcus aureus (21% of bacteremias led to a PJI) and beta-hemolytic 
streptococci (21%), whereas it was rare for gram-negative bacteria (1.3%). Having ≥2 bacteremias during the study period increased 
the risk for developing a PJI (odds ratio, 2.29; 95% confidence interval, 1.17–4.50). The risk for developing a PJI was highest for 
bacteremias occurring within a year of previous surgery. Chronic comorbidities did not affect the risk for PJI during bacteremia.
Conclusions. The development of a PJI during bacteremia depends on the pathogen causing the bacteremia and the timing of 
bacteremia with respect to previous joint replacement surgery. However, significant patient-related risk factors for PJI during bac-
teremia could not be found.
Keywords. bacteremia; prosthetic joint infection; risk factors; Staphylococcus aureus; streptococci.
Hematogenous periprosthetic joint infections (PJIs) are due 
to hematogenous spread from another infection site and can 
occur at any time after joint replacement surgery [1, 2]. Late 
PJIs are usually hematogenous, but there is no consensus on 
the definition of late PJI. According to the traditional defi-
nition by Coventry et  al., they occur 2  years after surgery or 
later [3]. However, other studies have used time limits from 
3 [4] to 12 months [5]. Late acute PJIs are also characterized 
by an asymptomatic postoperative period before the onset of 
symptoms of infection. The proportion of late hematogenous 
PJIs has been estimated to be 13%–27% of all PJIs [6–10], 
whereas the overall incidence of late PJIs is around 0.25%–0.7% 
[5, 6, 8, 9, 11, 12] or 0.069% per prosthesis-year [10].
The origin of hematogenous PJIs can be from the skin and 
soft tissues, urinary tract, dental sources [4, 5], cardiovas-
cular system [13], lungs [11], or the gastrointestinal tract [14]. 
Although most PJIs are caused by either coagulase-negative 
staphylococci or Staphylococcus aureus, hematogenous PJIs 
are mostly caused by S.  aureus, followed by streptococci and 
gram-negative bacteria [1, 2, 15–17].
According to previous studies, 25%–40% of patients with 
Staphylococcus aureus bacteremia (SAB) and a joint replace-
ment develop a hematogenous PJI [18–22]. The presence of 3 
or more joint replacements increased the risk for PJI consid-
erably during SAB in 1 study [21], but other studies have not 
been able to show patient-related risk factors for developing a 
PJI during SAB [20]. The risk for developing a PJI during bacte-
remia caused by other pathogens is unclear, as most reports on 
PJIs during bacteremia have been case studies [23–26]. Uçkay 
et al. reported a PJI rate of 6% in patients with any bacteremia 
[14]. Risk factors for developing a PJI during any bacteremia 
have not been studied.
The aim of this study was to examine the risk for developing 
a PJI during bacteremia caused by different pathogens and to 
identify possible risk factors leading to it.
METHODS
This is a retrospective study that was performed at the Coxa 
Hospital for Joint Replacement, Tampere, Finland. Patients 
from Pirkanmaa Hospital District (population ca. 500  000 
inhabitants) who had a primary knee or hip replacement 
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performed between September 2002 and December 2013 at the 
hospital were identified from the hospital database (see Figure 
1 for a description of the study patients). Patients could have 
had additional primary hip and knee replacements (performed 
elsewhere or before the study period), but information on these 
was not available. The follow-up period for each patient was 
from the date of the first joint replacement surgery during the 
study period to the date of death or December 31, 2014, which-
ever occurred first. According to national legislation, patient in-
formed consent was not required due to the retrospective design 
of the study. Institutional permission to conduct this study was 
granted by the authorities responsible for the patient records.
All positive blood culture results of the study patients 
occurring after the primary surgery until December 31, 
2014, were obtained from the electronic records of the ac-
credited microbiology laboratory of Tampere University 
Hospital. Positive blood cultures caused by coagulase-negative 
staphylococci, corynebacteria, micrococci, or Cutibacterium 
species were considered significant only if there was growth 
on 2 blood culture bottles (n = 28); otherwise, they were de-
fined as contaminants (n  =  89). Positive blood cultures by 
other pathogens were considered significant regardless of the 
number of positive culture bottles. All consecutive positive 
blood cultures with the same organism taken within 7 days of 
the first positive sample were considered part of the same epi-
sode of bacteremia.
PJI cases were identified from 6 different data sources: 
(1) prospective surveillance data from the national Finnish 
Hospital Infection Program of the National Institute of Health 
and Welfare, (2) postdischarge surveillance data gathered by 
an infection control nurse, (3) positive bacterial cultures of 
joint aspirates or tissue cultures from samples taken at the 
Coxa Hospital for Joint Replacement, (4) hospital discharge 
records with a diagnosis code of PJI (ICD-10 diagnosis code 
T84.5 or T81.4), (5) local joint replacement database records 
on revision arthroplasties performed due to PJI, and (6) Coxa’s 
own infection register. A  detailed description of these data 
sources can be found in a previous study of the patient pop-
ulation [27]. If the PJI occurred in a joint that was replaced 
outside of the study period (n = 4), it was not included in the 
analyses (but the patients remained in the study cohort, as 
they had other joints replaced at the Coxa hospital during the 
study period).
Patients with the same organism cultured from blood and 
from the affected joint were considered to have a PJI as a 
consequence of bacteremia. Cases where the PJI was deter-
mined to be the source of the bacteremia, based on the timing 
of symptom onset, were identified from the patient charts 
(n  =  9) by 1 of the authors (M.H.) and were not included 
in the analyses. If the patient had a culture-negative PJI and 
bacteremia, patient charts were also reviewed. If the treating 
clinicians considered the PJI to be caused by the pathogen 
identified in the blood culture, it was recorded as such. Also, 
patient charts of patients who had a long duration (>7 days) 
between the positive blood culture and identification of the 
PJI were checked to verify the association.
Information on patients’ chronic diseases (diabetes, rheu-
matic diseases, chronic heart failure, chronic coronary disease, 
arrhythmias, and chronic lung disease) was gathered from the 
drug reimbursement register of the Social Insurance Institution 
of Finland. For the statistical analyses, chronic heart failure, 
chronic coronary disease, and arrhythmias were grouped to-
gether (chronic heart disease). Information on body mass 
index (BMI), indication for joint replacement surgery, use of 
(antibiotic-impregnated) cement in the surgery, and date of 
death was gathered from Coxa’s electronic database.
14 378 patients with a
primary knee or hip
joint replacement in
the Coxa hospital
13 747 patients with no bacteremia
631 patients with a
positive blood culture
89 patients with only contaminants in the
blood culture(s)
542 patients with
signiﬁcant bacteremias
467 patients with bacteremia, but no PJI
17 patients with a PJI not associated with
bacteremia
9 patients with bacteremia due to a primary
PJI
4 patients with a PJI during bacteremia in a
joint operated in another hospital
45 patients with a PJI (in a joint operated in
the Coxa hospital) during an episode of
bacteremia
Figure 1. Description of the study patients. Abbreviation: PJI, periprosthetic joint 
infection.
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Statistical Analysis
All data analyses and management were performed using the 
SPSS for Windows 25.0 statistical software package.
The incidence of bacteremia and PJI was calculated as the in-
cidence rate per 1000 person-years. Incidence of PJI as a con-
sequence of bacteremias caused by different pathogens was 
calculated. Means or medians were calculated for continuous 
variables with a normal or skewed distribution, respectively.
The association between different potential risk factors 
(number of bacteremias, BMI, male gender, knee location, 
time since previous joint replacement surgery, age, indication 
for joint replacement surgery, use of cement in the operation, 
and chronic diseases) and the development of a PJI during bac-
teremia were examined for each joint separately. If the patient 
had multiple bacteremias during the study period, each was in-
cluded in the analyses separately when analyzing the effect of 
age and time since previous joint replacement surgery on the 
risk for PJI. Potential risk factors were analyzed using binary 
logistic regression with univariate analysis, and odds ratios and 
95% confidence intervals were calculated.
RESULTS
There were 14 378 patients with a primary knee or hip joint re-
placement performed during the study period. Of these, 4475 
patients had more than 1 primary joint replacement. A  total 
of 1346 patients had a revision arthroplasty performed during 
the study period. The mean follow-up time (range) was 6.0 
(0–12) years.
During the study period, 542 (3.8%) patients had at least 1 ep-
isode of bacteremia after the primary joint replacement surgery, 
and 85 (0.6%) patients had more than 1 bacteremia. The max-
imum number of separate episodes of bacteremia per patient 
was 8 (1 patient). In total, there were 643 episodes of bacteremia. 
The incidence rate of bacteremia was 7.4 per 1000 person-years. 
The bacteremias occurred 3–4285 days after the first joint re-
placement operation (median, 1460 days); 13% occurred within 
1 year (85/643) and 4% within 3 months (27/643). Escherichia 
coli was the most common causative pathogen (241/643, 37% 
of bacteremias). The distribution of pathogens causing the 
bacteremias is shown in Table 1.
There were in total 288 PJIs, and the incidence rate was 
3.3 per 1000 person-years. Of the infections, 131 (45%) were 
early infections occurring within 90 days of the previous sur-
gery, 53 (18%) occurred within 3–12 months, and 104 (36%) 
occurred after 1 year. The distributions of the PJIs over time 
for patients with and without bacteremia are shown in Figure 
2A and B.
Of the episodes of bacteremia, 7% (46/643) resulted in a 
PJI (Table 1). One of these was a bilateral knee infection. Of 
the PJIs during bacteremia, 29 (62%) were in the knees and 
18 (38%) in the hips. Seven PJIs occurred after revision joint 
replacement. One patient had 2 separate PJIs associated with 
different episodes of bacteremia. Thus, 45/542 (8%) patients 
with 1 or more episodes of bacteremia developed a PJI. The du-
ration between the first positive blood culture and identification 
of the PJI ranged from 0 to 512 days (median, 2 days). There 
were 10 (21%) PJIs where the pathogen could not be identified 
from the affected joint, but these were considered to be caused 
by the pathogen identified in the blood culture. In most cases, 
these patients had received antibiotics before taking the samples 
for bacterial culture from the joint.
The development of a PJI during bacteremia varied be-
tween different pathogens (Table 1). It was most common for 
Staphylococcus aureus, beta-hemolytic streptococci, and viridans 
group streptococci, but rare for gram-negative bacteria and 
coagulase-negative staphylococci; 1.3% of bacteremias caused by 
gram-negative bacteria resulted in a PJI. There were 11 PJIs as a 
consequence of bacteremia that occurred within 3 months of the 
previous surgery. These infections were caused by Staphylococcus 
aureus (n = 3), viridans group streptococci (n = 2), Streptococcus 
agalactiae (n  =  2), Clostridium perfringens (n  =  2), Klebsiella 
terrigena (n = 1), and group G streptococcus (n = 1).
Having more than 1 bacteremia during the study period 
increased the risk for developing a PJI (Table 2). Also, the risk for 
developing a PJI was higher for bacteremias occurring less than 
a year after the previous surgery than for bacteremias occurring 
later. Gender, obesity (BMI ≥  25), operated joint (hip, knee), 
indication for primary surgery, use of antibiotic-impregnated 
cement for prosthesis fixation, and chronic diseases did not 
Table 1. Distribution of Pathogens Causing Bacteremia and PJIs 
Developed During Bacteremias
Pathogen 
Total No. of 
Bacteremias 
(n = 643)
No. of 
Bacteremias 
With a PJI 
(n = 46)
No. % No. %
Escherichia coli 241 37 3 1
Staphylococcus aureus 105 16 21a 20
Beta-hemolytic streptococci 58 9 12 21
Streptococcus pneumoniae 43 7 2 5
Coagulase-negative staphylococci 28 4 0 0
Enterococci 28 4 1 4
Klebsiella species 27 4 1 4
Viridans group streptococci 25 4 4 16
Other gram-negative bacteriab 46 7 0 0
Anaerobes 20 3 2 10
Yeasts 3 0.5 0 0
Otherc 12 2 0 0
Polymicrobial 7 1 0 0
Abbreviation: PJI, periprosthetic joint infection.
aIncludes 1 bilateral infection, which is counted as 1.
bIncludes enterobacteriae, Pseudomonas species, Proteus species, Morganella morganii, 
Citrobacter species, Haemophilus inﬂuenzae, Serratia marcescens.
cIncludes lactobacilli, Listeria monocytogenes, Actinobaculum schaalii, Aerococcus urinae, 
Arcanobacterium pyogenes, Granulicatella adiacens.
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affect the risk of developing a PJI as a consequence of bacte-
remia (Table 2). Older age was associated with a lower risk of 
developing a PJI, but when the effect of bacteremias caused by 
E. coli was taken into account in a multivariable analysis, the ef-
fect of patients’ age was no longer statistically significant (odds 
ratio, 0.97; 95% confidence interval, 0.95–1.00).
DISCUSSION
This study shows that development of a PJI as a consequence of 
bacteremia is highly dependent on the type of pathogen causing 
the bacteremia. The risk was the highest in bacteremias caused 
by Staphylococcus aureus, beta-hemolytic streptococci, and 
viridans group streptococci and was associated with repeated 
episodes of bacteremia. On the other hand, the development 
of a PJI during bacteremia caused by gram-negative bacteria, 
especially E.  coli, and coagulase-negative staphylococci, was 
rare. Patients with a bacteremia occurring within 1 year of pre-
vious surgery had a higher risk of developing a PJI than those 
with bacteremias occurring later.
In the current study, 7% of the episodes of bacteremia resulted 
in the development of a PJI, corresponding to the rate described 
by Uçkay et  al. [14]. In their study, 6% (5/81) of bacteremias 
resulted in a PJI. Other studies examining the risk of developing 
a PJI during SAB [18–22] have reported slightly higher rates 
than in the current study. Uçkay et al. reported a rate of 2.9% 
for PJI during bacteremia caused by E. coli, 14% for SAB, and 
40% for anaerobic bacteremia, but the number of PJIs as a con-
sequence of bacteremia was so small (n = 5) that it is difficult to 
make meaningful conclusions from the results. No other studies 
have examined the risk of developing a PJI during bacteremia 
caused by pathogens other than S. aureus.
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Figure 2. A, The distribution of periprosthetic infections over time in patients without bacteremia. B, The distribution over time of periprosthetic joint infections as a con-
sequence of bacteremia.
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Interestingly, the risk of PJI was similar for bacteremias caused 
by Staphylococcus aureus and beta-hemolytic streptococci. 
However, it is not surprising, as streptococci have been reported 
to cause a considerable proportion of late hematogenous PJIs 
[1, 2, 16]. On the other hand, there were no PJIs during bacte-
remia caused by coagulase-negative staphylococci, even though 
they are significant pathogens that cause PJIs [1]. Coagulase-
negative staphylococcal bacteremias are mostly nosocomial 
[28], and it has been shown that nosocomial SABs are not as-
sociated with PJIs [20, 21], making it likely that this is the case 
for coagulase-negative staphylococci as well. Unfortunately, the 
differentiation between community-acquired and nosocomial 
bacteremias was not possible in this study. Despite the com-
monness of urosepsis caused by E. coli, especially in the oldest 
age groups, it rarely leads to the development of a PJI. Thus, 
patients with bacteremia caused by gram-negative bacteria do 
not warrant the special attention with respect to the develop-
ment of a PJI paid to those with bacteremias caused by S. aureus 
or beta-hemolytic streptococci.
This study demonstrates that viridans group streptococci can 
lead to the development of a hematogenous PJI, even though 
the absolute number was low. These bacteria are associated with 
dental or gastrointestinal sources [29, 30]. Unfortunately, due 
to the retrospective nature of the current study, patients’ dental 
status or previous dental procedures with or without antibiotic 
prophylaxis could not be evaluated, and thus conclusions on the 
risk for PJI after dental procedures could not be made.
No patient-related risk factors for the development of a PJI 
during bacteremia, such as chronic diseases, could be identified, 
and this has been the case in previous studies as well [14, 20]. 
However, having more than 2 bacteremias during the study 
period increased the risk of developing a PJI during bacteremia. 
This possibly reflects some unidentifiable factor that increased 
patients’ susceptibility to infection in general. Patients’ use of 
immunosuppressive medication was not evaluated, but rheu-
matic diseases did not increase the risk for developing a PJI 
during bacteremia, nor did diabetes. An important observation, 
instead, is that the risk for developing a PJI as a consequence of 
bacteremia was highest for bacteremias occurring within 1 year 
of previous surgery. Large studies have shown that the overall 
risk of developing a PJI is highest for the first 2 years after sur-
gery [7–9], and this is probably partly due to the increased risk 
for hematogenous PJIs. On the other hand, in a study by Rakow 
et  al., most of the hematogenous PJIs occurred after 2  years 
from primary surgery [13].
There are some limitations to this study. First, some of the 
patients could have had joint replacement surgery performed 
elsewhere, before the study period began, and thus all prosthetic 
joints at risk for infection could not be identified. In addition, 
there might have been other patients in the Pirkanmaa hos-
pital district with joint replacements inserted at other hospitals 
who developed PJIs during bacteremia, but they could not 
be identified, and this might have resulted in lower incidence 
numbers. However, as the number of patients with surgery 
performed elsewhere was probably not very high, its effect can 
be assumed to be insignificant. Second, due to the retrospective 
nature of this study, some of the data, such as dental procedures, 
were not available. To avoid other limitations related to retro-
spective data collection, such as missing PJI cases, multiple data 
sources were used. In addition, the source of bacteremia could 
not be investigated, and differentiation between recurrent and 
relapsing bacteremia was not possible in cases with multiple 
Table 2. Potential Risk Factors for Developing a Periprosthetic Joint Infection During Bacteremia
Risk Factor 
Joints With PJI 
(n = 47)
Joints Without 
PJI (n = 672)
Odds Ratio 95% Conﬁdence Interval No. % No. %
No. of bacteremias ≥2 13 28 96 14 2.29 1.17–4.50
BMI ≥25 kg/m2 38 81 473 70 1.82 0.70–4.72
Chronic lung disease 3 6 33 5 1.32 0.39–4.48
Chronic heart disease 6 13 72 11 1.22 0.50–2.97
Male gender 21 45 276 41 1.16 0.64–2.10
Knee joint 29 62 398 59 1.11 0.60–2.04
Time since previous joint replacement, ya       
 <1 17 36 94 12 1.00  
 1–10 28 60 672 85 0.23 0.12–0.44
 >10 2 4 24 3 0.46 0.10–2.13
Age at the time of bacteremia, mean (SD),a y 71 (11) 76 (10) 0.97 0.94–0.99
Rheumatic disease 3 6 59 9 0.71 0.21–2.35
Diabetes 5 11 103 15 0.66 0.25–1.70
Primary osteoarthritis as indication for primary joint replacement 43 92 588 88 0.65 0.23–1.86
Use of antibiotic-loaded cement in the primary operation 35 74 555 83 0.59 0.30–1.17
Abbreviations: BMI, body mass index; PJI, periprosthetic joint infection.
aCalculated for each bacteremia and joint (n = 837) separately.
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episodes of bacteremia. Third, it is impossible to say with ab-
solute certainty whether all PJIs attributed to bacteremia were 
truly so, but patient charts were reviewed carefully to minimize 
this error. The pathogens causing the early PJIs during bacte-
remia were not typical pathogens causing primary PJIs, thus 
supporting the fact that these PJIs were truly consequent to the 
bacteremia. Finally, as there was a limited follow-up period for 
each joint (maximum 12 years), PJIs as a consequence of bacte-
remia occurring after the study period were missed, thus poten-
tially affecting the incidence numbers.
In conclusion, this large study shows that the type of path-
ogen, history of infections, and timing of bacteremia should 
be taken into account when evaluating the risk of PJI in a pa-
tient with bacteremia. Developing a PJI during an episode of 
bacteremia caused by Stapylococcus aureus or beta-hemolytic 
streptococci is fairly common, and viridans group streptococci 
can lead to PJIs during bacteremia. This should be taken into 
account when a patient with a joint replacement presents with 
bacteremia caused by these agents, especially during the first 
postoperative year. Although diabetes, rheumatoid arthritis, 
and chronic heart and lung diseases did not affect the risk of PJI, 
there is possibly some unknown factor that increases patients’ 
susceptibility to infection in general and thus also to developing 
a PJI during bacteremia.
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